20|20 OptimEyes Technologies is a biotechnology spin-out company from McMaster University located in Hamilton, Ontario, Canada. We are developing a transformative drug delivery platform for ocular diseases normally controlled by eye drops.
Using a patent technology formulation, initially targeted for dry eye disease, we are able to change the dosing paradigm from twice daily to once or twice weekly. This will revolutionize treatment for patients, improving their comfort, compliance and clinical outcomes.
Enter Able Innovations, which has built a robotic medical device designed to address the problem of patient transfer, called the ALTA Platform.
Today, transfers require 2+ staff to exert back-breaking effort resulting in injuries, burnout, and added burden. Able’s robotic technology enables a single caregiver to conduct safe and automated transfers – transforming how healthcare is delivered.
Able Innovations’ mission to automate patient transfer has been manifesting for years. As Jayiesh Singh volunteered in long-term-care, he witnessed how unhappy patients and staff felt after patient transfer. Philip Chang then experienced the struggles of patient transfer first-hand when he was admitted into a healthcare facility for a prolonged period of time. Following the co-founders’ unique journeys, they arrived at the same conclusion; the status-quo of patient transfers is unsustainable.
Ably is working closely with users from across the hospital environment – physicians, nurses, service staff and patients – to ensure the design meets their specific needs and expectations. This collaboration lead us to our first idea: transforming the traditional hospital bed into a dynamic and intelligent bed that could mobilize and monitor patients at the same time that it uses cutting edge machine learning technology
In 2020, while developing our monitoring technology for the bed, we had a breakthrough that made it hard to not change our path. We saw the value a no-touch continuous monitoring system could have and decided we could not wait for the bed to finish and are therefore presenting Lyng as our first product.
Lyng enables continuous, non-intrusive monitoring of multiple patient status markers. These include: heart rate, respiration rate, blood pressure, and movement patterns. The first generation will be CE-marked and market ready in 2022.
The Accelerator Centre is an award-winning startup accelerator dedicated to building and scaling sustainable, globally competitive companies and giving startups the highest probability of long-term success.
We are ranked the #1 private business accelerator in Canada and are among the World Top 5 due, in part, to our reputation for meaningful, one-to-one mentorship and helping entrepreneurs go from the idea stage to high-growth enterprises.
AceAge Inc. is a healthcare technology company, creating intuitive products to ease the aging process and improve health outcomes.
Our product Karie is a personal health companion that organizes, schedules, and dispenses pills with one-button technology, ensuring that patients are taking the right medication at the right time. Karie is easy to use, enables greater patient autonomy and ensures better healthcare through a highly coordinated program.
In addition to the release of Karie in 2019, AceAge has been working on various other initiatives, including our I2P2 study with CABHI and the implementation of applied facial recognition.
Activation Laboratories Group (Actlabs) is a global company with a local presence. The Actlabs Group of Companies provides contract analytical services covering all aspects of analysis from academic research applications to routine quality control functions.
We provide our services to many fields, including Pharmaceutical & Clinical, Environmental & Occupational Health, Agricultural and Materials Testing areas.
We provide contract analytical services to a variety of market segments. The Life Sciences Division was established in 2003 and has evolved to offer a full suite of developmental, CMC and research laboratory services for the Life Sciences market. Clients include Pharmaceutical, Biotech, NHP, Medical device and Cosmetic companies world-wide.
The ISO 17025 accredited and Health Canada licensed GMP laboratories have also been inspected by FDA several times. Actlabs prides itself on being Technology Pioneers and were awarded an Innovationaward by the Federal Government in 2009. Drawing from their expertise in the fields of pharmaceutical analytics, biotechnology analytics and agriculture testing, their Life Sciences group offers scientific expertise across many platforms. Their core vision is to concentrate on development and delivery of
novel analytical assays, bioassays and pioneering technologies in conjunction with our academic and industry partners, while meeting regulatory compliance. With over 300 employees in our headquarters in Ancaster and over 1000 world-wide, Activation Laboratories continues to deliver excellence in all markets served.
Adapsyn is a chemical bioinformatics company that discovers and develops novel bacterial metabolites for use as therapeutics
Founded in 2016, Adapsyn Bioscience is developing a next-generation bioinformatics platform devoted to discovering previously unidentified natural product drug candidates by selectively isolating new agents with the potential to interrogate difficult-to-drug phenotypes. The company applies proprietary machine learning to genomic and metabolomic data from microbes in and around us to discover new natural products encoded within microbial genomes.
Early components of the Adapsyn platform are detailed in leading scientific journals, including PNAS, Nucleic Acid Research, and the Nature and Cell Series Journals. The company has ongoing collaborations with leading pharmaceutical companies and is actively developing an internal pipeline of therapeutic candidates.
A leading research centre in metal additive manufacturing, the Additive Manufacturing Innovation Centre (AMIC) provides designers and manufacturers with a collaborative applied research environment in which to explore the technology on an industrial scale. The Centre’s focus is on supporting industrial adoption of advanced manufacturing and industry 4.0 technologies for increased efficiency and better product design.
Industry partners can access laser sintering capabilities (utilizing metal (DMLS) and plastic (SLS) powders), bound metal, fused deposition modelling (FDM), optical and scanning electron microscopy to characterize materials, and a trained research team to operate the labs and collaborate on projects. AMIC projects help industry with innovative product (re)design and development; manufacturing process optimization; and new materials development. Workshops and specialized training are also available to industry.
Adiga Life Sciences is a clinical stage company working to develop and commercialize novel therapeutic vaccines to treat a variety of allergies.
Adiga Life Sciences, Inc. is based on the McMaster Innovation Park in Hamilton Ontario and is working towards its mission by maintaining a watch over ongoing life sciences research at McMaster University and other Canadian research institutions. Adiga also has offices in the United Kingdom
Adiga seeks to identify, fund, and support the management of early stage projects that it believes may yield commercial value. We are currently involved in the development of technologies for the control of immune function in allergic and auto-immune diseases. Adiga is currently managing a number of projects in Canada.
adMare BioInnovations is Canada’s Global Life Sciences Venture, building the Canadian life sciences industry from sea to sea. We do this by sourcing therapeutically and commercially promising research from leading academic and biotech partners to create new companies of scale, providing specialized expertise, infrastructure, and capital to help existing companies scale up, and driving the growth of those companies into Canadian anchors by training the next generation of highly-qualified personnel.
With a vision is to be a catalyst for the Canadian life sciences leading the world, our mission is to:
Translate Leading Academic Research Into New Companies of Scale
Help Existing Canadian Companies Scale-up
Train the Next Generation of HQP to Drive the Growth of Companies into Strong Anchors
We are a single-stop destination with the necessary resources, including scientific and business expertise, infrastructure, and capital to drive health-related technology to a company of scale.
Affinity enables healthcare educators to build engaging learning experiences based on real-life scenarios.
The Affinity Platform enables educators to easily build dynamic online scenarios using their existing educational content. Learners can practice their knowledge acquisition, application, and critical decision-making in a simulated, web-based environment.
With a strong background in hemostasis research and a focus on reagent development, Affinity has become a primary manufacturer of more than 250 reagents and kits used in hemostasis and thrombosis research and diagnostics. Affinity Biologicals Inc. (Affinity) was founded in 1987 by the principals Hugh and Patricia Hoogendoorn.
Our product line includes: coagulation related antibodies, matched-pair antibody sets for ELISA, depleted/deficient plasmas, protease inhibitor deficient plasmas, the VisuLize™ line of complete ELISA kits and the VisuCon™ & VisuCal™ coagulation controls and calibration plasmas.
All Affinity Biologicals products are manufactured in our Ancaster, ON (Canada) facility, products are sold direct in North America and world wide through a network of branded and private-label distributors. Affinity has an ISO 13485:2003 registered Quality System and is a licensed medical device manufacturer recognized by the US Food and Drug Administration, Health Canada and European regulatory authorities (CE Mark).
At AI Endurance, we believe in a modern way of endurance training. A more personalized, scientific approach to help athletes of all skill levels unlock new potential. We’re passionate about it, and our mission is to personalize training. We specialise in artificial intelligence and we’re here to bring it to the forefront of training. We’re excited to simplify training through our program and break the mold of “one size fits all” training plans.
A Canadian startup based out of Hamilton, Ontario set to create new artificial intelligence tools for the everyday athlete. We strive to create training plans that are responsive to individual users and easy to follow.
Smart healthcare is transforming the medical field. It’s helping doctors produce more accurate patient diagnoses, predict future health, and recommend personalized treatments. Our medical diagnostics technologies offer unparalleled sensitivity and specificity. We design custom solutions that are automated, accurate, accessible, and cost-effective. Our AI algorithms for medical diagnostics are breaking new and exciting grounds, recognizing patterns and making connections between an enormous number of parameters, from medical imaging, to personalized healthcare and custom therapeutics.
We are a team of highly qualified and energetic engineers and product managers united by a common vision: to deliver meaningful, data-driven solutions to our clients. Our core competency is the design and provision of specialty hardware and software development services to innovators across a diverse range of markets.
We work together with each of our clients to develop specialized end-to-end manufacturing solutions that suit their unique requirements. By combining the best of modern computing and technology, we help our customers increase productivity, reduce cost and time through automation, and enable a safer working environment using:
Real-time data analytics
With expertise in data science and analytics, software development, manufacturing and robotics, we deliver superior quality and support ensuring your successful digital transformation.
AIMA Laboratories Inc. is a Canadian, pre-clinical FemTech Biotechnology company co-founded by two scientists who have dedicated their professional lives to researching reproductive endocrinology and infertility. Our goal is to develop new products to fill current gaps in women’s health.
Algaeneers Inc is a biopharmaceutical and biomanufacturing company with headquarters and state-of-the-art facilities in Hamilton, Ontario, Canada. Our core strength is to harness microorganisms to produce things that people care about, in gentle, sustainable, and affordable ways.
Algaeneers provides contract R&D and contract biomanufacturing services. Our clients are pharmaceutical companies, companies that utilize enzymes (e.g. fermentation companies, cleaning product companies, and companies in the food industry), and federal and academic research laboratories.
We use microalgae and other microorganisms to produce industrial enyzmes and biopharmaceuticals (including biosimilars, biosuperiors, therapeutic antibodies, and vaccines). Using the tools at our disposal, we can also produce oils with customized properties such as a coconut-like oil, with uses in the cosmetics, personal healthcare, and health food industries.
Allarta Life Science is a pre-clinical life science company developing proprietary cell encapsulation technology to enable global, cell-based cures for chronic endocrine disorders such as Diabetes, Hemophilia and Lysosomal Storage Disorders.
The Allarta team has deep expertise in polymer science, immunology, cell biology, paediatrics, biomedical engineering and preclinical research.
The technology was originally developed in Harald Stover’s research lab at McMaster University over the last 20 years with the help of major national awards including an NSERC Industrial Research Chair, an NSERC CREATE program, and multiple CFI and NSERC grants.
AllerGen NCE Inc. (AllerGen), the Allergy, Genes and Environment Network, is a national research network established in 2004 by Innovation, Science and Economic Development Canada (formerly Industry Canada) through the Networks of Centres of Excellence (NCE) program to address these growing problems.
AllerGen unites Canada’s leading experts in allergic diseases and asthma. Working in trans-disciplinary and multi-sectoral teams, and in partnership with organizations and stakeholders across sectors, AllerGen addresses gaps in knowledge and seizes opportunities to generate new preventive strategies, diagnostic tests, therapeutic approaches, medications, public policies and patient education to reduce the morbidity, mortality and socio-economic impacts of allergy, asthma, anaphylaxis and related immune diseases.
Altius Analytics Labs is a Toronto, ON-based tech company developing AI tools to enhance the efficiency and efficacy of workplace health & safety programs.
Founded by experts in Biomechanics and Computer Vision Engineering, our flagship product allows users to quickly, easily and accurately quantify job task physical demands, ergonomic/musculoskeletal injury risk and human performance using objective 3D human motion data by simply filming them with a camera.
Conduct objective physical demands analyses, ergonomic risk assessments and other work-related audits by simply taking a video. No wearable suits. No external sensors. No calibration process. Just point, film and receive accurate 3D human motion data in near-real time.
Innovative workplace safety and ergonomics professionals can enhance the efficiency and scalability of their services, and develop data-driven risk control solutions.
At Altus Assessments, we believe great professionals are more than just book smart. We deliver a robust academic admissions screening test for people skills.
Our primary tool is the online Casper test, delivered at takecasper.com. We unburden admissions departments while helping them find holistically better students. Research shows that Casper can do this more effectively than standard interviews, reference letters, and personal statements while helping widen access for disadvantaged applicants. This evidence-based approach has led to widespread adoption of Casper.
The Casper test has been used to screen over 100,000 applicants to medical school, health care programs, and teachers education, including 50% of all US Med school applicants, 70% of all Canadian Med school applicants in 2017 and all of Victoria State (Australia) Teacher Education applicants.
We are savvy investors and proven company builders who, at the core, are driven to bring the best healthcare innovations to market to help improve the lives of patients one patient at a time.
We have spent decades working with healthcare entrepreneurs to realize their vision of bringing life changing therapies to patients, while delivering superior value to investors.
Most recently, we worked together to lead healthcare venture investing at Canada’s most active venture investor, creating, building and growing globally competitive Canadian healthcare companies. This strong track record has attracted leading institutions as investors in Amplitude.
Angel One Network Inc. is a member-based not-for-profit organization of high net worth investors who live, work or have strong interests in Hamilton, Toronto, Mississauga, Oakville, Burlington, and other communities in Southern Ontario.
Our mission is to find quality companies for our Members to consider and invest in. On average, 20-30 companies are presented to the membership annually. Angel One’s membership base gives angel investors the opportunity to expand their network of like-minded investors and reduce their risk through syndication.
Arinai gives health providers and caregivers access to real-time medical translation and comprehension services. Our ultimate goal is to restore independence to patients and improve their quality of care by leveraging artificial intelligence.
The company’s objectives include simplifying medical jargon, removing language barriers, ensuring consent, providing encounter transcript and improving overall comprehension and accessibility.
Arya is a Vancouver-based startup, that produces clinical, enterprise software solutions (EHRs) for Canadian physicians and allied health professionals. We are a team of <15 clinicians, developers, and business leaders from across Canada, including Hamilton Ontario.
Our goal is simple: to make health IT simple, integrated & transparent by recruiting the best healthcare talent to create software products that put the needs of providers and patients first.
Arya EHR seamlessly integrates incoming and outgoing e-fax for convenient handling of documents. It generates automatic patient reminders, allows patient online self-booking and provides tele-health functionality for virtual visits. It is cloud-based and accessible anywhere on PC, Mac, Tablet or SmartPhone. Most importantly it does all of this while adhering to the highest standards of security and privacy
In multiple case studies of clinics converting to Arya EHR, a 50% reduction in clerical workload was observed, freeing up clerical time for more meaningful activities or reducing overall clerical hours.
Finally, Arya EHR has been built with a full backend database and analytics functionality. This enables the possibility of a high-quality data set that can drive quality improvement, answer research questions, contribute to national initiatives and inform regulatory decisions. The benefits of this cannot be understated.
Bay Area Health Care Solutions serves companies from the around the corner to around the world who are looking to benefit from the expertise of the only hospital system in Ontario providing specialty care to people throughout the entire life cycle, from pre-birth to old age.
With access to one of the largest healthcare systems in Canada, including a cancer centre and and children’s hospital, Bay Area Health Care experts provide a consultative role in the development and/or distribution of programmatic, managerial and infrastructure related health-care initiatives anywhere in the world.
At the intersection of health, life sciences and business, Bay Area Health Trust is an example of a successful partnership between hospitals and the for-profit private sector. Leveraging its unique affiliation with Hamilton Health Sciences, McMaster University and the other members of the Synapse Life Science Consortium, Bay Area Health Trust promotes entrepreneurship and invests in growth oriented businesses to support patient care.
Established in 2002, Bay Area Health Trust creates businesses and partnerships in support of our vision and mission. These enterprises provide health care related services for local and global markets. Bay Area Health Trust is constantly looking for new opportunities to generate profit to be used to support health care and health care research.
Bay Area Health Trust maintains a diverse portfolio of independent commercial business interests:
Bay Area Realty Limited predominately manages properties, buildings and leases on behalf of Hamilton Health Sciences. Its role can be owner, landlord, manager and/or liaison. Bay Area Realty has resident expertise in the life sciences and healthcare market segments. Its focus is on maximizing net operating income by minimizing vacancy and utilizing our niche turnkey services. Areas of specialization include:
Lease & contract management
Bay Area Realty is committed to providing strong supervision of all properties under its care and strives to deliver value for its stakeholders. Other services that Bay Area Realty are engaged with include:
Bay Area Records designs custom document scanning and records management solutions to help your organization or business shift to a paperless environment. We’ll save you time and money by turning paper records into digital files for uploading into electronic records systems for safe, accessible archiving.
We provide end-to-end digitization services, from project planning and box pickup to the scanning and destruction of paper records. Bay Area Records also offers secure, web-based document management and cloud-based storage solutions for your ongoing records management needs.
Established in 2003, Bay Area Records has built a reputation for superior customer service and high-quality document management in the Hamilton-Burlington-Niagara area. We work with hospitals and other clients in the health-care sector as well as researchers, universities, lawyers, architects, engineers and others who value Bay Area Records’ expertise in managing complex and sensitive medical, legal, financial, research and human resources records.
Our facility operates 24/7 and provides Bay Area Records clients with safe, secure access and round-the-clock support. We also work in partnership with Richmond Hill-based Octacom Limited, one of Canada’s leading full-service data management, automation and archiving companies. Together, we have scanned more than 150 million pages of documentation to help clients throughout the Golden Horseshoe region save money and optimize workflow processes.
Bay Area Research Logistics (BARL) is a global, clinical trial logistics organization focused on helping the global healthcare industry to successfully develop new medications and treatments.
Bay Area Research Logistics is known for its superior management of all components of clinical trial logistics – from drug procurement to blinding, packaging, labeling, storing and distribution. Bay Area Research Logistics has developed or assisted in the design and packaging for all phases of clinical trials, ranging from pilot studies through Phase IV clinical trials.
From its cGMP compliant facility in Hamilton, Ontario, Bay Area Research Logistics provides seamless coordination for large, global trials as well as small-scale INDs, specializing in the clinical supply and logistics management of clinical trials ranging from Phase I to Phase IV. Bay Area Research Logistics is the preferred vendor for vaccine, pharma, and biological trials for leading pharma companies and research institutes in North America.
As one of the leading accounting and advisory firms in Canada, BDO offers services to businesses and individuals in Hamilton and throughout Southern Ontario. BDO helps healthcare organizations of all kinds navigate risk, make informed investment decisions, and seize opportunities.
BDO provides guidance to pharmaceutical, biotech, and medical device manufacturers at every stage of development. From understanding the complexities of research and development tax credits and Health Canada and FDA regulations, to licensing agreements and due diligence, our professionals have the experience and insight necessary to navigate the world of life sciences.
Most importantly, BDO advises clients on how best to access capital, which is key to fueling innovation, research, and development efforts. Our professionals also provide a holistic perspective, helping our clients structure their operations to be as tax-efficient as possible and identifying opportunities to drive additional value.
The Biointerfaces Institute at McMaster University is a state-of-the-art facility implementing high-throughput research pipelines to investigate the nature of the biological/material interface, or biointerface.
The institute is led by Dr. John Brennan, Professor and Canada Research Chair in Bioanalytical Chemistry and Biointerfaces. Dr. Brennan is a world leader in the development of advanced sol-gel based biomaterials, biosensor technologies and high-throughput drug screening platforms.
The institute has ten additional core faculty members with expertise in high-throughput synthesis, surface characterization, polymer chemistry, bioassay development and opthalmic biomaterials, with backgrounds in Chemistry, Chemical Biology, Biochemistry, Chemical Engineering and Biomedical Engineering.
The Biomedical Zone is a physician-led, hospital-based health technology incubator in downtown Toronto. Our supportive, dynamic environment allows entrepreneurs to engage with like-minded innovators, while accessing dedicated clinical expertise and entrepreneurial resources from our partnerships with Ryerson University and St. Michael’s Hospital. The Biomedical Zone offers the resources needed to accelerate product development from early prototype stages to commercialization. Our aim is to create scalable, sustainable healthcare solutions with global reach.
The Biomedical Zone is:
An innovative collaboration space for entrepreneurs, clinicians, and scientists,
A domain of clinical immersion for entrepreneurs and biomedical innovators to advance commercial ventures, and
A conduit for clinicians and scientists to leverage entrepreneurial resources of the DMZ.
The Biostatistics Unit provides comprehensive, flexible and timely statistical support tailored to the ongoing needs of researchers affiliated with the Research Institute of St. Joe’s Hamilton and at the Faculty of Health Sciences at McMaster University.
Members of the Biostatistics Unit can provide a variety of services ranging from the beginning to the end of a study’s duration. Taking advantage of a free consultation with the Biostatistics Unit at the inception of your research study can help to ensure that your design, methodology and data collection is optimized from the beginning.
Services provided include:
Grant writing support
Study planning & study design support
Guidance with data collection methods
Data entry support
Data cleaning support
Assistance with data analysis & interpretation
Report writing & manuscript preparation
General statistical support
The Unit is happy to assist both new and established researchers performing studies in any clinical area.
Blake Medical is continually innovating medical products to enrich the lives of people who experience discomfort in their everyday lives. They have a dedicated sales team across Canada focused on providing customized solutions for end users using a simplified product selection approach with their dealer network. Using proprietary Geo-Matrix™ Gel, Blake Medical products are known in the marketplace for their comfort, cleanliness and pressure management properties.
Centrally located in Hamilton Ontario Blake Medical is continually searching for and developing products that comfort, enrich and improve the lives of our customers. We have simplified a complicated problem with our Low Maintenance Geo-Matrix™ line as well as offered other unique and effective therapeutic and preventative surfaces.
Blake Medical Group Inc. has over 15 years experience in medical manufacturing, medical service providing and advanced wound care.
We create products that prevent injury from untreated wounds, pressure ulcers/sores or prolonged periods of vibration and multiple shocks/impact. We design and manufacture Geo-Matrix™ polymer gel – a critical component in our products because of its unique ability to dampen vibration and improve pressure redistribution, shear and friction making it effective for medical and industrial seating. We are also proud of our wound and pressure injury prevention program which uses a combination of education and wound care therapy strategies to prevent the onset or progression of costly injury.
Each company under the Blake Medical Group, has its own specialty, business model, management and R&D team to maintain our success, growth and focus on innovation in the healthcare market.
Blake Medical Distribution: is continually innovating medical products to enrich the lives of people who experience discomfort in their everyday lives.
Shift Seating: Military & industrial seating developed to address the risk of occupational exposure to whole-body vibration, prevalent in military and industrial occupations.
Therapeutic Surface Solutions: preventative wound and therapeutic solutions specializing in pressure injuries. With a combination of mattress products, surface solutions and education, assists long-term care (LTC) homes across Ontario with treating and preventing wounds and sores while in their care.
Oke Polymer Systems: manufacturers the polymer-based material (Geo-Matrix™ gel) utilized in Blake Medical Distribution’s and Shift Seating’s product lines.
The goal of all investors, companies and organizations is to achieve a monetizing event, such as the ability to raise capital, perform meaningful research and development, license or commercialize products, reach profitability or execute a strategic transaction.
The people who work at Bloom Burton have deep knowledge in medicine, science, patent and corporate law, finance and healthcare invention, development and commercialization.
From start-ups through commercial launches, we are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness.
Blue Orchid was founded based on a simple mission to create and design simple and innovative solutions for challenges millions of caregivers face every day.
A new experience in providing care. ORCHIDLift is a complete solution for everyday mobility needs. Our innovative design allows our product to improve the caregiver experience in areas such as Transfer, Restorative Care, Support and Lifting. ORCHIDLift helps mitigate the loss of mobility from aging, and provides an affordable, simple solution with regards to lifting, moving and handling the patient at home.
We create and develop assistive living products aimed towards increasing the quality of life for both patients and caregivers. Our goal is to analyze and design products that would allow the patient to maintain their independence for as long as possible within the comfort of their home.
The Boehringer Ingelheim group is headquartered in Ingelheim, Germany, and operates globally with 140 affiliates and more than 46,000 employees, making it one of the world’s 20 largest human pharmaceutical research and development businesses.
Through our participation in medical and pharmaceutical research, both in Canada and worldwide, we have contributed to significant improvements in healthcare and developed innovative and cost effective medicines.
We have earned a reputation as a leader in the treatment of respiratory diseases, in particular Chronic Obstructive Pulmonary Disease (COPD), and have broadened the scope of our work to include diseases such as hypertension, stroke, arthritis, benign prostatic hyperplasia (BPH), Parkinson’s disease and HIV/AIDS.
The Brain-Body Institute is focused on understanding the structural and physiological links between the brain and nervous system and bodily functions in health and disease. One major objective is the study of the effects of environmental factors, including stress, early life experience and microbial exposure on the brain and the enteric nervous system, hypothalamic pituitary axis (HPA), and key somatic organs such as the gut.
To determine to what extent the microbiome influences, and in turn is influenced by the brain in the regulation of functions of the brain including behavior. Tied to this main objective, the Institute aims to:
unite basic and clinical scientists from diverse backgrounds and foster collaborations locally, regionally, nationally and internationally
conduct and translate research to improve the health and healthcare of the population
train the next generation of research leaders and provide them with the culture, intellectual stimulation and opportunity to significantly influence the future of science and health care
foster relationships with relevant private sector partners such as the pharmaceutical and nutrition industries
Operating out of state-of-the-art laboratories at St. Joseph’s Healthcare Hamilton. The open laboratory design has sophisticated microscopic imaging, neuro-electrophysiological recording equipment, and molecular biological capacity. The animal care facility has dedicated space for behavioral assessment and surgery.
There are many issues surrounding the injection of botulinum toxin due to the precise, tiny amounts used and the multiple number of injections needed for these treatments. Clinicians collectively acknowledge frustration around the injection process.
There is no dial-a-dose medication pen/syringe on the global market that can be filled by the user. UNTIL NOW
Our mission was to create the ultimate device for injecting botulinum toxin and we delivered a complete solution for each concern identified. This technology is also a perfect solution for pet owners to give their pet insulin and can be used for many other injectable medications.
The Buffalo Niagara Medical Campus, Inc. (BNMC) is a non-profit organization formed in 2002 to facilitate collaboration and address shared issues among member institutions that form the 120-acre Medical Campus and our surrounding neighborhoods in Buffalo, NY.
Our team builds on the assets of our world-class Medical Campus – known for its clinical care, research, and education – to support its mission of furthering economic growth, igniting urban revitalization, and building a strong, thriving community.
We do this through fostering conversation and collaboration among our member institutions, partners, and the community and take a proactive approach to leverage opportunities and to help to solve challenges faced by our overall community so that we can create a better future for all.
The Coordinated Accessible National (CAN) Health Network is a national partnership comprised of leading Canadian health organizations, referred to as Edges, and companies across Canada. The Network works together to introduce new solutions into the health care system, and pave the way for Canadian businesses to scale not only across Canada, but globally.
We tackle market access barriers enabling Canadian health innovation companies to compete on a national and international level by providing companies with:
Access to buyers’ sites to demonstrate the value of their technology
Fast-tracked and scalable procurement utilizing existing guidelines
An integrated marketplace allowing businesses to scale rapidly
The Edges identify market-ready needs for the Network and the best suited companies are selected and paired with an Edge who provides them with multi-level support to ensure optimal product market-fit. A national competitive procurement process is then launched where all of the Network’s members can procure the solution without having to repeat the process.
Ontario South is led by Trillium Health Partners (THP) in Mississauga, Ontario. THP is one of the largest community-based hospital systems in Canada and is a teaching hospital affiliated with the University of Toronto, an associate member of the Toronto Academic Health Science Network and home to the Institute for Better Health (IBH). St. Joseph’s Healthcare, Hamilton and Hamilton Health Sciences are both part of the Ontario South CAN Health Network.
The Canadian Centre for Electron Microscopy provides world-class electron microscopy capabilities and expertise to Canadian researchers and industry working in a broad range of fields, including bio and soft materials.
The CCEM houses a variety of electron and ion microscopes, including the only atom probe in Canada, and is used by researchers and industry from a broad range of fields including energy, metallurgy, electronics, nuclear and nanomaterials. Researchers are also able to train on any of the CCEM’s instruments.
In a move that increased accessibility and collaboration at McMaster’s electron microscopy facilities, the Canadian Centre for Electron Microscopy (CCEM) recently merged with the Faculty of Health Sciences electron microscopy facility to create a joint initiative.
CCEM has partnered with NRC-IRAP to provide specialized services for companies looking to access world-class electron microscopy capabilities and expertise. Funding excepted to be available starting April 1, 2021
CCEM can provide
· Chemical specimen processing and resin embedding of biological samples
· Room temperature and frozen sectioning of samples
· Structural and compositional data and elemental maps of biological cells/tissue, polymers, viruses, and small molecules
· Immuno-labelling techniques
· 2D and 3D imaging and data reconstruction
· chemical analysis, mapping, 3D reconstruction
· analysis of beam sensitive materials
The Canadian Longitudinal Study on Aging (CLSA) is a large, national, long-term study of more than 50,000 individuals who were between the ages of 45 and 85 when recruited. These participants will be followed until 2033 or death. CLSA is headquartered in Hamilton, Ontario.
The aim of the CLSA is to find ways to help us live long and live well, and understand why some people age in healthy fashion while others do not.
Data collection for the study is conducted through telephone and in-home interviews, as well as during visits to Data Collection Sites (DCS). Nationally, there are 11 Data Collection Sites and four Computer-Assisted Telephone Interview (CATI) sites. Data collected are managed and stored centrally in a secure and protected environment.
The seed of the CLSA germinated in 2001, when the Institute of Aging of the Canadian Institutes of Health Research first issued a request for development of a protocol for this new initiative. The groundwork continued through to 2009, when the first funding was provided by governments and institutions to establish infrastructure and begin recruitment.
CanChild is a non-profit research and educational centre located within the School of Rehabilitation Science at McMaster University. Research programs at CanChild concentrate on children and youth with disabilities and their families within the context of the communities in which they live. The focus of research conducted by CanChild is broad, and includes children and youth with physical, developmental, and/or communicative needs who require rehabilitation services, as well as their families.
Founded in 1989, CanChild is a world leader in the field of childhood disability. Our cutting-edge research and active strategies for making findings easily accessible to a wide range of audiences make CanChild the premier source for childhood disability information. CanChild has developed strong collaborative research partnerships, creating an alliance between families, world-class scientists, and established research organizations in Canada and internationally. These partnerships are vital to CanChild’s future growth and success.
CanChild’s multidisciplinary team includes researchers from pediatrics, rehabilitation medicine (physiatry), occupational therapy, physiotherapy, speech and language pathology, kinesiology, social psychology, epidemiology and biostatistics.
Caro Meats have devised a way to make meat by stacking thin sheets of cultivated muscle and fat cells grown together in a lab setting. The technique is adapted from a method used to grow tissue for human transpants. The cells produce a fibrous texture by forming myofibres as the fuse with each other, incorporating fat cells in the tissue directly. As a result, it feels and tastes just like meat.
Providing capital markets and investment banking advice
Cassio Capital Advisors helps organizations achieve corporate milestones faster by providing knowledgeable and practical advice on financing and acquisitions, as well as strategic planning, business development, and investor relations services.
With decades of experience analyzing the public technology sector, Cassio Capital is expert at advising technology-advantaged companies in the capital markets.
Cassio Capital saves clients time and expense by providing expert advice to busy executives who have limited time or experience dealing with the capital markets or M&A activities.
CBRE is Canada’s leader in Office Services, with the most comprehensive investor and occupier services platform, and more professionals specializing in the office sector than any other firm.
Occupiers come to CBRE to improve productivity, optimize locations, portfolios, ownership and capital structures and gain holistic solutions for workplace performance, cost reduction, talent attraction and retention.
CBRE Office Services partners with clients to make the most strategic and informed decisions regarding their real estate. We provide industry-leading local market expertise, which is supported by unique and insightful economic forecasting and market research tools.
Celerite Labs is a biotechnology spin-out from McMaster University and located in Hamilton, Ontario. Celerite Labs has developed an innovative magnetic printing technology that allows 3D printing of cells within a few hours, without the need of any scaffolds.
The magnetic printing technology supports cancer research, wound healing, toxicity screening, disease modeling, and tissue engineering. The method is compatible with high-density microwell plate format, easy to use, and allows creating complex hierarchical in-vitro models.
The Canadian Entrepreneurs in New England (CENE) is a volunteer, member-based organization that helps emerging Canadian companies in tech and life sciences succeed in the US and globally. Our members are Canadian executives and innovators living in New England.
In addition to our member-oriented networking and social events, we offer two distinct programs to help Canadian entrepreneurs and innovators. Our programs are tailored to address the specific challenges each firm faces and to offer the right mix of knowledge, mentorship, expertise and guidance.
Our members share their talents, experience and knowledge with Canadian firms looking to impact the world. We work with companies, incubators, banking partners, government agencies and others to design programs to support the global growth and success of Canadian entrepreneurs in technology and life sciences.
Light microscopy is an essential visualization, investigation, and characterization technique for many areas of research in the sciences, life sciences and engineering.
Recognizing the importance of light microscopy techniques to the university research community, the Centre for Advanced Light Microscopy(CALM) was established as a joint collaborative effort between the Faculties of Science, Engineering and Health Sciences.
CALM aims at providing a shared environment, designed to foster academicand industrial partnerships through enhanced accesstoestablished, cutting-edge light microscopy, photo-patterning, and light-assisted 3D printing techniques. Our staff provides expert training, technical support, and imaging services to best serve our users’ needs.
CALM facilities and instruments include Confocal Microscopes (e.g., Nikon A1R HD25, Zeiss LSM 700, Nikon A1R HD25), Atomic Force Microscopes (e.g., Asylum Research MFP-3D, AFM Bruker Dimension iCon), Super-Resolution Microscopes (e.g., Structured Illumination Microscope, TIRF/PALM-STORM), Widefield Microscopes (Inverted Plate Reader EVOS FL, Upright Widefield Microscope Olympus), and others.
Centre for Commercialization of Regenerative Medicine (CCRM) supports the commercialization regenerative medicine technologies, and cell and gene therapies, with strategic funding, dedicated infrastructure and specialized business and scientific expertise.
By partnering with leading research institutions to launch new ventures, enabling industry by providing innovative contract development and manufacturing organization (CDMO) services, and scaling emerging companies by catalyzing investment, CCRM is accelerating the translation of promising technologies, processes and therapies into life-changing health outcomes for patients. Our 40,000 ft² facility is custom-built for cell and gene therapy.
A network of researchers, leading companies, strategic investors and entrepreneurs, CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients, with specialized teams, funding, and infrastructure. CCRM is the commercialization partner of the Ontario Institute for Regenerative Medicine and the University of Toronto’s Medicine by Design.
Established in 2011, CCRM is a Canadian not-for-profit organization funded by the Government of Canada, the Province of Ontario and leading academic and industry partners.
The Centre for Health Economics and Policy Analysis (CHEPA) is an interdisciplinary research centre that is committed to producing high-quality, original, socially relevant research in health economics and health policy analysis. CHEPA seeks to disseminate research evidence to decision makers in the health sector.
Home to one of the largest concentrations of health economists and health policy analysts in Canada
27 faculty members from 3 Faculties, 2 Schools and 6 University Departments
Talented, discipline-based and inter-disciplinary researchers who address a broad range of health and social system problems through independent and collaborative research programs
Pioneers in the fields of knowledge transfer, economic evaluation, health technology assessment and public, patient and community engagement
Notable contributions to health human resources, needs-based and primary care funding models
An incubator for new graduate training programs in health policy, health economics and health services research
McMaster University launched the Michael G. DeGroote Centre for Medicinal Cannabis Research in 2017. The Centre is dedicated to conducting research on medical cannabis, curating, analyzing and sharing evidence-based information, and creating an active and productive network of medical cannabis scientists.
The Centre provides evidence-based content and drives research initiatives to further the interests of researchers, healthcare providers, policymakers, industry professionals, patients, and others. As a platform to launch interdisciplinary research collaborations and critical discussions on the topic of medicinal cannabis, the Centre hosts a conference, as well as webinars, panel discussions and roundtable conversations throughout the year.
The Centre for Microbial Chemical Biology provides easy access to expertise and equipment necessary for chemical biology research. Expert staff are on hand to maintain the equipment and offer training and assistance for all users. Alternatively, CMCB staff members are available to assist with designing and completing individual experiments and projects for researchers.
Services offered, include:
Cell growth and lysis
Protein expression & purification
The CMCB features six core labs that enable chemical biology research to be conducted in one central location. We provide the capabilities necessary for cell culture, assay development, high throughput screening, small molecule synthesis, natural product isolations, molecule identification for drug discovery and basic research applications. The six labs include:
High-Throughput Screening Lab:
Offers a diverse collection of chemical compound libraries available for use in cell-based and biochemical screens on our integrated robotic systems. One of the systems is enclosed in a biosafety enclosure, enabling biosafety level 2 screening. The CMCB HTS lab has over a decade of experience in screening, and our instrumentation allows us to screen a diverse range of targets accurately and at a fast pace. We offer training on the equipment to allow academic users the opportunity to become experienced users. Screening campaigns are offered to both academic and industrial clients.
Chemical / Synthesis Lab:
Full-service open access chemistry lab that offers synthesis tools to satisfy your synthetic organic chemistry needs. We provide the tools necessary for organic chemistry related projects, including natural product isolation, medicinal chemistry, and drug discovery projects. We train users on all of our equipment, and we also offer industry collaborations.
Core area for cell growth, protein purification, assay development, and enzyme kinetics. Protein lab staff are experienced in the design, development and analysis of a wide range of applications. Our protein lab also features a Biosafety Level 2 area for growth and manipulation of Level 2 organisms. Training is provided on all equipment, allowing trainees the opportunity to become expert users in a wide variety of equipment. Staff are available for consultation around experimental design, and can be hired for custom projects serving both internal and external clients.
Equipped with a Bruker AVIII 700 MHz NMR that is outfitted with an automated sample changer (SampleJet) and Cryoprobe for high-resolution experiments on proton, carbon, nitrogen and phosphorous nuclei with a very high degree of sensitivity. It is available for both academic and industrial clients.
Lab Specializing in the identification and quantification of small molecules, the lab delivers high mass accuracy data. We provide analyses on a range of samples, including small molecules in complex and pure samples, metabolomics, proteomics sample preparation, and instrument training and use. We have experienced staff available for consultation, assistance with experimental set-up, and troubleshooting. Training is available on the Bruker microTOF, and for high resolution experiments we have a Thermo LTQ XL Orbitrap that is operated by our expert technician. Instruments are available for academic and industrial clients
Provides common Information Management/Information Technology services to facilitate universal access to information throughout networks and offers support on web technologies, Database design and Managements, data collection, data retrieval, data analysis software and the processing platforms using the most up-to-date methods
Air Clean Cabinet
Bio-Rad Proteon SPR System
BioFlo 115 Benchtop Fermenter/Bioreactor
Biological Safety Cabinets
Constant Systems Cell Disruptors
Envision Multilabel Plate Reader with Stacker
Bio-Rad Experion Automated Electrophoresis Station
Microson Ultrasonic Liquid Processor (Sonicator)
Sorvall Superspeed Centrifuge
Spectramax PLUS384 Plate Reader
Synergy Plate Reader
Tecan Ultra Evolution Plate Reader
Novaray Detection Platform
Typhoon Imaging System
High throughput screening lab
Envision Multilabel Plate Reader with Stacker
System 1: Biomek FXP Automated Liquid Handler
System 2: Biomek FXP Integrated Liquid Handler
System 3: Biomek FXP Integrated Liquid Handler for Biosafety Level 2
LECO 2D GAS Chromatography with Time-of-Flight Mass Spectrometer (GCXGC-TOFMS)
CMAS is a McMaster University Centre located in St. Joseph’s Healthcare Hamilton. The Centre provides state of the art facilities, education and training in minimally invasive procedures for surgeons and nurses.
CMAS promotes and supports world-class research into the outcome and development of new minimal access procedures in both applied and clinical research, promoting innovative surgical techniques and offering support and mentorship to participants.
Clinical Research projects included comprehensive clinical studies, multi year randomized trials and complex projects like the; “Laparoscopic Bariatric Surgery for Treatment of Complicated Type 2 Diabetes in Obese Patients: A Prospective Randomized Controlled Pilot Study” being embarked upon in collaboration with St. Joseph’s Healthcare and Hamilton Health Sciences are among the clinical research projects currently being conducted at the Centre.
Applied Research conducted at CMAS includes telehealth and telerobotic initiatives, telementoring and research into the development and testing of novel surgical robotic devices that include the Image Guided Automated Robot (IGAR) systems currently being developed by the Centre for Surgical Invention and Innovation (CSii) for use in the early detection and treatment of diseases in the breast, lungs, liver, kidneys, spine, bone, etc.
The multidisciplinary centre provides skills training, produces educational seminars, special events and conferences, supports corporate and industry partnerships with information sessions, participation in product launches, demonstrations and tutorials.
At the CPDC we discover, develop, and distribute radiopharmaceuticals. The CPDC was founded in 2008 as a Centre of Excellence for Commercialization and Research (CECR), specializing in radiopharmaceutical research and development. Since its inception, CPDC has gained recognition as a leading radiopharmaceutical organization. It is one of a very few R&D centres that has the full range of scientific, technical, regulatory and business expertise combined with the full specialized infrastructure required to translate radiopharmaceuticals to the clinic and provide them to the commercial marketplace
CPDC has assembled a superb team comprised of seasoned executives, entrepreneurs, and drug developers to complement its unique and strong foundation of specialized staff that have a depth of scientific, technical, regulatory and market experience. Working with our academic and pharma partners CPDC has completed over 50 radiopharmaceutical discovery, development, and manufacturing programs. We have brought over a dozen radiopharmaceuticals into clinical development, which currently support more than 25 clinical trials in Canada, North America and Europe.
The Centre for Surgical Invention and Innovation (CSii) is a National Centre of Excellence research accelerator committed to enhancing the quality and access to healthcare for all Canadians through the development and commercialization of innovative medical robotic technologies and novel techniques. CSii is leveraging Canadian expertise in minimal access surgery and space technology to build a legacy industry that will create high tech jobs, strengthen the economy and create better medical outcomes.
Our vision is to create the next generation of personnel protective equipment to become global leaders. The funding will establish the center as a core facility to assist the large number of new companies that are being setup in Canada to design and develop PPEs, choose appropriate materials and their combinations as well as develop and provide advanced technology that will make them leaders in the world.
The CEPEM was established in response to a call from Hamilton Health Sciences (HHS) to start local manufacturing of face masks and face shields due to the anticipated supply chain breakdown in March of 2020 caused by COVID-19. In just over a month, the CEPEM team provided design, identified suitable materials and developed validation tests so that local manufacturers are now producing 20,000 face shields/day (Whitebird) and 20,000 masks/day (Niko apparel) to supply HHS.
In this process, the centre has also developed a testing facility that can assess various filtration materials for breathability (pressure drop), particulate filtration efficiency (PFE), bacterial filtration efficiency (BFE) and fit testing.
Century Therapeutics is developing novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies. Our commitment to developing accessible cell therapies provides an unparalleled opportunity to advance the course of cancer care.
The Chanchlani Research Centre is dedicated to understanding the genetic and environmental causes of common diseases among diverse cultural groups, women and the socially disadvantaged while providing innovative training to the next generation of health researchers.
We have the infrastructure both human and physical to undertake large scale genomics projects as related to chronic diseases. The Centre provides an ideal training group for students in statistics, epidemiology, and medicine and by investigating how genomics intersects with health, some of our researchers consider the socio-cultural and clinical application of such information.
A port City located on the western tip of Lake Ontario, Hamilton is home to +580,000 people, world-class universities, colleges, and research-intensive companies that have created an ideal environment for new product development and innovation.
Hamilton’s location provides businesses with ample opportunities for trade, transportation, and talent acquisition. Hamilton offers excitement and urban downtown vibes plus relaxing scenic backdrops. Industry and academia work together in Hamilton to lower the cost of commercialization and bringing products to market.
The nation’s most diversified economy, the fastest growing mid-sized city for tech talent and a fantastic community approach to supporting investment big and small. With a quarter of residents born in another country, the city is a welcoming place for newcomers. Within a one hour drive of Hamilton is a workforce (and customers) of over 2 million people.
Hamilton’s Economic Development Office is the central point of contact for business assistance. Its services are geared to serve new start-up companies, corporate relocations, and the expansion and retention of existing business. Its mission is to serve as the catalyst for continued economic growth, job creation, and revitalization in Hamilton.
The City of Hamilton’s staff of experienced economic development professionals will work with your business to provide the up-to-date information and personal assistance needed to make your business expansion and relocation seamless and convenient. Our services also include:
Information and research
Coordination of City of Hamilton services
Industrial land development
Small business creation
Witness more of Hamilton’s strength in the tailored experience team members provide to individual businesses: make contact, get information and connect with feet-on-the-ground experts that can help.
CLARITY represents the formal alliance of a group of researchers who have enjoyed a long-standing and fruitful collaboration. Through formal collaboration, Clarity’s clinical advances through research and information translation has been pivotal in creating a renewed sense of spirit, vision and commitment.
CLARITY faculty include 9 clinician researchers united through a common vision of evidence based health care through: advancing research methods transformative clinical research innovative knowledge translation pioneering education
The researchers associated with CLARITY include: Mohit Bhandari Jason Busse Deborah Cook PJ Devereaux Gordon Guyatt Alfonso Iorio Maureen Meade Bram Rochwerg Michael Walsh
The CRLB was established in 1987 to provide scientific, analytical, and Biobank support for large multinational clinical trials and epidemiologic studies.
The analytical and storage capacities of the CRLB have expanded significantly in support of numerous large multinational studies of the affiliated Population Health Research Institute. Extensive expertise has been developed in the shipment, reception, storage and analysis of large numbers of samples from more than 85 countries representing every region of the globe. To date, the CRLB has received more than 20,000 shipments of specimens. The clinical trials and epidemiologic studies in which the CRLB has been involved have been supported by peer-reviewed grants from Canada and the United States and by the pharmaceutical industry.
The Laboratory and Biobank has independently received contracts for organizational and analytical support for pharmaceutical industry funded clinical studies, from diagnostic companies for analyses in clinical trials, and as a specialized referral Laboratory and Biobank for research contract organizations and commercial laboratories. The CRLB Biobank currently houses approximately 3 million samples, primarily stored in nitrogen vapor at -160°C to -180°C.
Clinical Trials Ontario is a leading organization in the clinical trials community dedicated to strengthening, promoting and capitalizing on Ontario’s competitive advantages for conducting high-quality clinical trials.
We work collaboratively with industry, research institutes, patients and the public and other health innovation organizations to improve the clinical trials environment and attract investment to the province, while supporting the highest ethical and quality standards.
Cloud DX combines core competencies in biomedical hardware engineering, cloud-based medical device architecture, algorithm-based result generation, regulatory approval experience and internationally ISO certified quality management, brought together to create a new category of medical device: the medically accurate, consumer/clinical vital sign platform. Cloud DX is a first-mover in the race to combine clinical grade data collection with a consumer-friendly user experience.
Cloud DX is pushing the boundaries of medical device technology, with smart sensors, ease of use, cloud diagnostics, artificial intelligence and incredible design. We focus on the critical mission of collecting better vital sign data. Our partners choose Cloud DX for vital signs because we offer the best value, period.
Cloud DX can be integrated with many popular EMRs, improving efficiency and ROI. The net result of innovation, collaboration and integration is a platform that unifies the clinical and home monitoring experience, delivering the connected health solutions needed in the 21st century.
CoMotion brings small businesses, startup teams, like-minded entrepreneurs and professionals of all kinds together to operate their businesses under one roof, and share common amenities (such as conference rooms, kitchen, etc) to keep overhead costs down, as well as have a supportive community to network with and be inspired by.
CoMotion coworking spaces are built around the community of professionals that work within them, continually evolving to meet the needs of the members within each space. We have a diverse network of members from a range of industries with different professions and skill sets.
CoMotion also has a full-time Community Manager within each space that helps to facilitate member connections as well as internal member-only events.
We provide innovation as a service – a fancy way of saying that we are a fee-for-service R&D team that can help develop your ideas into products, solve difficult problems or answer critical questions that are important to your business.
FyeLabs is a service brought to you by CIRC @ McMaster University. CIRC, the Computing Infrastructure Research Centre, puts the bright minds and comprehensive resources of McMaster University at your fingertips. We work across a variety of different technologies and applications areas, but our core strength is in maximizing the value of data through algorithm development, image recognition, data fusion, machine learning, natural language processing and artificial intelligence.
Our fast-paced and cost-effective solutions offer ambitious emerging companies access to the cutting-edge technologies that are shaping today’s innovation economy.
Coreprint Patterns’ is a family-run business whose current core business is mold making. These are predominantly for floor mold castings, match plates castings, investment castings and injection molded plastics, as well as machining with a focus on castings.
They have started to manufacture critical components for COVID-19 polymerase chain reaction (PCR) tests for hospitals and labs across the province. They will be the first made-in-Ontario sources for these important components, which are difficult to acquire due to high global demand.
In addition, CorePrint Pattern offers services across several areas:
Patterns, Molds, Tools and Die: We use CNC precision at our Hamilton workshop to produce accurate and easy to use patterns, molds, tools and dies for all foundry/molding processes. We can help you with floor mold tooling, match plates, investment casting dies, core boxes, injection molds and much more.
Production Machining: CNC milling and general machining with expertise in machining castings and the challenges they present. We do everything from prototyping to high production runs giving you accurate parts on time. We provide in-house fixture design, production and programming.
Turnkey Solutions: We help you move from concept to creation. We are your one-stop-shop for tooling, castings, forgings, and machining for one-off prototypes to large production runs. Let us help you optimize the entire manufacturing process. Starting with selecting the ideal manufacturing process and optimizing the design of your part through to a finished part.
Additional Services: We help with 3D modeling, scanning, design and 3D printing services, reverse engineering of existing products, CAM programming, rapid prototyping and milling. Advances in 3D printing technology have made it easier and more cost-effective than ever to roll out new products. If you have an idea in your head, we can help put it in your hands to hold, test, refine and polish into a marketable product.
CREATE was founded to support research and innovation at Hamilton Health Sciences. Our multidisciplinary team is made up of specialists in health systems, data engineering, data science, software engineering and interoperability. Our mission is to partner with scientists and innovators to invent the future of health care.
Our data team focuses on applied machine learning and artificial intelligence, as well as managing high volume, high velocity, high variability data. Our data scientists are skilled in a range of machine learning approaches, including deep learning, for variety of applications, including risk prediction, image recognition and natural language processing. Our data team partners with researchers interested in incorporating machine learning techniques into their research to provide support with grant writing,
study design, data engineering, model development and manuscript preparation.
Our digital team specializes in the design, development and deployment of clinical applications. Our solutions architects are experienced in deploying large-scale software solutions in both Canada and the developing world and are experts in health care interoperability standards to ensure our solutions can be integrated with other digital systems. The team is continuously developing a reusable software library for core application components, such as authentication services, that allows them to rapidly
develop new applications and keep development costs low for our partners.
One of the unique aspects of CREATE is the ability to bring together our data and digital teams to develop fully formed data products. Data scientists typically lack the software engineering experience to develop a promising predictive model into a product that can be deployed in the real world. By building a team that can work across the full lifecycle of a data product – from engineering of raw data to model building to software development – we are positioned to not only support novel research, but to support its translation into practice via a deployable data product.
CREATE offers a variety of services for researchers and innovators, including:
Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies.
CDL Health, offered at CDL-Oxford, CDL-Toronto and CDL-Vancouver, helps technical teams bring their health innovations to market by providing access to industry-leading mentors and investors in the life sciences domain.
The startups attend five in-person objective-setting sessions between October and June. CDL is a non-profit organization. There are no fees for participation and CDL does not take any equity.
CDL Health serves ambitious teams with strong backgrounds in chemical, biological, medical, materials, mechanical, electrical, and computer engineering who are working on projects and technologies with the potential to meaningfully enhance human health and wellness. CDL Health is tailored towards early-stage companies (early venture or growth) or even projects (pre-incorporation) however, startups at all levels of maturity will be considered.
The CRLB-GMEL laboratory was born as a new entity in late 2020, a combination of the Clinical Research Laboratory (CRLB), established in 1987 at McMaster University to support clinical trials, biobanking, and biochemistry testing and the Genetic and Molecular Epidemiology Laboratory (GMEL), established in 2010, a collaboration between McMaster, PHRI, and TaARI. The GMEL conducts genetic testing, and researches new methods to conduct those tests.
The CRLB-GMEL offers a full range of laboratory services including:
Biochemistry & biomarker analysis
Genomics including DNA sequencing, gene expression, epigenetics
The genetics and molecular epidemiology team at CRLB-GMEL provides a broad range of genomic and proteomic solutions:
Specializing in large-scale population genetic studies, capable of handling project sizes ranging from single samples to >10,000 samples.
Supporting experimental design considerations, bioinformatics and statistical analyses, and interpretation/reporting of results.
We are proud to have the largest research biobank in Canada today. With the 1993 launch of PHRI’s study, HOPE (Heart Outcomes Prevention Evaluation), the Clinical Research Laboratory and Biobank (CRLB) needed to expand its capacities in collection, transportation and analytics to accommodate samples. The long duration of many PHRI studies – ranging from five to 10 years – resulted in the decision to store all samples from -160 C to -180 C (almost twice as cold as before) in nitrogen vapour for long-term stability.
Based in Montréal and Toronto, CTI Life Sciences Fund, a Canadian venture firm makes venture capital investments in high quality emerging life science companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences Fund currently manage $245 million of assets.
Out of the four inflection points indicated in the figure below, the Fund’s strategy will be to focus on two key junctures in the pharmaceutical development process highlighted in color namely and primarily: from Pre-clinical to Proof-of-Concept and secondarily on Proof-of-Concept to Phase III.
Successfully addressing the global antimicrobial resistance (AMR) crisis requires a creative, strategic, and multifaceted approach. As a world-leading institution in AMR research and innovation, McMaster University is leveraging its impact through the David Braley Centre for Antibiotic Discovery.
Through the generous support of dedicated donors, partners, and governments, this Centre of Excellence will provide McMaster’s team of distinguished scientists with the opportunity to translate new knowledge into real impact.
Building on McMaster University’s strengths, resources, and partnerships, researchers at the David Braley Centre for Antibiotic Discovery are equipped to lead in international efforts against AMR. Our assets include:
A world-class team of scientists and clinicians, who specialize in all levels of AMR research
An impeccable track record of successful and innovative AMR research, publications and developments An expansive multi-user laboratory, which includes Canada’s first antimicrobial drug discovery facility and largest university-based compound library
A newly-renovated BSL3 containment lab for the study of deadly human pathogens
A variety of animal models of infection for the testing of antibiotics and antibiotic alternatives
Platforms for the testing of hundreds of drug-resistant bacteria retrieved from clinical samples across the globe
Unique bioinformatic tools and big data platforms, such as the Comprehensive Antibiotic Resistance Database (CARD) – a tool used daily by scientists worldwide
A long-standing and globally recognized capacity for clinical trials at all stages.
The David Johnston Research + Technology Park is one of Canada’s largest innovationparks. Leveraging the strengths of the University of Waterloo, Canada’s Most Innovative University,R+T Park brings together world leading companies, brilliant talent, leading researchers, and pioneering startups in place where ideas become reality.
R+T Park is more than office space. It’s a community of barn raisers that comes together to drive groundbreaking results, making impacts that ripple around the globe.
The DMZ at Ryerson University is one of Canada’s largest business incubators for emerging tech startups. The top-ranked university incubator in North America and third in the world, it helps startups succeed by connecting them with customers, advisors, influencers and other entrepreneurs.
The DMZ is open to all startups that meet its criteria — no Ryerson affiliation is required. Startups must: be addressing an important economic or social problem, make innovative use of technology, and have a prototype (at minimum) that is already in the market with or is ready to launch. Once accepted, startups receive four months of access to tailored connections, mentorship, dedicated work space and programming (after which they can pay a membership fee to stay on).
Since 2010, we’ve helped fuel, grow and graduate 477 startups. They’ve raised $916 million in seed funding and have fostered the creation of more than 4,142 jobs. They’ve acquired customers, won awards, grown their teams and developed products and solutions that are positively changing lives and businesses in Canada and abroad.
Health researches and develops innovative oral hygiene products that can safely and selectively eliminate cavity causing bacteria. We manufacture revolutionary oral healthcare products made only with naturally occurring ingredients. Because of this, our products can be used safely by children.
Elarex Inc. is a Canadian healthcare technology company commercializing its proprietary PT120 formulation technology which has proven to stabilize biologicals (including live vaccines!) so that they are as effective when stored at 40C as if they had been stored at -80C.
The Elarex PT120 Formulation Technology has many merits. The most startling? Live attenuated vaccines formulated with PT120 have equivalent performance after storage at 40C as unformulated vaccine stored at -80C. That’s 120 degrees of stabilization.
The final product form is highly customizable including powders and coatings. We aim to partner with vaccine leaders, to help improve your products. Our vision is a future where vaccines will not need refrigeration.
At EmergConnect we are leading the way in revolutionizing emergency care by empowering patients and giving clinicians the power of data. We are using cutting edge AI and ML to improve patient waits, enhance patient care, increase ER efficiency and save hospitals money.
The engine behind Empirica is a powerful functional genomics platform combined with unique patient-based models of brain cancer and recurrence, which are enabling the discovery of new therapeutics options that have emerged from the patient’s actual tumour biology. The company is focused on the development of adoptive immunotherapies against the most aggressive and treatment-resistant forms of cancers, including glioblastoma (GBM) and brain metastasis (BM).
Empirica Therapeutics was founded in July 2018 by Dr. Sheila Singh, a pediatric neurosurgeon, and Dr. Jason Moffat, an expert in functional genomics and gene-editing platforms.
The first product in Empirica’s preclinical pipeline is ET001. ET001 is based on genetically engineered T cells with chimeric antigen receptors that specifically bind to a CD133 antigen to recognize and kill the cancer cells. The Empirica team has validated CD133 as an essential marker of therapy-resistant GBMs and developed ET001 that targets the treatment-refractory disease reservoirs, showing great preclinical efficacy against GBM recurrence. This potential therapeutic could also be trialed in patients with brain metastases that also express high levels of CD133.
EngineeringCPR is dedicated to providing only the best service for the contract design and manufacture of medical devices.
As a company of seasoned industry experts we have the experience you need to protect your development and manufacturing schedules. We aim to deliver work that not only benefits you, but the health and well being of your clients and customers.
The same diligence that goes into our design and process work follows into our manufacturing. At our disposal is a 10 000 sq. foot facility with room to grow into the needs of your company and product. Our facilities are primed to handle a variety of manufacturing needs and what we can’t perform in house we have the contacts to accomplish swiftly and efficiently to meet any deadline.
Enhanced Medical Nutrition Inc. is engaged in developing, researching, producing, and distributing evidence-based clinical nutrition.
Enhanced Medical Nutrition is a university-based life sciences organization engaged in the research, development, and distribution of evidence-based clinical nutrition in the perioperative setting. EMN supports the patient’s journey through surgery with clinical nutrition, helping patients prepare better and recover faster.
The foundation of our company is directly related to current research and innovation in clinical nutrition products: PreCovery a peroperative carbohydrate therapy for the preparation and recovery of elective surgery; and, ISOlution a pure protein to increase muscle protein synthesis and promote healthy aging.
Epineuron Technologies is a medical device company developing tomorrow’s gold standard of care for damaged or impaired nerves by developing a set of devices for intra- and post- operative use that supercharges neurons and the regenerative process, that will substantially shorten recovery times for patients and maximize sensory and motor function.
Epineuron is developing electroceutical devices that supercharge neurons and kick-start the regenerative process. Our technology delivers electrical stimulation that boosts the nerve’s natural biochemical process to heal and repair itself when injured. These devices can be used by medical professionals at the time of injury or during surgery to deliver therapeutic electrical stimulation. This technology will substantially shorten recovery times for patients and maximize sensory and motor function allowing patients to resume their lives normally.
Equation Angels is the second-largest angel investor network in Canada.
Combining the vast expertise and resources of three angel groups from Southern Ontario, we accelerate the innovation ecosystem for investors and entrepreneurs.
Our powerful network is made up of nearly 200 angel investors who are excited to partner with aspiring entrepreneurs on their transformative visions and ideas which will be essential to the growth of the Canadian economy.
Escarpment Cancer Research Institute (ECRI) brings together well-established and successful cancer research groups, as well as emerging groups, from McMaster University, Hamilton Health Sciences, and the Juravinski Cancer Centre. ECRI will be a national leader of innovative and sustainable solutions that will put research into action for the benefit of people affected by cancer.
The Institute has three core programs of research: Clinical Trials, Quality Health Care and Knowledge Translation (‘bench to bedside’) research
ECRI brings together scientists representing many disciplines, including anatomical pathology, clinical chemistry, nuclear medicine, immunology, medical oncology, radiation oncology, surgical oncology, gynecological oncology, nursing, psychology, health policy, cancer epidemiology, and biostatistics. ECRI has an integrated research agenda which encompasses translational research, clinical trials, quality health care and knowledge translation, all focused on the rapid transfer of research to patient care, system design and health care policy.
Exerkine Corporation is a biotechnology company developing novel therapies for the treatment of genetic and aging-associated diseases. Exerkine’s focus is on developing and commercializing therapies that can materially improve the lives of patients.
Recent developments in exercise physiology are identifying novel biologic compounds and delivery systems that can be harnessed to treat a variety of diseases. We have built on this emerging understanding to create exosome-based therapies that are substantially superior to current approaches and methodologies.
Results from preclinical trials of our exosome-based therapies in genetic disorders, such as lysosomal storage diseases, have shown improvements in molecular and clinical outcomes that significantly exceed those of existing treatments. Our therapies are also effective against any known genetic disease group including; mitochondrial and neuromuscular diseases, and cystic fibrosis. Our Exerkine protein therapies show substantial efficacy in the treatment of aging-related diseases, such as muscle atrophy, obesity and type 2 diabetes.
At eye3, we are committed to improving road and workplace safety with the development of a revolutionary handheld detection device that will set a new global standard for drug screening. The cost-effective eye3 hand-held device detects THC quantitatively at ultra-low levels in under one minute with superior roadside/field functionality.
FACIT strategically invests in the most promising technologies arising from Ontario’s outstanding research base. We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario’s economy.
FACIT is the gateway to the cancer research pipeline in Ontario. As a bridge between the public and private sectors, we apply an entrepreneurial approach, along with strong business expertise and industry connections, to continuously identify and advance breakthroughs in science and technology. An active partner in all of our projects, we help move oncology innovations to real world opportunities that benefit investors, patients and our economy through:
Technology Assessment to help identify the most commercially or clinically promising ideas.
Project Development to help implement a project through all necessary steps in order to reach market.
Embedded Management working directly within a team to provide the guidance and resources help to strike a deal or launch a company.
Business Intelligence and Strategies providing expert advice, insight and management processes to successfully bring an idea to market.
Business Development connecting researchers and inventors with the right partners, and providing guidance on structuring deals and licensing ideas.
The Farncombe Family Digestive Health Research Institute is an integrated group of clinical and basic scientists dedicated to understanding the impact of digestive health and nutrition on disease across the life span.
The Institute is focused on developing new strategies for the diagnosis, treatment and prevention of intestinal diseases such as Crohn’s disease and ulcerative colitis, which will have global benefits. However, the focus of research in the Institute is not limited to digestive diseases; rather, it includes diseases of many other organ systems that may be caused and/or profoundly influenced by digestive health and nutrition.
There is a strong focus on the role of the intestinal microbiota in health and disease and the Institute contains Canada’s only gnotobiotic laboratory, a metagenomics platform and a microbiology laboratory specializing in the culture of human commensal bacteria. There is a clinical research centre within the institute that conducts clinical trials, meta-analyses epidemiological studies conducted in affiliated hospitals as well as on a national and international basis. The institute has a large complement of technical staff, graduate students and research fellows as well as administrative staff.
McMaster is home of Canada’s only gnotobiotic, or germ free, research facility for gastrointestinal disease and other research including immunology and microbiology. The $5 million Farncombe Family Gnotobiotic Facility, located at the Health Sciences Centre, was opened in 2005.
The 3,000-square-foot laboratory’s strict controls ensure sterility and control of the bacterial environment for research into the host-microbial interaction in the gut, a significant issue for understanding immune reactivity in the gut and susceptibility to a range of gastrointestinal and other diseases such as inflammatory bowel and functional bowel diseases, allergy and autoimmunity including diabetes.
What we offer:
Sterility and a strictly controlled bacterial environment for the study of host-microbial interactions in the gut
Axenic (germ-free) mice which can be purchased from the Facility or housed in the Facility in germ-free status for a per diem rate
We can help you:
Purchase germ free mice
Re-derivate a mouse strain in germ-free conditions
Obtain tissues and ship to your facility
How we do it:
Axenic (germ-free) mice obtained by two-stage embryo transfer (ET)
Axenic breeding and limited microbiota breeding (ASF, oligoMM)
Facility equipped with recently renewed flexible film gnotobiotic isolators as well ISO Cage Positive isolators
Specific experimental facilities (e.g. animal behavior isolator), sterile procedure rooms, as well as Level 2 biohazard housing and procedure area available
FERO creates disruptive, flexible, proprietary mobile infrastructure solutions at a fraction of the cost of traditional infrastructure and does so while creating jobs, saving money, innovating and helping the economy grow.
We collaborate with healthcare professionals, stakeholders and other sectors to develop customizable units for our clients’ unique needs. We provide full-service solutions in a flexible and reliable manner – we create, we sell or lease, we install and assemble, we service and troubleshoot, we disassemble, we staff, and we store and stockpile. Our 130,000 sq ft of manufacturing space at two locations, allows us to produce our mobile units and distribute them on demand.
FERO builds scalable, pressurized mobile medical units using breakthrough patented technologies that support hospitals, long-term care homes, remote communities, schools, military and more.
The Firestone Institute for Respiratory Health is a world class respiratory program providing comprehensive patient care, research and education. The program is comprised of an outpatient service, an inpatient unit managing severe or chronic respiratory diseases and the regional thoracic (chest) surgery program. The intent of this institute is to provide optimal patient care through clinical practice, translational research and the training of health care professionals.
The Firestone Institute for Respiratory Health (FIRH) is based out of St. Joseph’s Healthcare in Hamilton, Ontario, Canada and is affiliated with McMaster University. Clinical, research and educational activities are integrated and largely collaborative within the FIRH. The intent of this institute is to provide optimal patient care through clinical practice, translational research and the training of health care professionals.
Research is wide-ranging, from basic studies of animal models of lung disease (asthma, COPD, fibrosis) to clinical trials and epidemiological studies such as the Canadian Healthy Infant Longitudinal Development Study (CHILD) birth cohort study, for which the FIRH is hosting the coordinating center. Specialized facilities have been established at the FIRH, such as the Sputum Research Laboratory and the Aerosol Research Laboratory. Scientists at the FIRH are performing studies of bone marrow progenitor cells, airway peptide challenges, electrophysiological studies of airway smooth muscle cells, chronic allergen challenges, preclinical models of lung injury and repair, and more. The Institute is largely responsible for the ranking by the International Scientific Citation Institute of McMaster University’s respiratory research as the second most cited in the world, surpassed only by the National Institutes of Health in the United States.
Flinn Scientific was established in 1977, providing safely packaged chemicals, free safety training and unique safety products to customers across the United States.
Flinn Scientific Canada was registered in 2015 and established itself as a unique source for science education supplies by continuing the tradition of putting customers first, providing quality products, outstanding service, fast delivery, and safety leadership. Backing every single order is a team of individuals drawing on their own personal experience serving Canadian science teachers as well as almost 40 years of knowledge, support, and resources from our founding company.
For over 40 years, Flinn has been known as the Safer Source for Sciecne, partnering with studetns and teachers and leading the way in lab and personal safety. Now we are offering PPE, sanitizer, and more, to help create a safe place for your business, office or school
After almost 20 years, we can confidently say that our core focus is custom software product development in partnership with companies and organizations. We are a full service partner when it comes to software development services with in-house user experience experts, software engineers and system administrators.
Our specialty is in end-to-end product development, from idea to implementation to iteration. We are a “full stack” shop when it comes to software development services.
E-Commerce and Content Management systems in Kentico CMS Platform
Custom Web Application Development in Microsoft .NET and Ruby on Rails
Native iOS, tvOS, WatchOS application development for iPhone, iPad, AppleTV and Apple Watch
Android development in ReactNative and ReactJS
Web Service and API design/development
Amazon Web Services (AWS) architecture design, deployment and management
From concept to product launch and beyond, we are scientific consultants with the expertise to guide your product safely into the hands of consumers.
Focal Point Research is a new-product consulting company, which has the unique ability to assist in many aspects of developing, launching and improving new and innovative products. From early concept to regulatory approvals, product and packaging development, manufacturing and quality assurance, we provide comprehensive insight you need to see your vision become reality.
Founded on almost 40 years of experience of bringing innovation to market, Focal Point Research provides comprehensive insight not typically found in a single firm.
Forge & Foster is committed to generating positive social and economic value for communities, tenants, investors, and other stakeholders through commercial real estate projects in Hamilton and across Southern Ontario. We bring vitality to cities as a leading value-add commercial real estate investment management company.
Forege & Foster operates 21 acres of space in the Hamilton Innovation Zone, adjacent to the McMaster Innovation Park. Those interested in office or lab space, should reach contact us.
Forsythe Lubricants is a Hamilton-based manufacturing company since 1911, and has recently stood up a hand sanitization business unit in response to COVID-19 related PPE. Forsythe manufactures both liquid and gel USP grade hand sanitizer, with production capacity of up to 1.5Mkg per month, if needed. They produce both 250 / 500ml bottles of hand sanitizers.
Forsythe core business is the of manufactures industrial and automotive fluids and lubricants. Handling automotive factory-fill, packaging, and distribution, we offer a full range of lubricants and fluid blending services, as well as lab services, inclusive packaging, maintenance solutions, 24 emergency services, and plant lubricants surveys. From supporting small 4 drum blend projects to major oil company multi million gallon requirements. Forsythe is an ISO 9001 IATF 16949 certified facility that provides exceptional quality and service to its customers.
The Fraunhofer Project Centre for Biomedical Engineering and Advanced Manufacturing (FPC-BEAM) at McMaster University is a 20,000 sq. ft. facility with the goal of enhancing early stage intellectual property in the areas of cell therapies, diagnostics and biomaterials to further develop the technology and accelerate commercialization.
FPC-BEAM has infrastructure and expertise to facilitate the development phase of your project, including the creation of design, prototyping and manufacturing methods for academic, clinical and industrial IP. The space boasts a series of office, meeting and instrument suites that creates a workflow allowing rapid generation, optimization, validation and scale-up of your technology, moving IP to commercial product.
FPC-BEAM brings together expertise from both the Fraunhofer IZI (Europe’s Leader in Cell Therapy Manufacturing) and McMaster University (2017 Most Research Intensive University) to create a unique institute with a core focus on applied research. Leveraging McMaster’s research expertise and Fraunhofer’s proven ability to translate research to industry, FPC-BEAM will allow academic and industry partners to translate their ideas into commercially viable products.
Areas of Focus
Access to advanced, scalable manufacturing processes
Facilitate market deployment of the most promising technologies
Contract research and assisted product development
Licenses to existing companies to commercialize academic inventions
Fusion is a clinical stage company focused on developing novel targeted alpha therapeutics (TAT) for the treatment of chemotherapy resistant cancers.
Our first product, FPX-01, combines the precise targeting of a human experienced antibody with Fusion’s linker technology and the alpha emitting cytotoxic isotope Actinium-225 to induce cancer cell death. FPX-01 is presently in a Phase I proof-of-concept clinical trial.
Fusion Pharmaceuticals is a spinout of the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production centre. CPDC has established an international reputation for innovation and excellence in the discovery, development and GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. Fusion will leverage the CPDC’s technology and infrastructure to access new inventions and optimize its capital efficiency
FYELABS exists for one purpose, and one purpose only… to build products really fast and in a no frills model. Thus our clients can focus on their path to market and count on us to deliver the solution.
We deliver innovation as a service. In other words, we help you transform an idea into a selling product. And we do this really really fast, and at a fraction of the cost. Do you have a product idea, and want to go to market tomorrow? Armed with our carefully curated cross-functional team, and the collective wisdom of having developed over 70 products, we acts as your one stop shop for developing your product for you.
Our core team is incredibly diverse, with strengths in software, DevOps, algorithms, IoT, hardware, etc. In addition, FYELABS is architected to leverage the facilities and expertise of McMaster University.
Gene Blueprint is ushering in an era where health and wellness will become more tailored to a client’s particular biology, genetics and environmental influences. Not everyone responds to health and wellness interventions in the same way, and this individual response is largely determined by genetic variations present in our cells. Moving away from a one-size-fits-all approach to something more personalized is a novel approach to aid optimal health and wellness.
Gene Blueprint uses a combination of the client’s DNA, proprietary algorithm, patented gene scores and relevant lifestyle data to make evidence-based recommendations on the type of nutrition and exercise strategies that are most likely to be effective.
Their patented methods to generate genetic risk scores are powered by proprietary algorithms. These algorithms use cutting-edge machine-learning tools to extract a maximum of information from genome-wide data.
Ultimately keeping clients motivated and engaged in better health and wellness activities aided by genetic information will lead to an improved overall quality of life. Using the power of science and genetic data Gene Blueprint is committed to making healthy living achievable, fun and entertaining.
The Genesis Pain Relief Light™ is an effective medical device that alleviates pain and stimulates healing at the cell level by concentrating broad spectrum light through an innovative water based filter.
Developed and tested in Canada, this Health Canada licensed and FDA approved handheld device can be used to diminish age and athletic related muscle pains and injuries, as well as accelerating the healing process.
The first commercially available model of the Genesis Health light family is the Genesis Pain Relief Light CS1000. Our innovative and ergonomically advanced design is targeted primarily for home use. It can be used safely and effectively by people of all ages. From sports injuries to back pain to carpal tunnel syndrome and much more this unit will see multiple uses for an active family for years to come.
Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology. We have a proven track record of identifying emerging bioscience opportunities, and transforming them into commercially successful companies. That track record is fuelled by robust industry relationships, broad business expertise, and a deep understanding of the life sciences sector.
Genesys has generated more than 18 exits from 36 portfolio companies and has invested more than $200M. Our third institutional fund is closed and we’re actively considering new, high-potential life science companies for investment.
The Genetic and Molecular Epidemiology Laboratory (GMEL) provide high-quality, affordable, cutting-edge genomics services. Our labs are equipped with the latest technology to perform a range of experiments, including next generation sequencing, microarray analysis, and bioinformatics.
GMEL provides a broad range of genomics and proteomics solutions from high-throughput DNA/RNA extraction to sample quantitation and quality assessment, microarray-based experiments (genotyping, gene expression, methylation), next-generation sequencing (exome, RNA, custom target, low-pass whole-genome), multiplexed protein biomarker assays, and many other services. Additionally, we provide support for experimental design considerations, bioinformatics and statistical analyses, and interpretation/ reporting of results.
The laboratory specializes in large-scale population genetic studies, is automated and handles projects ranging from a few hundred to >10,000 samples. To date, the GMEL has analyzed over 50,000 DNA samples.
The GMEL possesses a broad variety of instrumentation (QIAsymphony, BioAnalyzer, Fragment Analyzer, Gene Titan array scanner, Illumina iScan, 2 Ion Torrent S5XL Sequencers, BioNano Genomics Irys System, Thermofisher ViiA7 RT-PCR System, QuantStudio 3D Digital PCR System, Pyromark Q24 instrument, BioMark HD System, Bio-Plex Luminex Multiplex assays, Olink panel assays, SomaLogic SOMAscan assay) as well as the necessary bioinformatics infrastructure (10 dedicated servers) to process large genomics projects at reasonable turnaround times.
These services are available to researchers at McMaster University, as well as academic and non-academic users locally, nationally and internationally, on a fee-for-service basis. Our technical staff can also assist in the setup and design of experiments.
Genome Canada is a not-for-profit organization, funded by the Government of Canada. We act as a catalyst for developing and applying genomics+ and genomic-based technologies to create economic and social benefits for Canadians. We:
connect ideas and people across public and private sectors to find new uses for genomics
invest in large-scale science and technology to fuel innovation; and,
translate discoveries into solutions across key sectors of national importance, including health, agriculture and agri-food, forestry, fisheries and aquaculture, the environment, energy and mining.
Since its foundation in 2013, the Geriatric Education and Research in Aging Sciences (GERAS Centre) has emerged as an international leader in fractures, frailty, and dementia research.
We are at the forefront of several innovative research initiatives focused on maximizing the resilience of vulnerable older adults. With our rapidly aging population, and with more people living with chronic disease, our work has never been more important. We have been working hard towards our goal to enable people to age with dignity and independence.
The Centre, based out of St. Peter’s Hospital (SPH) in Hamilton, aims to advance health care through education and research. This aim is operationalized by linking research, practice, and education to realize point-of-care improvements for seniors.
Strong partnerships with the St. Peter’s Centre for Healthy Aging, the Health TAPESTRY primary care initiative, Osteoporosis Canada, Medical Pharmacies Group Ltd., and many others support the success of the GERAS Centre’s activities.
The Gilbrea Centre is an interdisciplinary research hub that is dedicated to address issues of aging through collaborative and policy relevant research.
Based on a collaborative undertaking by outstanding researchers and educators , the Centre produces and communicates socially-relevant knowledge which helps to broaden understandings of aging, the challenges that exist, and the suggested directions for change.
Our vision is to address the needs of an aging society through research that is grounded in community partnerships, and knowledge exchange with target groups including students, faculty, community organizations, decision-makers, and older people.
Created as a major step forward in addressing contemporary issues of aging, the Centre’s work on aging extends beyond McMaster’s campus through partnerships and collaboration with National and international research teams, and partners in the public, private and non-profit sectors.
As an international, sector-focused law firm with more than 1,400 legal professionals around the world, Gowling WLG is here to help you overcome your complex business challenges. Our Canadian team is made up of more than 700 legal professionals in seven cities across the country
Boasting an exceptional wealth of natural resources, a sound financial system and world-class infrastructure, Canada is one of the world’s premier locations for business investment. Its generous research and development incentives, low corporate tax rates, and easy access to major US markets make it a top destination for foreign companies seeking a foothold in North America.
As a global, sector-focused law firm, Gowling WLG can help you navigate the complexities of establishing and conducting business in Canada. With expertise that covers a wide range of services and sectors, our team understands the distinct challenges you face – and is uniquely positioned to help you succeed.
At Gowling WLG, we want to unlock Hamilton’s potential by acting as an economic accelerator and a global connector. Our firm continues to play a growing role in the region’s innovation ecosystem as the research, technology and manufacturing sectors thrive at home and abroad.
In keeping with that mission, Gowling WLG Hamilton will soon call McMaster Innovation Park (MIP) our home. This move will strengthen our ability to enhance strategic partnerships by staying close to those who are driving progress – the researchers, the engineers, the designers.
By becoming part of Hamilton’s growing hub of innovation – where people live, work and create – we can spark positive social impact by actively supporting city-building and economic development as we forge new pathways between local possibilities and global opportunities.
Meet Grin – the new way to brush your teeth. Unlike disposables, Grin’s beautiful metal handle doesn’t roll over, collect germs or end up in landfill. It’s the new way to be eco-friendly, twice a day. For every Grin toothbrush sold, we donate $1 to a charitable organization.
Better – Ditch the disposable: Keep Grin’s handle and recycle the brush heads.
Cleaner – Stop brushing with old germs – Grin’s handle rinses clean and stays that way.
Easier – Let us deliver fresh brush heads and remind you when they need replacing.
Providing methodological support to clinical practice guidelines developers
Officially established in 2017, GUIDE is an academic group providing methodological support to clinical practice guidelines developers. The group is comprised mostly of critical care physicians and experts in the field of clinical practice guideline development and systematic reviews.
GUIDE is comprised of experts in the field of clinical practice guideline development and systematic reviews, mostly, critical care clinicians with methodology expertise. Guide experts can provide methodological support to your guideline development and other evidence synthesis, and conduct onsite or remote education and training.
GUIDE trainees are mentored under our expert methodologists and are offered opportunities to participate in a variety of activities; including various stages of the guideline development process, educational activities, and other methodological projects.
HaloHealth is a physician-only angel network that provides specialty-matched advisory, connections and capital to early stage healthtech ventures.
Our network of nearly 200 physicians collaborates with and invests in transformative companies that seek to maximize patient outcomes and breathe new life into the healthcare system. Since launching in January 2020, HaloHealth physician members have invested over $1.7 million in 16 startups.
HaloHealth holds offices in Toronto and Vancouver and is partnered with venture capital firms, angel groups, accelerators and incubators across the continent.
Our physician network provides healthtech ventures advisory, connections and capital. We work with ventures that:
Belong to one of three verticals: digital health, medical technology device, biopharmaceuticals.
Are prototype- or MVP-ready.
Come referred by one of: local incubator or accelerator, venture capital partner, local university, angel group, HaloHealth physician member.
Are seeking pre-seed, seed or intermediate financing.
Are compliant with a $25K-$100K cheque size on an individual basis.
HalTech is at the nexus of Halton Region’s innovation ecosystem, working with technology companies to accelerate innovation for business growth. We help technology entrepreneurs and companies to connect, collaborate and transform good ideas and product innovations into well positioned, growing ventures. HalTech offers a wide range of services for eligible tech entrepreneurs and businesses: Business accelerating advising, Entrepreneur development, Corporate innovation support, Customized Market Intelligence from MaRS, Access to funding opportunities and Referrals to professional services.
Haltech’s staff and team of experienced advisors are passionate about bringing the right education, advisory services, and strategic connections to develop and grow innovation-oriented businesses to the next stage. From startups to large global corporations, Haltech is available to help you advance your technology-based innovations to market or to scale up your business.
Contact us to inquire about our range of free business advisory services, learning workshops on entrepreneurship and commercialization, or for assistance with your corporate innovation program.
Since its inception, the Hamilton Centre for Kidney Research (HCKR) has become one of the premier research centres in Canada combining expertise in both basic science and clinical research. Our mandates are to translate our world class biomedical research into clinical practice to prevent and treat progressive kidney disease in children and adults across all walks of life, and to define best approaches to treat kidney disease and its complications.
In affiliation with the Division of Nephrology, HCKR members investigate key aspects of kidney function and disease, including fundamental and translational research in hypertension, vascular calcification, glomerulonephritis, transplant rejection, diabetic nephropathy, genetic studies of chronic kidney disease and complications of dialysis. The resulting genetic targets and seminal discoveries uncovered by researchers at the HCKR represent the foundation for the development of novel medicines and treatment approaches for chronic kidney disease and its complications.
Founded in 1848 as the first hospital in Hamilton, Hamilton General Hospital is a leading healthcare provider for the entire South Central Ontario region. With state-of-the-art facilities, the General is recognized as a regional centre of excellence in cardiovascular care, neurosciences, trauma and burn treatment.
The Hamilton General has one of the province’s few Burn Units and an Integrated Stroke Unit caring for acute and rehabilitation patients. Patients who require open-heart surgery or cardiac catheterization are served by the General’s innovative and integrated approach to care.
The General is home to leading edge research, including the David Braley Cardiac, Vascular and Stroke Research Institute, the Population Health Research Institute (PHRI) and the Henderson Research Centre focused on cardiovascular research. The 100,000-square-foot Regional Rehabilitation Centre, opened in September 2009, has 91 inpatient beds, providing care to stroke, spinal cord injury, amputee, trauma, neurobehavioural and acquired brain injury patients.
Hamilton Health Sciences (HHS) is a community of 15,000 staff, physicians, researchers and volunteers that proudly serves southwestern Ontario residents. We also provide specialized, advanced care to people from across the province.
We’re the only hospital in Ontario that cares for all ages, from pre-birth to end-of-life. We offer world-leading expertise in many areas, including cardiac and stroke care, cancer care, palliative care and pediatrics.
We are a world-renowned hospital for healthcare research. We focus daily on improving the quality of care for our patients through innovation and evidence-based practices.
As the largest employer in the Greater Hamilton region, we play a vital role in training the next generation of health professionals in collaboration with our academic partners, including McMaster University and Mohawk College.
For the third consecutive time, Hamilton Health Sciences (HHS) has been Accredited with Exemplary Standing by Accreditation Canada. Learn more about our standing.
The mandate of the Hamilton Integrated Research Ethics Board (HiREB) is to safeguard the rights, safety, and well-being of all research participants.
All research projects involving McMaster University, St. Joseph’s Healthcare Hamilton and Hamilton Health Sciences physicians, staff (including staff acting as investigators outside the Institutions), students (i.e., research within the institution or using institutional resources), volunteers, visitors, or patients, must obtain ethical approval from the HiREB before research can begin.
The HiREB is responsible, on behalf of the institutions, for ensuring that all research involving human subjects under the auspices of its institutions meet current ethical standards. The HiREB reviews and approves research projects that meet acceptable ethical and scientific standards and for which adequate facilities and resources are available. The HIREB also provides advice on the ethical, scientific and technical aspects of planning research projects.
Hamilton Medical Research Group (HMRG) delivers a unique partnership in drug development and commercialization through working with our partners in development and introduction of safe and effective medicines that improve lives of Canadians.
Our expert network of scientists and medical professionals, demonstrates our clinical expertise, to provide an in-depth understanding and execution of clinical research for Canadian and International results. We leverage this network for expert opinion and expert support to deliver marketing and medical objectives for new and existing products.
Range of Services
Advisory Boards – HMRG leverages a multidisciplinary approach to understand unique challenges of different healthcare professional groups to build positive support amongst key opinion leaders – specialists, primary care physicians and other healthcare professionals
Sales/Marketing Training – HMRG will develop and deliver learning based on adult learning principles to sales teams and marketing personnel
Drug Development Consultation
Regulatory Submission Support
Scientific and clinical expertise in diabetes, cardiovascular disorders, vascular disorders, bone health, dermatological disorders, immunology, neurological disorders, oncology
Deep understanding of patient management and Family Health Teams
Competency in the analysis of therapeutics to identify GAPS in knowledge and usage
Hamilton Regional Laboratory Medicine Program (HRLMP) is one of the largest integrated laboratory service programs in Canada. Providing laboratory support and clinical testing for clinical trials and research studies in the Hamilton area.
The HRLMP delivers services across many disciplines.
– Anatomic Pathology
– Clinical Chemistry and Immunology
– Core Laboratory
– Special Hematology
– Transfusion Medicine
Services provided for research studies include:
– Sample collection
– Sample preparation – centrifugation and separation of serum and plasma, making blood smears
– Sample testing on fresh and/or frozen samples
– Sample storage – short term storage in both -20 and -70°C freezers
– Tissue processing, embedding and slide preparation
The Hamilton Technology Centre (HTC) is a private innovation hub located in Canada’s Innovation Corridor owned and operated by Clearcable. HTC is a modern 40,000 square foot, fibre optic equipped facility that opened its doors in 1993 and is currently striving to foster the development of technology companies by providing space and community to new and accelerating companies who choose the Hamilton area as their home. HTC would like to encourage ongoing cooperation with the region’s other innovation spaces.
The Hamilton Technology Centre is contributing to Canada’s Innovation Triangle by building and supporting a community of innovation leaders. We’re a dynamic and flexible community in Hamilton, Canada with access to 120 million people within a 500 mile radius.
The Health Information Research Unit (HIRU) in the Department of Health Research Methods, Evidence, and Impact (HEI) at McMaster University conducts research in the field of health information science and is dedicated to the generation of new knowledge about the nature of health and clinical information problems, the development of new information resources to support evidence-based health care, and the evaluation of various innovations in overcoming health care information problems.
HIRU has created the Web-Available Population Pharmacokinetic Software (WAPPS-Hemo). Healthcare professionals who treat patients with hemophilia can use the WAPPS-Hemo platform to collect advice from a network of approximately 500 hemophilia treatment centres worldwide to create a customized treatment and prevention plan for patients. The solution is a leader in its field and has been licensed to several pharmaceutical companies.
Health Information Technology Services (HITS) is an information technology consulting and hosting service provided by the Information & Communication Technologies team at Hamilton Health Sciences. We are here to serve healthcare organizations in the region we know so well, including family health teams, regional hospitals, solo practitioners, and any related healthcare businesses.
Our team of more than 100 customer support representatives, analysts, designers, technicians and project managers can help healthcare organizations transform the capacity and functionality of their information technology.
We will help you leverage all opportunities to maximize effectiveness, efficiency and affordability. Most importantly, the experience and knowledge we have gained from working within the healthcare system for many years means that we understand the challenges you’re facing.
Health Innovation Hub (H2i) was established to create a culture and infrastructure that aligns, connects, serves and facilitates student driven translation of discoveries and ideas into problem-solving designs that impact positively on health matters.
The Health Leadership Academy strives to have a transformative impact on global healthcare by nurturing a community of future leaders.
Thanks to our interdisciplinary and forward-thinking approaches to education, these leaders will be prepared to succeed in a number of fields – from informing government policy to developing and supporting health innovations.
The Health Leadership Academy proudly supports collaboration and showcases new projects and pedagogy in health innovation within the McMaster community and surrounding area. We promote and endorse interdisciplinary research that shows strong potential for training and development of tomorrow’s health care leaders and transforming Canada’s health care system, with a focus on leadership and one or more of:
In addition to offering world-class academic programs and informative public events, we encourage innovations with the potential to revolutionize healthcare as we know it.
Helpers is the Uber of home care with a technology platform that helps seniors and families request home care services on demand from a trusted network of caregivers. Helpers is focused on improving the convenience and flexibility of services by allowing customers to only pay for what they need, when they need it.
Today’s care can be rigid, unreliable and expensive. Helpers is setting out to change that with a passionate group of professionals on a mission to provide fast, personalized and reliable home care.
HRL is a provider of non-diagnostic laboratory services, specialising in coagulation testing with over 100 validated assays and multiple testing platforms.
While the common coagulation test panels are offered, we specialize in esoteric coagulation testing and custom assays with specific reagent/instrument combinations. We support our clients that range from diagnostic and reagent manufacturers requiring validation support to pharmaceutical and academic research projects.
We are also the only laboratory in North America commercially conducting international reference standard testing according to the World Health Organization (WHO) protocol. Please see our case studies to learn more about our capabilities and client collaborations. We would look forward to customizing our services to meet your project specific testing needs.
Founded in 2016 to help the millions of people who suffer from strokes every year.
HiNT stands for Healthcare Innovation in NeuroTechnology and we are developing a wearable point-of-care monitoring device that detects when patients at high-risk are having a stroke. The device is a comfortable, wearable headband that will alert patients, caregivers, and emergency services in the case of a stroke.
The HiNT mobile app is connected to the wearable device. Not only will it notify the patient, their caregiver, and emergency services in the event of a stroke, but it also allows the patient to call for help and track the location of the ambulance en route
A laboratory of National Research Council Canada, HHTR is committed to achieving improved health outcomes for the benefit of society by accelerating the discovery and development of innovative biologic medicines in Canada.
Through the fostering of science excellence and talent development, we drive step-change innovation in collaboration with industrial, academic and government partners.
Our expertise spans across a range of areas including immunobiology, translational bioscience and bioprocess engineering (bacterial, viral and mammalian platforms), as well as downstream processing and analytics to enable progression through the drug development value chain.
We host the largest research and development team dedicated to biologics development in Canada, helping our partners to accelerate and de-risk the drug development pathway through pre-clinical research support. Through engagement with a variety of partners and stakeholders, we provide collaborative research, technical expertise and advisory services, service agreements in biomanufacturing and bioprocess engineering, and technology transfer (e.g. asset licencing, co-development of assets, and intellectual property management). Our aim is to build a strong pipeline of assets suitable for commercial exploitation, across a range of expertise including:
Broadly applicable technology platforms for drug delivery.
Proprietary cell lines for the production of biologics.
Specialized in vitro and in vivo disease models, as well as step-change vaccines and biologic products.
Unique in Canada biomanufacturing expertise, including the ability to process at scale:
up to 1500 L in microbial expression systems
up to 500 L in mammalian expression systems for biologics production
In vitro and in vivo research laboratories, which encompass containment up to biosafety level III.
Through our facilities, laboratories and extensive expertise, our role is to catalyze business innovation and public health solutions for unmet medical needs of importance to Canada in the areas of cancer, neurobiology and emerging infections, including:
Disruptive technologies to advance made in Canada solutions for cell and gene therapy.
Business innovation for multifunctional antibody-based therapeutics.
Public health solutions such as vaccine development.
We work with a broad range of partners and stakeholders, including industry (start-ups, small and medium sized enterprises, and multi-nationals), hospitals and health networks, academia and government.
HyIvy Health creates a pelvic rehabilitation device with trackable data for women who have pelvic cancers and diseases to help alleviate pelvic health symptoms after a devastating diagnosis, treatment or surgery.
Our connected, smart device provides real time information to give you the most comfortable and informed experience through your pelvic health recovery.
ICON Life Sciences Canada Inc (formerly MAPI), is part of the global ICON group. ICON is the leading Patient-Centered Research company serving academia, life science researchers, and the pharmaceutical industry for over 40 years.
Established in 1996, is one of Canada’s largest regulatory affairs consulting firms. With over 100 consultants and staff, we manage all aspects of regulatory affairs, Quality and PV for our clients around the world. ICON clients benefit from our broad experience at every stage, including product development, licensing and post-licensing activities, Medical Devices, strategy and government liaison, training and audit support.
ICON’s commitment to patient-focused research is demonstrated not only by our expertise and nearly four decades of service but also through our direct contribution back to the industry.
ICON is among only a handful of global organizations that is capable of engaging with a patients’ complete ecosystem, their HCPs, Patient Communities, payers, and even regulators. And only ICON has the unique history to make us the most experienced at interacting with all of them.
IDEAWORKS is Mohawk College’s applied research and innovation department. IDEAWORKS fills the space between research and solutions by delivering customized support to organizations. Innovation helps organizations grow. In some instances, what’s needed to achieve success is not available within the organization.
We help Canadian and international businesses, non-profits, governments and other organizations grow and innovate through applied research and innovation projects. Advancing innovation, design thinking, entrepreneurship, and applied research, IDEAWORKS collaborates closely with industry to commercialize ideas and improve business productivity by providing access to knowledge, staff, state-of-the-art labs and research capacity.
IDEAWORKS activities and services include:
Research, design, develop, prototype, test and commercialize new products, processes and technologies
iGan Partners is Canada’s health technology VC investing in entrepreneurs to commercialise and scale their disruptive innovations.
We partner with exceptional founders focused on commercializing and scaling technological advancements in healthcare. We provide portfolio companies with smart-capital, active support, and access to a network of industry partners and sector specific co-investors to help them grow and succeed.
We are long-term investors, and we build lasting partnerships with founders and leaders of great businesses. These partnerships are often established after the company has raised seed capital, developed a proof of concept, and obtained some market validation. Our initial investment is typically into Seed or Series A rounds and we stay with our companies through follow-on investments
We are ‘hands-on’ investors. We take an active approach, we provide ongoing support, help build teams, and secure key customers when needed. With a strong network of industry partners and co-investors, we ensure our portfolio companies have capital and resources to grow.
ImaginAble Solutions creates assistive devices to improve the quality of life for people living with impaired motor movement.
Guided Hands is an international award-winning assistive device that enables anyone with limited fine motor skills to write, paint, draw and access technology through a touch-screen device and computer.
Guided Hands assists people experiencing limited hand dexterity, hand weakness or difficulty grasping and controlling objects as a result of an injury or medical condition such as Cerebral Palsy, Arthritis, Huntington’s Disease, Dementia, as well as spinal cord injuries and strokes.
Infinotype provides custom bioinformatic solutions for health technology companies – tailored to the specific end-user needs of each client. We help companies realize the most from their data, with a broad range of advice and services covering:
Custom bioinformatic pipelines
Infinotype staff expertise includes bioinformatician, computer science, and hands-on clinical and research biomdical experience.
Clinic and Practice Management Software & Services
Innocare is a global technology company that merges communications, marketing, healthcare, and technology. Innocare draws on the expertise, resources, and solutions of other innovative group companies in a diverse range of sectors.
A Canadian-based technology company, Innocare specializes in clinic management software and services tailored to healthcare, wellness, physical rehabilitation clinics. Innocare helps clinicians all over the world manage their clinics so they can do less paperwork and more patient care using software and services that work together with our partnerships to help clinics deliver the best patient experience.
Innocare partners with clinics and connect them with patients in their area, combining centralized marketing and billing services with clinical expertise to create an optimal customer service and patient care experience. By building an accessible network of great clinics, Innocare allows patients to get excellent care close to where they live and help boost the revenue of our clinic partners.
Innovation Factory (iF) is a not-for-profit Regional Innovation Centre funded by the Ontario Network of Entrepreneurs and located in Hamilton, Ontario since 2011.
iF ignites innovation. Through workshops, programming, one-on-one mentoring and aiding with access to funding, we help startups commercialize their ideas and small/medium enterprises innovate within their organizations. Whether you have an idea on the back on a napkin or a working product with paying customers, we can help get you to the next level.
Our mission is to strengthen Greater Hamilton’s next generation of job and wealth creation by helping:
Entrepreneurs bring new ideas to life and to market
Small/Medium Enterprises (SMEs) get to the next level
Hamilton build a dynamic culture and a community of innovation
InnovoGENE Biosciences Inc. is a research-driven biotechnology company with an innovative platform for developing diagnostic sensors targeting pathogenic bacteria.
To solve many of the underlying challenges faced in various industries that require a quick, easy, and affordable method to identify pathogens, InnovoGENE has created a series of probes based on a molecular material known as Functional Nucleic Acids. This proprietary technology can accurately identify pathogens in a variety of environmental and biological samples without loss of efficiency.
This unique feature differentiates InnovoGENE from competing technologies and enables us to enter markets that have yet found an alternative solution to their currently encumbered method of pathogen detection
At InnovoGENE Biosciences, we firmly believe that Functional Nucleic Acids such as aptamers and DNAzymes have the potential to significantly advance our ability to develop sensors and be used as therapeutics. Our mission is to realize this potential by supporting a community of researchers willing to adopt and utlize this extraordinary material. In additon to developing our own sensors using Functional Nucleic Acids, we provide a whole suite of products and services that will enable your research to discover new and more innovative technologies. With a team of more than 20 years of research experience within this field, we highly encourage you to connect with us to see how Functional Nucleic Acids can be integrated into your own research and development.
INO is the largest centre of expertise in optics and photonics in Canada and is among the best technological research centres in the world. Through multiple light applications, from laser and fibre optics technologies to imaging systems, INO controls light to capture, identify, predict, decide or transform the real world.
Its innovative solutions support Canadian businesses in several key industries through four business units: Biomedtech; Defense, Security and Aerospace; Sustainable Resources, Agriculture and Infrastructures; and Advanced Manufacturing.
With our ISO 13485 certification, we specialize in custom solutions designed to your specifications, from medical device design through to prototyping and fabrication.
Both advanced medicine and point-of-care medicine—now often connected—shape how we view traditional medicine. Innovations like early diagnosis and microsurgery help improve quality of life. These changes come with significant challenges that keep our teams on the lookout for new possibilities and drive them to innovate.
Not only do we design cutting-edge medical devices, but our experts can also help pharmaceutical industries by providing tools to help with new drug discovery. The society we live in faces major challenges ranging from population aging to new viruses and pollution. Healthcare costs have exploded, and we are often in a race against time to find new vaccines, treatments, or medications. With INO, you get a technological leg-up that allows for more effective monitoring during the discovery phase and increasingly advanced clinical testing, so you can take full advantage of the commercial opportunities that arise.
We develop highly advanced systems for a variety of specialized fields, including:
Thanks to the skills and knowledge of our experts, we provide support in numerous areas of specialty:
Inovex is a digital transformation partner for leading enterprises and SMEs. We help businesses skillfuly build technology and custom software solutions to drive innovation and operational efficiency. We’re constantly reimagining digital innovation to deliver state-of-the-art and skilfully engineered cloud, web, mobile and IoT solutions.
Our aim is to create simple and meaningful solutions that leverage data science to drive insights and empower you to achieve your business goals.
The Canvass Health platform can help organizations fight Covid-19 through our disease registry & supply chain software. Track the course of the disease, changing demographics, treatment patterns and consolidate research. Manage inventory allocation of scarce supplies, manage order placements, predict demand and proactively allocate supplies. Entirely Microsoft-based, Canvass Health is a cutting-edge data interface management solution that accelerates collection, integration and development of healthcare data.
InputHealth facilitates outcomes-based health care delivery at the point of care through a beautifully designed, cloud-based platform. InputHealth has developed a comprehensive cloud based health platform referred to as the Collaborative Health Record which facilitates outcome driven interactions between healthcare providers and patients.
Their solutions have demonstrated proven results in its application at world-class health care institutions including the Mayo Clinic. InputHealth differentiates itself by meaningfully integrating patient-reported outcomes into clinical encounter documentation through a beautiful, intuitive interface. By mixing these two conventionally disparate elements, InputHealth streamlines a process that integrates PRO data collection at every patient-clinician encounter.
Insight Medbotics has clinically tested an MRI-guided robotic device that positions a biopsy device with unprecedented precision and patient comfort, and is now moving to commercialization clearances for both Canada and the USA.
As a precision placement platform, it is able to navigate to a specific point in three dimensions with startling accuracy and repeatability. This is an essential capability in assisting a biopsy procedure that is so innately location dependent.
The system is envisaged to ultimately provide superior imaging, precision biopsy, accurate therapy, and a growing dataset providing prognostic potential
The Michael G. DeGroote Institute for Infectious Disease Research (IIDR) at McMaster University is a world-leading centre of transdisciplinary infectious disease research.
Since its inception in 2007 through an unprecedented gift from Hamilton businessman Michael G. DeGroote, the IIDR has brought together a successful team of over 30 principal investigators and 2000 trainees, all of whom are committed to delivering new knowledge and solutions to some of the most pressing challenges in infectious disease. Our members span a variety of disciplines ranging from medicine and biochemistry to mathematics, anthropology, and engineering, among others. Through collaborative research that spans the lab and the clinic, our team is dedicated to finding new treatments and preventions to control infections that have devastating impacts on health.
McMaster University’s cutting-edge genomic, imaging, Biosafety Level 3 (BSL3) and animal facilities enable the IIDR’s fundamental and applied research initiatives. The IIDR’s core supporting infrastructure – the Centre for Microbial Chemical Biology – is a 7,000-square-foot laboratory that features six integrated labs, allowing chemical biology research to be conducted in one central location.
IIDR continually advances its research objectives to align with the evolving infectious disease landscape. Such initiatives fall into three general categories:
1) Microbial Research – Including fundamental research into the causation, detection and treatment antibiotic resistance, the discovery of new antibiotics and antibiotic alternatives, and the study of microbial physiology and microbial evolutionary biology;
2) Host-Pathogen Interaction Research – Including the study of immunity and pathogenesis, microbiome research, and the mathematical modelling of infectious disease from the level of molecules to populations;
3) The Discovery and Development of New Technologies – Including novel inventions and innovations in drug discovery, diagnostics, vaccinology, and materials science.
Encompassing an array of technologies, disciplines and specialties, the Michael G. DeGroote Institute for Pain Research and Care (IPRC) is exploring the causes of a number of different types of pain, developing new strategies for its prevention, diagnosis and management, and innovative care for patients.
The institute places a special emphasis is on thalamic pain. This type of pain is centred in the thalamus of the brain and may cause sufferers to experience numerous forms of discomfort. Michael DeGroote himself has suffered from a severe form of thalamic pain after experiencing a stroke.
Ironstone Product Development (IPD) is an ISO 13485:2016 certified medical device development company. We assist our clients with all aspects of medical and health product development and commercialization. Our team members have successfully commercialized dozens of innovative medical and healthcare products. These products have changed the practice of healthcare and have generated transformative revenue for the companies involved.
We work with entrepreneurs and established companies to help define the right product and find the most efficient way to get it in the hands of the clinicians and patients that need it. Our background includes extensive work in engineering and clinical affairs as well as regulatory strategy. This enables us to understand the details underlying how your product works both technically and clinically while clearly communicating this to regulatory bodies.
Our team has experience in the development, clinical evaluation, and worldwide regulatory approval of the following product types:
Imaging: MR devices, ultrasound, and impedance based products
Oncology: Radiotherapy equipment and ablation technologies
Neurology: Implantable stents, ablation devices, pain management products, laser based therapies, deep brain stimulation products, and transcranial magnetic stimulation (TMS) systems
For the healthcare system to have a sustainable future, it must adapt to the changing needs of an aging population. At iUGO Health, we’re building the future of healthcare today. With innovative technology, we’re creating solutions that bring healthcare to home and community settings; improving health outcomes for patients and driving efficiency for providers.
Our innovative and comprehensive solutions include remote patient monitoring, care management, wound care tracking, and telemedicine. We’re making it possible for patients to receive the care they need when they need it while making it easier for providers to deliver that care. Designed by clinicians with patients in mind, our products streamline healthcare delivery and management and empower patients to be active participants in their own health and wellbeing.
iUGO Health is a wholly-owned subsidiary of Reliq Health Technologies, Inc.
Jan Kelly is an award-winning creative digital agency.
Beyond developing, implementing and optimizing strategic digital-first campaigns through our Humanology philosophy, we invest in what we know will drive client growth and success. Everything from establishing partnerships with regional innovation centres to developing our own digital solutions like LeadHatch and supporting high-potential startups.
As the first JLABS to open outside the United States, JLABS @ Toronto joins a network of life science facilities that are based throughout the United States in San Diego (the flagship JLABS), San Francisco, South San Francisco, Boston and Houston. These facilities are home to over 100 early-stage companies advancing pharmaceutical, medical device, consumer and digital health programs.
JLABS @ Toronto supports over 50 resident companies and has over 20 alumni companies within its network. Companies advancing consumer products, therapeutics, medical devices, health tech and cross sector focuses make up the vibrant JLABS @ Toronto resident and alumni community. The current resident demographic reflects the region’s leadership in the fields of artificial intelligence, regenerative medicine, oncology and vision care.
JLABS @ Toronto is the JLABS for Canada. With 43% of resident companies coming from outside the GTA, from places like Halifax, Vancouver, Montreal and Calgary, we provide a second “home-base” for R&D and management teams. JLABS @ Toronto also brings external and internal Johnson & Johnson expertise to over 15 cities across the country through educational programming, webinars and speaking engagements.
The 40,000-square foot facility includes cutting-edge, modular and scalable lab space, state-of-the-art equipment, with access to scientific, industry and capital funding experts. The space also features JLABS’ inaugural device and digital prototype lab that provides entrepreneurs with access to highly specialized tools and skills building programs to design and develop smart health technologies.
Juravinski Cancer Centre serves more than 1.7 million people in the central west Ontario region and sees more than 7,000 new patients each year. As a regional referral centre, the JCC collaborates and coordinates with care providers in each patient’s home community. In September 2014, the state-of-the-art CIBC Breast Assessment Centre opened at the JCC to provide comprehensive, multidisciplinary and leading-edge care in the diagnosis of breast cancer.
JCC is where cancer treatments such as chemotherapy and radiation take place, as well groundbreaking cancer research. There are no overnight beds at the cancer centre. It is adjacent to Juravinski Hospital on Concession Street, with internal hallways linking the two.
Juravinski Hospital, located on the brow of the Niagara escarpment, is best known as the host hospital for the Regional Cancer Program.
Juravinski Hospital provides acute inpatient and palliative care, diagnostic services and an educational environment to support the needs of cancer patients and the Juravinski Cancer Centre. In addition to dedicated wards for cancer patients, Juravinski Hospital is also a general medical/surgical hospital with a community Emergency Department.
Juravinski Hospital’s highly regarded Orthopedic program combines health care and research to offer patients a range of services dedicated to helping them prepare for and recover from joint replacement surgery.
At KPMG, we work to provide you with the one-on-one personalized service you desire. We strive for the highest professional standards and are committed to producing leading results for you.
KPMG has the resources required to provide a full range of services to clients situated in the Hamilton and Halton areas, while offering the strength of our national and international member firms.
We recognize that for our clients, personalized service at the local level is essential. We know that earning your business and your trust comes down to superior service and delivering value. We are dedicated to serving you for years to come because we want to grow with you and see your organization succeed year after year.
Founded in 2022, Kultura Diagnostics is a medical technology with a vision is to change the game for individuals with gluten sensitivity.
Kultura Diagnostics is developing a machine learning powered technology that helps you understand your gluten sensitivity in a more accessible and cost-effective way. Spend as little time as 5 minutes each week and unlock a deeper understanding of your health like never before.
A venture studio provides funding, but unlike a venture capital company, we assemble the right team for each venture. We work with our Board of Advisors to develop and nurture new ideas. The involvement of the studio throughout the entire growth process offers a much more predictable path to success.
Current startup communities are not attracting the teams best suited to solve healthcare’s biggest challenges. It takes seasoned entrepreneurs to successfully launch these novel ventures. Launchit is the team that will do this.
We offer a unique model that combines funding, entrepreneurship, business acumen, along with a shared business services model. Our approach reduces cost and significantly increases the chance of success for the companies we support.
At Lennard, the foundation of our service are the strength and depth of our commercial real estate specialists. By drawing on years of direct experience across the Greater Toronto Area and Canada, our agents possess a thorough understanding of the industry and their specific markets.
Lennard is an all services shop and as such is able to fulfill even your most complex real estate requirements. The services we offer to occupants, tenants, owners and investors include: property search and selection, lease audit, project and facility management, and investment services. You can count on your Lennard professional to have the experience, knowledge and resources needed to meet the unique challenges of your transaction, and ensure that you make the most informed decision possible.
Fostering commercial success for Ontario's life sciences sector through advocacy and education
LSO is a member-funded, not-for-profit organization advancing Ontario life sciences through advocacy and policy work, educational and networking events, and support services for our sector.
Members of Life Sciences Ontario include established and emerging life sciences companies, along with individuals, members of academia, and service providers.
Member companies consist of a diverse range of stakeholders from across our sector, including companies operating in biopharmaceuticals, agriculture, agri-food, the bioeconomy, medical devices, animal health, environmental technologies, and more.
Live Easy is an action orientated company that connects the dots between companies and consumers. 30 years of real-life accessibility challenges and a wealth of product knowledge means that we can navigate almost any challenge that accessibility or Aging in Place can present.
Live Easy has partnered with Bay Area Health Trust to form a boutique distribution company that will focus on companies that aim to make aging in place safe and comfortable. The combination of BAHT resources with LEI’s experience and connections will serve an attractive model to small innovative start-ups who wish to penetrate the Canadian market or scale beyond their current sales.
The LIVE (Large Interactive Virtual Environment) Lab is a unique 106-seat Research Performance Hall designed to investigate the experience of music, dance, multimedia presentations, and human interaction.
The space includes Active Acoustic Control; Sound Recording Equipment; and measurement of Behavioural Responses, Movement (motion capture), Brain Responses (EEG), Muscle Tension (EMG), Heart Rate, Breathing Rate, and Sweating Responses (GSR).
The aims include:
A neuroscientific understanding of how performers interact, what moves audiences during a performance, and the cognitive, social and emotional impact of these experiences;
Incorporating technology and real-time audience feedback into creative performances;
Development and evaluation of new technologies for health (e.g., hearing aids, dance for Parkinson’s) and artistic expression;
Neuroscientific evaluation of human responses (e.g., market research; defining important aspects of culture) and what makes for successful human interactions (e.g., educational techniques, group problem solving).
Research in the LIVELab is aimed both at theoretical understanding and applications to business, health, education public policy, and artistic creation.
Lumedi EDC is designed from the ground-up, based on the principles of Learning Health Systems.
In Learning Health Systems, clinical/medical research influences practice and practice influences research. This creates a continuous feedback-loop that prioritizes patient outcomes and leads to faster innovation.
Over 800,000 clinical/medical research studies are conducted in North America every year, and yet the majority of the data is not reusable. Poor data quality, lack of standardization, lack of security compliance, and teams working in silos, prevent research from impacting patient care.
We created Lumedi EDC to be integrated and secure, a cloud-based platform to help medical/clinical researchers collect high-quality electronic data from anywhere. As a collaborative solution, it connects research teams, clinicians, caregivers, and study participants in a way that improves patient outcomes.
Lumira executes a consistent, proven investment strategy as a lead investor and active partner with our portfolio companies. We focus on companies whose products offer transformative (not incremental) improvements to patient health outcomes, and the promise of dramatic reductions in the cost of healthcare delivery. Our Canadian heritage helps us “skate to where the puck is going to be,” investing in the new science and clinical insights that we expect will be driving the next decade of patient care.
Since our inception, we’ve been a different type of venture capital investor. We often focus on backing companies in regions of North America bypassed by most other investors. We manage right-sized funds where the financial interests of our fund investors are tightly aligned with our own. And we differentiate ourselves to entrepreneurs as an investor-of-choice by helping them leverage our multi-decade team stability, global industry relationships and lessons learned from building over 100 companies over our careers.
Lunar Medical Inc. (LMI) was founded to solve the challenges of providing medical support for human spaceflight.
LMI was born out of a research program that looked at the medical challenges faced by humans in extreme environments. NASA and Canadian Space Agency funded work by LMI’s leads have included work on psychological stressors in Antarctic over-winter personnel, and telemedical support simulations conducted at Devon Island’s Haughton Mars Project Research Station (HMPRS), the NASA-CSA-DLR In Situ Resource Utilization (ISRU) expedition on Mauna Kea in Hawaii, and at the Eureka Weather Station on Ellesmere Island in the Canadian Arctic. These remote locations serve as Space-Analogue Environments, and replicate some of the remote and harsh conditions of spaceflight.
We believe that the advanced system concepts currently being designed to provide medical care on the Moon or Mars can inform terrestrial efforts to improve remote and rural medical care. Lunar Medical was born from this vision – to develop autonomous, high quality medical care systems for spaceflight, and to bring that technology back to Earth. State-of-the-art medicine anywhere, anytime, for everyone.
m-Health Solutions specializes in remote patient monitoring and cardiac diagnostics. Using leading-edge technologies, m-Health Solutions has created a system where the patient is the center of care. Once attached to the patient, the mobile technology sends cardiac data directly to a centralized and secure facility where acardiac technologist reviews the information in near real-time. In the event of an urgent finding, the cardiologist is immediately notified.
The service includes a patient-centric system that delivers the monitoring technology directly to a patient’s home. Easy access and hook-up improves patient compliance and prevents the need for the patient to have multiple trips for device hook up and removal. The system can also be used by health care facilities to monitor patients in the comfort of their own home post-discharge.
MacData was created to identify synergies to foster collaboration among McMaster University’s many institutes, centres, and researchers whose work involves the many facets of data.
MacData promotes the engagement of researchers and students within McMaster as well as externally with industry, government and community to strengthen McMaster’s position as an international leader on all matters related to data.
We are a university-wide institute founded in 2015 and operate under the office of the Vice-President of Research. Our mandate is to promote innovative research and training programs on big data. We work with, and support faculties and institutes on data issues and initiatives.
Marchese Health Care is an independent community-based health care provider dedicated to the delivery of compassionate, client-focused care. We provide a wide variety of medication, supplies and equipment; clinical knowledge; and specialized services to meet your health and wellness needs.
In addition to our dispensing pharmacy, we reach out to patients receiving care in their homes with a wide range of medical supplies and specialized medication programs.
Founded in 2016, Mariner Endosurgery Inc. develops and commercializes innovative computer assisted medical devices for future-facing laparoscopic surgeries.
Their platform LaparoGuard is a novel soft-tissue surgical navigation platform that augments visualization during laparoscopic surgeries, enhancing the safety profile of laparoscopic surgery to assist surgeons in delivering a superior quality of care to their patients. LaparoGuard unites machine learning, robotic assistance and advanced visualization with one common goal: augmenting surgeon performance
We create deep learning representations of cancer that uncover more profound insights than ever before. Our largely unsupervised approaches will rebuild pathology from first principles and unlock previously inaccessible insights.
Eliminating Human Error: automate tedious and error-prone tasks like cell counts and morphological analysis and do more of what humans excel at. magnifying glass
Augmented Diagnosis: Receive insights on previously inaccessible features of patient biopsies, including information on the bone marrow niche. cells
Occupying 1.5 million square feet in downtown Toronto, MaRS is a diverse community of more than 120 tenants, including research labs and global tech companies, each selected to create a community that is collaborating on real solutions to important problems.
From advisory services to connections to talent, capital, customers and more, MaRS offers a range of high-value services that help high-growth companies succeed. We also provide access to the MaRS ecosystem, a curated community of entrepreneurs, investors, corporates, academics and government partners.
The work carried out by the innovators in our community is making innovation mean something again. For example, it helps streamline our healthcare system, reduce the effects of climate change, unlock new cures for disease, envision the jobs of the future, improve mobility in crowded cities, and provide food and clean water for a growing population.
MaRS Investment Accelarator Fund (IAF) invests in passionate entrepreneurs with ground-breaking technologies. We are the leading seed stage investor in Ontario, investing in IT, health and cleantech companies with a minimum addressable market size of $100M.
We invest at the seed stage, with investments of $500K. We do 10-12 deals per year, but see well over 300 companies. We target early-stage technology companies that are close to commercialization. Ideally the product has been built, and there is some early market traction. No significant revenue, assets or institutional investment.
Established in 1984, MMSI represents manufacturers from Canada, United States, England and Europe.
Through our business units: Hospital Specialty Products, Home Health Care/Retail Pharmacies, Respiratory Home Care, Dental and Medical Supply Dealers we are proud to offer innovative, cost effective and high quality products, prompt service and informed advice.
McFocal Advanced Imaging develops novel optical imaging technologies that enable discovery in health and life sciences including high content screening of drug leads, precision medicine, and quantitative biotechnology.
McFocal develops optical imaging technologies that enable discovery in health and life sciences including high content screening of drug leads, precision medicine, and quantitative biotechnology.
McFocal is a spin-off from the McMaster Biophotonics Research Group, which works on a number of imaging/sensing related technologies that have the potential to be translated to application.
The McMaster Centre for Transfusion Research (MCTR) is an academic research group whose mission is advancing transfusion science through innovative methodology and collaborative research to improve patient health outcomes. MCTR brings together clinical, methodological, and translational experts to perform cutting-edge research; foster collaborations; and train future leaders in Transfusion Medicine.
MCTR is built on the foundation of an internationally-acclaimed research program formerly known as the McMaster Transfusion Research Program (MTRP), which was formed in 2001 as a joint collaboration between Canadian Blood Services (CBS) and McMaster University. Over the past 16 years, the program has produced research outputs with local, national, and international impact.
MCTR supports 7 core faculty and 8 associate faculty investigators, employs 11 staff including research coordinators, research assistants and biostatisticians, and occupies renovated space at McMaster University.
Researchers at the McMaster Child Health Research Institute are looking beyond medical treatments of individual conditions to explore the deeper connections between childhood illness and long-term health. The mandate of the MCHRI is to foster collaborative research and educational efforts dedicated to understanding the forces and experiences that shape human development and health as children and youth with complicated lives and their families move through the life-course.
The MCHRI is comprised of internationally recognized child health research programs organized under a common umbrella. Our research partners have significant research expertise in child and youth mental health, childhood disability, childhood cancer, obesity, exercise and nutrition, bone and muscle disorders and child maltreatment. Working together, they share knowledge and address the common themes of children and families with complicated lives.
The MCHRI brings a fresh and innovative perspective to child and youth health, and expects to learn lessons that will benefit children and families everywhere.
McMaster Children’s Hospital is a pediatric academic health science centre serving the special and unique healthcare needs of children and youth using a family-centred model of care.
The hospital is home to the fastest-growing kids-only emergency department in Ontario, one of Canada’s most advanced neonatal intensive care units, and a range of programs and clinics with unique expertise in a number of areas including children’s cancer, digestive diseases, and mental health.
Founded in 1988, Master Children’s Hospital (MCH) has rapidly become a leader in pediatric evidence-based care, collaborative research and innovative leading edge education. MCH is home to 165 acute care beds and 10 day beds, 80 subspecialty clinics, a Children’s Treatment Centre and one of the largest and most impressive Neonatal Intensive Care Units in Canada. Each year MCH has over 210,000 patient encounters in our subspecialty clinics, diagnostic areas, emergency department, inpatient wards and operating rooms.
McMaster Digital Transformation Research Centre (MDTRC) is a world-class research organization bringing together top researchers from the DeGroote School of Business, McMaster University, and beyond. MDTRC engages in cutting-edge multidisciplinary research to understand how digital technology is impacting individuals at the physical and neurological level, as well as transforming organizations and society at large.
The MDTRC is designed to facilitate collaborative multidisciplinary research, technology assessments, student training, and executive education. This is facilitated through collaborations with key partners and affiliates in academia as well as the public, private, and not-for-profit sectors.
McMaster University’s Faculty of Health Sciences is unique as the only Canadian university that combines, in one Faculty, schools of medicine, nursing, rehabilitation sciences, and the programs of midwifery, bachelor of health sciences, physician assistant and postgraduate health sciences education. This is a specific initiative to train members of the medical team in a collaborative, interdisciplinary approach to develop effective and efficient health care.
Our sites include:
The administrative offices of the Faculty of Health Sciences are sited within the Health Sciences Centre on McMaster University’s beautiful campus, a building shared with the McMaster University Medical Centre, one of five hospitals of Hamilton Health Sciences
Students of the Faculty of Health Sciences learn in the affiliated academic hospitals of Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton, as well as affiliated community hospital partners in Niagara, Haldimand-Norfolk, Brant, Kitchener-Waterloo, Wellington and Halton.
Classrooms, laboratories and offices for the Faculty’s schools and programs are also housed on campus in the Michael G. DeGroote Centre for Learning and Discovery and the Mohawk-McMaster Institute for Applied Health Sciences, and in downtown Hamilton at the David Braley Health Sciences Centre at the McMaster Health Campus.
The Waterloo Regional Campus of Michael G. DeGroote School of Medicine is located on the Downtown Kitchener Health Sciences Campus of the University of Waterloo in Kitchener Ont.
The Niagara Regional Campus of Michael G. DeGroote School of Medicine is located in purpose-built space on the first floor of the Cairns Family Health and Biosciences Research Complex on the campus of Brock University in St. Catharines, Ont.
Students have the opportunity to learn in a multitude of clinical situations, with placements in more than 60 Ontario communities including in rural and Northern Ontario.
McMaster Genomics Facility encompasses both the Farcombe Metagenomics Facility (FMF) and the Mobix Lab.
The Farncombe Metagenomics Facility (FMF) provides Next Generation Sequencing (NGS) using a variety of platforms including: Illumina MiSeq and HiSeq-1500 and the Pacific Biosciences (PacBio) Sequel I System. We offer DNA, RNA and protein analysis using Nanostring nCounter technology. Other services include DNA and RNA quality assessment (Agilent Bioanalyzer and Tapestation), DNA shearing (Covaris) and size selection (Blue Pippin). We encourage you to contact us regarding your project design for any new study. Our bioinformatician can assist you with data analysis on a fee-for-service basis.
The Mobix Lab provides high-quality capillary-based fluorescent Sanger Sequencing and Fragment analysis using our Applied Biosystems 3730 Genetic Analyzer. Our services also include DNA and RNA Oligo synthesis service through our IDT portal as well as access to our onsite FroggaBio Biobar.
For concerned citizens and influential thinkers and doers, the McMaster Health Forum strives to be a leading hub for improving health outcomes through collective problem solving. Operating at regional/provincial levels and at national levels, we harness information, convene stakeholders and prepare action-oriented leaders to meet pressing health issues creatively. The Forum acts as an agent of change by empowering stakeholders to set agendas, take well-considered actions and communicate the rationale for actions effectively.
Health- and social-system leaders looking to strengthen health systems, and get the right programs, services and drugs to those who need them, can draw on our services in any of five domains:
learn how to make decisions based on the best available research evidence;
find evidence through our own products and the best available sources of pre-appraised, synthesized research evidence;
spark action through stakeholder dialogues, citizen panels and more;
embed supports for evidence-informed decision-making, by institutionalizing promising and proven approaches; and
evaluate innovations in supporting evidence-informed decision-making.
McMaster HealthLabs (MHL) is a non-profit organization focused on curbing the human, economic and social costs of COVID-19 through research initiatives and testing solutions. Our scientific research informs evidence-based decisions that keep Canadians safe and accelerate business recovery.
McMaster HealthLabs was created to respond to the urgent need of COVID-19. MHL is working with a team of scientists and doctors from McMaster University, the Research Institute of St. Joseph’s Hamilton and other Canadian universities and research organizations to generate the scientific data critical to developing innovative ways to keep Canadians safe and to support a strong economy.
Dr. Jack Gauldie, Vice President (Research) at St. Joseph’s Healthcare Hamilton, and Dr. Marek Smieja, Microbiologist and Professor, Pathology and Molecular Medicine at McMaster University helped bring together some of the brightest minds to create MHL.
We work with scientists and doctors who are affiliated with McMaster University, The Research Institute of St. Joe’s Hamilton, and other Canadian Universities and research organizations.
The McMaster Immunology Research Centre (MIRC) is a vibrant, highly successful research grouping, with a unique model of research excellence, teaching/research training, and service provision (including Core facilities) aligned with the mission of the Faculty of Health Sciences, the University and of major funding bodies such as the CIHR. The Centre has an outstanding record of research and training in mucosal immunology, infectious disease, aging, allergy, cancer and lung disease. MIRC enables ease of collaboration and integration of basic and translational research themes, and is characterized by impact discoveries of immune mechanisms and new approaches towards therapeutics in disease.
Research from the centre has spawned a novel vaccine for tuberculosis, innovative methods for cancer treatment, new perspectives on the mechanisms and treatment of food allergy, and creative strategies to prevent and manage lung disease.
MIRC as a whole provides a key resource to the FHS and University to support investigations requiring immunological expertise/facilities. MIRC PIs and staff have expertise in technologies that enable standard, new and entrepreneurial approaches and platforms for discovery and translation. These include:
Well-developed animal models of immune mechanisms
Expertise in virology, recombinant Adenoviruses and lentiviruses, a GMP production facility which is unique to the institution
A central core histology facility, unique to the institution with automated staining capability for immuno-staining, FISH and CISH (Unique in Canada)
A central core flow cytometry facility which is unique to the institution, that also has a GLP-like immune analysis facility (HITS, which is unique to Ontario and one of only 2 in Canada)
A level III biohazard approved facility with Flow cytometry capability
A staff scientist maintained for consultation and collaboration in bioinformatics
Expertise in translation of discovery to clinical trials
The McMaster Industry Liaison Office (MILO) supports the research endeavors of McMaster University by facilitating collaborative research with industry partners and disseminating research results through commercialization. MILO is a unit of the Office of the Vice President of Research at McMaster University.
Advancing collaborative research
We review and negotiate all industry-sponsored research agreements and all research contracts performed by the University, whether from government, industry or other sources.
We work with researchers and industry to ensure that appropriate legal agreements are in place to enable the exchange of cells, other biological or chemical materials and confidential information.
We assist researchers in applying for industry matching grant programs, such as NSERC’s Alliance program, Mitacs Accelerate and Elevate, and the Ontario Centres of Excellence’s Voucher for Innovation and Productivity, as well commercialization funding though programs such as NSERC’s Idea to Innovation.
We evaluate inventions, discoveries and copyright materials developed by researchers at McMaster and its affiliated hospitals, Hamilton Health Sciences and St. Joseph’s Health Care Hamilton to assess their commercial potential.
We secure intellectual property protection, through patents, copyright, trade-mark and other means to protect and enhance research discoveries.
Using market research and our industry connections, we identify industry receptors or investors who can support further development and commercialization of these discoveries.
We assist in creating spin-off company opportunities by connecting researchers with industry representatives, early stage investors and management or other service providers.
We support the Forge and Michael G. DeGroote Initiative for Innovation in Healthcare (MGDII) in educating the McMaster community to foster a culture of entrepreneurship
McMaster Innovation Park (MIP) is Canada’s premier research and innovation park supporting startups, business, research and offering collaborative space to transform ideas from vision to commercial reality. Our mission is to help companies grow.
MIP acts as a bridge between academia and industry. Supporting researchers with commercial aspirations and enabling students to develop their ideas in our incubator and accelerator programs, while also connecting industry with the technical prowess of McMaster University and other academic institutions. MIP is an integral part of Hamilton’s innovation ecosystem where anyone can find a slew of resources to help begin your journey.
Aligned with the research priorities of McMaster University, MIP primarily works with companies in our main sectors of focus: Life Sciences, Advanced Materials and Manufacturing, and Information Communication Technology.
McMaster University is a recognized leader in aging research, and is building on its infrastructure and expertise in this area through the McMaster Institute for Research on Aging (MIRA).
MIRA was created to stimulate and facilitate interdisciplinary research in aging, as well as to develop innovative educational programs for students within the academic and clinical realms. The Institute’s approach is to conduct research in cross-Faculty teams and engage the older adult community, their families, healthcare providers and other key stakeholders through every stage of the research process, from design to evaluation and implementation of interventions and technologies.
At MIRA, we examine biological, behavioural, technological and environmental factors that affect how people age. Our approach is interdisciplinary, and we combine the following strategies:
A coordinated, collaborative research agenda between academics and clinicians from all faculties.
The use of design thinking to generate human-centred solutions.
Ongoing interaction with a diverse group of stakeholders, such as policymakers and older adults.
Research at the McMaster Institute for Research on Aging is intended to generate solutions that are practical, readily implemented, and that promote aging in place
The McMaster Manufacturing Research Institute (MMRI), one of Canada’s most advanced and best equipped research laboratories, combines research excellence with state-of-the-art equipment to meet the sophisticated research and development needs of leading manufacturers. Created in 2000, the MMRI provides a focus for high-profile research and serves as a vehicle for university-industry-government interaction. In addition the institute promotes, encourages, and performs fundamental and applied research in cooperation with its industrial partners and provides systematic mechanisms for technology transfer and infusion of knowledge and research results.
The McMaster Manufacturing Research Institute consists of seven research labs. Each lab specializes in a unique branch of manufacturing:
Machining Systems Research Laboratory (MSL)
Centre for Advanced Polymer Processing and Design (CAPPA-D)
Micro Manufacturing Laboratory (MML)
Metal Forming Laboratory (MFL)
Robotics and Manufacturing Automation Research (RMAL)
Thermal Processing Laboratory (TPL)
Renowned faculty members from several departments; mechanical engineering, chemical engineering, materials science & engineering, engineering physics and electrical & computer engineering, combine their expertise in machining, metal forming, polymer processing, thermal processing, micro-manufacturing, grinding, robotics and manufacturing automation to conduct industry-relevant research, educate undergraduate and graduate students and train post-degree professionals.
The McMaster Nuclear Reactor, the first university-based research reactor in the British Commonwealth, began operations in 1959. It now serves a core group of researchers exploring the smallest structures of matter, developing new probes for medical diagnostics and studying radiation safety. It also is one of the world’s largest suppliers of the medical radioisotope iodine-125 which is used for the treatment of prostate cancer.
McMaster University’s Faculties of Engineering and Health Sciences have been brought together to create a unique research and training program under the umbrella of the School of Biomedical Engineering (SMBE). Improved healthcare and outcomes grounded in Biomedical Engineering require new approaches emphasizing integration and collaboration among traditional research areas.
The School provides a unique collaborative environment that leverages our existing expertise in medical sciences and engineering, and that links current and emerging areas of molecular, medical and bioengineering research.
The McMaster School of Biomedical Engineering (SBME) was established to train professionals who are equally at home in both biomedical and engineering environments. We are at the forefront of training a new breed of health care professional who are capable of integrating into research studies and embracing and utilizing new technologies.
For over 60 years the McMaster School of Nursing has provided leadership within the Hamilton community, and beyond, in nursing education, nursing scholarship and research, and nursing practice. Through a vast network of partnerships locally, nationally and internationally, and through the work of our faculty, staff, students and graduates, the School hass been successful in having a positive impact on the development of the nursing profession for the 20th and 21st centuries.
Part of the McMaster Faculty of Health Sciences, the School of Nursing operates in a fully integrated consortium with Mohawk College and Conestoga College, and is now graduating more than 500 nurses a year with a McMaster’s Bachelor of Science in Nursing degree.
We support the Canadian ecosystem in the development, translation and implementation of medical device innovations. Relying on scientific fundamentals and biomedical engineering expertise, we maintain a deep understanding of the research path from idea to market. To achieve this, we rely on an extensive collaborative network of industry, clinicians, academics and government collaborators.
Polymer lab-on-a-chip and microfluidics laboratories
Digital health software platforms, developed to industry standards
An innovative, exciting initiative at McMaster University has came to life, bringing Medical Imaging together with a range of disciplines such as Medicine, Medical Physics, Biomedical Engineering, Computer Science, e-Health, Nuclear Medicine, Statistics, and Psychology.
The Medical Imaging Informatics Research Centre at McMaster University ([email protected]) is the result of efforts of the radiologists at Hamilton Health Sciences, and the researchers and scientists at McMaster University and the University of Waterloo, along with other prestigious Canadian and International universities.
[email protected] brings together radiologists and engineers in order to bridge the gap between clinical studies and computer sciences and to solve specific issues in Medical Imaging. Its goal is to provide a nurturing environment to the researchers interested from McMaster or other institutions, match the adequate skills and resources, and facilitate access to grants and industry partnerships.
[email protected]’s vision is to foster seamless integration of medical images in the daily world of healthcare professionals with appropriate delivery of relevant content and decision support, and to educate the new world of imaging and Electronic Health Records (EHR) professionals. [email protected] seeks to establish McMaster, Ontario and Canada as leaders in image enabling the EHR and driving utility from regional and national imaging infrastructure.
[email protected] is a joint initiative of the Faculty of Health Sciences and the Faculty of Engineering, leverages engineering, clinical and business expertise to identify and bring together the skills required to solve a specific problem.
MIX is a 30,000 square foot accelerator located in Kitchener, Ontario. It is Canada’s first industry-led hub dedicated to helping medical technology startups scale successfully in Canada. Spearheaded by anchor tenant Intellijoint Surgical, MIX was created to reduce the barriers and bridge the resource gap facing medical technology startups.
MIX provides a collaborative environment for Canadian medical technology companies that supports their individual growth and contributes to the overall success of the local ecosystem.
Technology has become the newest member of the healthcare team. The Medical Technologies Innovation Centre (MTIC) supports research initiatives that strengthen the innovation of existing and emerging medical technologies and advance patient and community care by creating pathways to adoption within our healthcare system through community and industry partnerships.
MTIC provides an interactive collaborative space for research and innovation. In partnership with industry, the community and experts in engineering, education and health, MTIC supports quality patient care in a rapidly evolving healthcare landscape.
Located within a $25.85 million, four-story facility, MTIC represents a unique partnership between McMaster University and Mohwak College. It is home to 1,200 full-time and 3,500 part-time students from both Mohawk College and McMaster University.
The 174,000 square foot Centre provides education and training for Mohawk College students in Nursing, Practical Nursing, Personal Support Worker, Medical Imaging Technology, Medical Diagnostic Ultrasonography, Diagnostic Cardiac Sonography, Pharmacy Assistant, Cardiovascular Technician, Occupational and Physiotherapist Assistant, and Continuing Education Health Sciences.
MITC houses McMaster University’s School of Rehabilitation Science, which offers Masters Degree programs in Occupational Therapy, Physiotherapy and Clinical Health Sciences (Rehabilitation Science), and conducts research to advance knowledge in the rehabilitation field.
MedStack is a cloud hosting platform for healthcare applications that significantly reduces the time and cost to develop solutions by building in privacy compliance and an integration-ready data model, prioritizing developer flexibility and ease of use without compromising best-in-class security.
MedStack simplifies and accelerates achieving privacy compliance and system integration for healthcare apps, getting them to market faster. MedStack software enables companies to create HIPAA-compliant environments in minutes and get to market up to 60% faster with fully-managed and built-in privacy compliance.
MedTel Software Ltd. is committed to providing efficient, cost saving billing and medical software solutions at a reasonable price. We’ve been offering industry leading software solutions and top notch client support since 1997.
A Canadian market leader in providing billing solutions for physicians, MedTel Software Ltd. also provides the same quality with our new integrated medical information products that target specialty physicians and clinics. MedTel offers four core service solutions:
Online: The Personal Billing Assistant (PBA) is a web based OHIP billing application that can access claims from any computer with an internet connection. It provides an incredibly simple interface and a vast array of billing features.
Desktop: The desktop Personal Billing Assistant was MedTel’s original software product way back in 1997 and evolved greatly over the years, making it the premier OHIP physician billing software for a generation.
OHIP Billing Software: enter and submit OHIP claims, enabling fee-for-service claim processing, alternative payment program and direct claims submissions. Error resolution (ie version codes, birthdays etc.), claims reconciliation and reconciliation reporting are also covered to ensure claims are paid to your clinic
Chronic Pain Management System: the IT Infrastructure for the Chronic Pain Center of Excellence for Veterans
MEDTEQ+’s mission is, through collaborative, industry led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry, thereby generating major economic impacts while improving healthcare systems for the ultimate benefit of patients in Canada and around the world.
With a dual provincial and federal mandate, MEDTEQ+ continues to be a focus point for Canada’s medical technology sector in terms of research, innovation and the integration of leading-edge solutions in the delivery of health care.
Meridian Credit Union is the fourth largest credit union in Canada, and the largest credit union in Ontario, serving more than 275,000 members with total assets under administration of over $14 billion.
Meridian offers banking, wealth management, credit products and services through 86 branches, and eleven Commercial Business Centres
As a credit union, we are 100 percent owned by our Members. We work only for them, with profits returned to our Members in the form of the best products and services we can offer.
We offer any number of laboratory services to help your operation. We can evaluate the applicability and feasibility of automation in your lab. We design world class laboratories and process floor plans. With full in-house design and fabrication capabilities, we can bring to life concepts regardless of how big or small. Let us help you for any custom laboratory needs.
Solving laboratory challenges is at the core of what we do. Lab equipment design and automation are our primary focus but we also support with custom tooling, fixtures, repairs, service, floor plans, building design and process improvement.
We also offer standard off-the-shelf lab equipment with industrial grade robustness. Contact us directly for any custom laboratory needs. We support anything from jigs and fixtures to custom tailored machinery.
The mHealth & eHealth Development and Innovation Centre (MEDIC) conducts digital health applied research, provides advanced skill development services, and leads the design, development and testing of electronic medical records (EMR) systems, patient health records (PHR) systems, clinical assessment tools, and patient-facing mobile and web application development and device integration. MEDIC’s Digital Health User Experience Lab, the only one of its kind in southern Ontario, supports MEDIC’s usability research team to offer customized user-testing and validation of new and existing products and solutions.
Globally recognized for its expertise in Digital Health since 2009, MEDIC partners with government institutions, public health teams, clinician groups, researchers, NGOs, and commercial software vendors to accelerate the development of interoperable and secure healthcare IT solutions. MEDIC is Canada’s only Digital Health Technology Access Centre with a focus in digital health, healthcare standards and interoperability.
Through MEDIC, clients can access a working eHealth ecosystem, including the technology, know-how and industry contacts that are necessary in the development and commercialization of new health IT innovations. As an online “living-lab” environment, MEDIC allows stakeholders to work through a significant part of their development in a cost-effective, secure, efficient manner.
The MEDIC team works with clients to provide services across three categories:
Product Development (Tooling): MEDIC supports new technology development at every stage of the development process, from supporting the design of the concept to developing a working proof of concept. For partners with existing products, MEDIC assists with process improvements as well as product redesign in accordance with international digital health standards.
Testing and Validation Services: MEDIC supports the development and deployment of new digital health products and the enhancement of existing software solutions. Services include technology and workflow consultation, concept valuation, product evaluation and validation as well as field trials and simulation testing.
Training: MEDIC hosts industry-focused workshops and customized corporate training focused on advancing technical knowledge in digital health topics, such as FHIR and interoperability.
MEDIC team and clients can access world-class facilities, with a wide range of hardware, software and digital assets, including:
Health Systems Interoperability Lab: a centre of expertise for healthcare systems interoperability. The digital assets of the lab support interoperability with systems such as the open IHE sandbox infrastructure (Cross Enterprise Document Exchange (XDS), Patient Identity Cross Referencing (PIX), Patient Demographic Query (PDQ), and Audit Trail and Node Authentication (ATNA)). The team also has extensive experience with FHIR.
Mobile Device Experimental Lab: supports prototyping, testing and validation of mobile digital health software solutions. The lab contains over 100 mobile devices and peripherals to facilitate the testing of diverse consumer and clinical mHealth solutions.
Digital Health User Experience Lab: the only one of its kind in southern Ontario, supports MEDIC’s usability research team to offer customized user-testing and validation of new and existing products and solutions. It is affiliated with Mohawk’s Digital Accessibility Lab in order to support accessibility user-testing and legislative compliance.
Discover how we can help you solve your digital health challenges.
The Michael G. DeGroote National Pain Centre (MGD NPC) was established in 2010 and draws on McMaster’s expertise in evidence-based medicine to identify, collate, review, revise, update and develop clinical practice guidelines for the treatment of chronic pain. Guidelines will then be disseminated, using best practice techniques of knowledge translation.
Mission. The mission of the MGD NPC is to improve the management of pain through the dissemination of best practice information.
Part of the McMaster Faculty of Health Sciences, the Michael G. DeGroote School of Medicine is renowned worldwide for its innovative method of small group, problem-based education, and a focus on self-directed, life-long learning. Its three campuses –the Waterloo Regional Campus in Kitchener, the Niagara Regional Campus in St. Catharines as well as the Hamilton campus, ensure new physicians are prepared in both community and tertiary health care. Flagship program with an international reputation for its unique three-year program based on small group, problem-based study and early introduction to the clinical experience.
Approximately 5,000 applicants a year, more than any other Canadian medical school. In 2015, 609 undergraduate MD students were enrolled, along with more than 1,000 medical residents in 59 specialties and sub-specialties.
Since our inception 40 years ago, we at Microart Services Inc. have earned the trust of customers by providing complete circuit board assembly services.
With our vast industry experience and knowledge, we can take up any project brought forward by our customers. This includes simple single sided, double sided assemblies and multi-board merge as well as complex PCBs with SMT, PTH, or mixed technologies.
Our advanced facility includes the latest in design, assembly, and testing equipment,which helps us to provide custom PCBs known for their quality and durability.
Our services are designed to cater to the exacting needs of clients from different industries. With each service, we are able to offer standard and custom solutions, depending on the client’s requirements. All our design, prototyping, and assembly processes adhere to the regulations laid out in IPC-A-610, and IS0 13485:2003 certifications.
Mitacs is a national, not-for-profit organization that has designed and delivered research and training programs in Canada for 20 years. Working with 70 universities, 6,000 companies, and both federal and provincial governments, we build partnerships that support industrial and social innovation in Canada.
Mitacs has the connections you need throughout Canada’s innovation ecosystem — connections that will help you achieve your innovation goals. We provide funding for projects — up to 55% — and connect highly trained researchers with the businesses that need them and help guide you through the process.
Mohawk College educates and serves 30,000 full-time, part-time, apprenticeship and international students at three campuses and two City School locations at the Eva Rothwell Resource Centre and the Central Public Library in Hamilton, Ontario.
Mohawk has ranked first among all Greater Toronto and Hamilton Area colleges in student satisfaction for six consecutive years and first in graduate satisfaction for the past four years. Mohawk ranks 15th among all colleges in Canada for applied research activity and has been named among Canada’s greenest employers and the region’s top employers for the past three years.
Mohawk offers 23 programs and diplomas in health and health-related disciplines.
The Mohawk College Institute for Applied Health Sciences (IAHS) at McMaster University is a technologically advanced facility that houses specialty labs used to train students and future health care providers. It is also home to the Medical Technologies Innovation Centre (MTIC) and future home to the Centre for Integrated and Advanced Medical Imaging (CIAMI), resources dedicated to research and industry partnership.
This beautifully designed 174,000 square foot educational building offers functional facilities, state-of-the-art health sciences technologies and newly renovated meeting spaces ideal for any health-care oriented conference or event.
ACCESS OUR STATE-OF-THE ART HEALTH SCIENCE TECHNOLOGIES
Whether you are planning a bootcamp or facilitated training session, our team recognizes that every booking is unique. With over a dozen rooms and specialty labs, our team is here
to facilitate equipment use and develop any learning or preeducation material needed to make your event a success.
All simulation/lab-based bookings include one Technologist (who will run the equipment, set up the space and assist in the facilitation of the session) as well as all equipment
associated with the booked space.
My Well Self is a health and mental wellness marketspace that makes it easy for the public to find health and mental wellness providers suited to their health needs. With our paid subscription, My Well Self enables providers to have one-to-one online engagements to address general health questions at the critical moment for consumers: decision time.
We help health and mental wellness providers gain more online visibility and book more appointments easier. Our community of consumers have made us the leading online resource for finding trusted health and mental wellness advice and providers.
NanoPhyll develops innovative nano-composite coatings for applications in the buildings, construction, transportation and industrial processing industries that are environmentally sustainable in both their use and benefits. We produce the only multifunctional, ultra durable and sustainable coatings available in our target markets. Our cost-effective solutions are tailored to address client-specific needs, typically reducing materials consumption, improving labor productivity, and extending the life of their assets.
NanoPhyll harnesses the power of nanotechnology by functionalizing nanoparticles and incorporating them into a range of durable, robust and efficient products that can be tailored for different applications. These functionalized nanoparticles are bound to a polymer matrix with a strong covalent bond that prevents the leaching out phenomenon suffered by many other nanocomposite coatings. These multi-functional nanoparticles deliver multiple benefits in a single coating solution.
CuraPhyll is a unique, long-term, high-performance nanocoating that is designed to protect textiles and fabrics from stain and microbes. EasyClean Anti Microbial is a biocompatible coating repels and kills bacteria, providing surface protection for walls, floors & HVAC systems.
Founded in 2015, NanoPhyll is headquartered in Montreal, Quebec, with a research and development facility in Hamilton, Ontario and a sales office in the Bay Area of San Francisco, California. In 2016, the Company formed a partnership with McMaster University, in Ontario, and the University of Sherbrooke, in Quebec, to bring state-of-the-art research work in nanotechnology to market.
NERv Technologies aims to create a paradigm shift in post-operative care, utilizing the plethora of data within the body, to help in the detection of post-operative complications at their onset. NERv’s platform sensing technology augments existing wound drains and catheters, providing healthcare providers with a smart monitoring tool that can enhance the delivery of care. NERv’s technology is being built with the goal of decreasing surgeon’s response time to potential complications, making patient recovery easier, and hopefully saving lives.
For patients undergoing general surgeries, the worries are not over once a surgery is complete. Complications, such as leaks, bleeding, and infection, can occur during recovery. These complications require a timely response to prevent serious damage or death. In some cases, it can take 2-3 days to detect, which is sometimes too late.
We developed a Smart Catheter System that can actively monitor patient status, analyze what’s happening inside the patient, then reliably report the data to the surgeon.
NGen is a not-for-profit organization that matches manufacturing companies with new technologies to drive advanced manufacturing in Canada.
Our aim is to strengthen the competitiveness of Canada’s manufacturing sector, drive more innovation and investment in advanced manufacturing technologies in Canada, generate new commercial opportunities for Canadian companies in global markets, grow more large-scale world-leading Canadian enterprises, and develop a modern and inclusive workforce with the skills required to excel in advanced manufacturing today and in the future.
By combining Canada’s manufacturing and technology strengths, and facilitating access to supporting infrastructure and services, NGen aims to achieve exponential benefits for Canadian industry and the Canadian economy as a whole.
NuGeneris Specialty Pharmaceuticals is a privately held subsidiary of the CPDC specializing in late-phase clinical and commercial manufacturing of therapeutic radiopharmaceuticals for international distribution. Our teams have transferred and developed processes for PET & SPECT imaging agents, alpha and beta radiotherapeutics, small molecules and biologics.
Your process has a lot of moving parts. API synthesis, drug product formulation, fill and finish, product packaging, testing and release all must be carefully orchestrated – even while you’re racing against the clock.
The Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-profit, membership based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario’s human health science companies positioning Ontario as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, patients and government.
OBIO offers numerous ‘Interconnectivity’ related activities that bring together people in the fields of industry, academia, government and the investment community for networking and learning over meals, at workshops and events. Cross stakeholder experiences allow people to share knowledge and ideas, solve problems, and advance a shared vision of a fully-functioning ecosystem in which companies are founded, operate and grow.
OBIO’s Access to Capital initiative advances policies and programs designed to increase investment in the Ontario health sciences sector. The Capital Access Advisory Program (CAAP) provides strategic guidance to enhance the venture-readiness profiles of Ontario companies. The CAAP international advisor network includes senior members of the venture community and successful health sciences executives. OBIO’s MINT (Mentoring, Investors, Networking, Targeted Advice) program operates upstream of CAAP and benefits companies currently raising “seed” or later rounds of financing. The Health to Business Bridge (H2BB) program supports the development of business-trained talent across Ontario’s health science sector.
Research at the Offord Centre for Child Studies is focused on child development and finding scientific solutions that will improve the lives, health and development of children and youth.
The Centre hosts a multidisciplinary group whose work falls into a number of themes: (1) child mental health and neurodevelopmental disorders; (2) influences on child health and development arising from early experience, families, schools and neighbourhoods; (3) services and interventions for children with mental health needs; and (4) knowledge translation, community connections, and partnerships.
Through collaboration across fields such as child psychiatry, psychology, epidemiology, pediatrics, policy development, social work, and nursing, the Centre’s aim is to better understand children’s mental health problems with the overall goal of improving the lives of children and youth.
As a One Health organization, we focus on the important and integral connections among human, animal, and environmental health. We offer innovative, state-of-the-art products and technologies that meet the highest standards for efficacy, efficiency, and safety.
Our team comes from a diverse background of education, experience, and expertise, and collectively offers best-in-class knowledge and service in the areas of infection protection and biosecurity across veterinary, farm/agriculture, animal shelter, and boarding kennel sectors.
As our name suggests, our solutions are what we are known for. And our track record of working with unique organizations – including government agencies, corporations, and small businesses – and providing best-in-class solutions for their unique challenges speaks for itself. We take pride in our work and its resulting impact on the health and safety of humans and animals; employees and customers; and our broader global community.
OmniaBio Inc., a subsidiary of Toronto-based CCRM, is a contract development and manufacturing organization (CDMO) producing gene-modified cell therapies and viral vectors, compliant with Good Manufacturing Practices (GMP) standards. At approximately 250,000 ft2 (23,225 m2) in phase one and with plans to reach 400,000 ft2 (37,161 m2), OmniaBio will be the largest facility of its kind in Canada.
OmniaBio will be the anchor tenant in a biomanufacturing centre of excellence at McMaster Innovation Park in Hamilton, Ontario. It is expected to catalyze life sciences jobs and innovation in Ontario while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson’s and diabetes.
OmniaBio will support a broad range of cell and gene therapy companies from Canada and internationally, and tap into a global demand for cell and gene therapy manufacturing that outstrips supply by at least five times. By providing commercial-scale manufacturing in Ontario, cell and gene companies across Canada will be able to commercialize their therapies domestically, ensuring that Canada retains the intellectual property, technical know-how and talent.
OmniaBio will complete CCRM’s continuum of process development, clinical and commercial capabilities, building on the work that takes place at CCRM’s Centre for Cell and Vector Production (CCVP) located at the MaRS Centre in Toronto’s Discovery District. CCVP is a GMP-compliant facility for Phase I/II in-human clinical trials. OmniaBio will enable pivotal/Phase III and commercial-scale manufacturing for cell and gene therapies.
The Ontario Association of Medical Radiation Sciences (OAMRS) is a provincial professional association representing the Medical Radiation Sciences profession in Ontario. We are the recognized advocate and voice for Medical Radiation Technologists (MRT) and Diagnostic Medical Sonographers across the province.
OAMRS was founded by practicing members of the profession to represent and help grow the profession and increase the standard of care to patients in Ontario. Led by the Board of Directors (volunteer industry professionals) OAMRS mission is to provide advocacy, support, and service for MRTs and Sonographers across the province.
The OAMRS is a non-profit organization that relies on voluntary membership and non-dues related revenues such as educational services to meet annual operation expectations. In addition, OAMRS offers educational programs, PLI and services nationwide under the banner, MedicalImagingEd.
OCE focuses on ensuring the people of Ontario reap the personal and economic benefits of leading-edge research underway at our publicly funded universities, colleges and research hospitals – research that can be transformed into technologies and services that enhance quality of life and help build a globally competitive, job-creating economy in Ontario.
Specifically, OCE supports the commercialization of academic intellectual property (IP), industry-academic collaborations and the development and adoption of emerging technologies. This includes overseeing the execution of advanced technology platforms that will equip Ontario companies to compete in a competitive global digital economy.
We also support and invest in early-stage projects where the probability of commercial success and investment return on innovation are substantial. OCE’s strong expertise in de-risking innovation helps attract private investors and other funders to new ventures, bolstering their success. We contribute as well to the development and retention of talent to ensure that industry has access to personnel with the most advanced skills and knowledge and that highly trained personnel find opportunities to apply their expertise in Ontario.
Our mission is to lead the application of genomics-based solutions across key sectors of the economy to drive economic growth, improved quality of life and global leadership for Ontario. To accomplish this, we work with four key stakeholders:
Researchers: We help you access funding and find the right industry partners
Companies: We help you identify potential genomics solutions to boost your productivity
Startups: We help you take the next best step towards business growth
Policymakers: We mobilize and educate stakeholders to embrace genomics as a key driver of Ontario’s future wealth and well-being
The Ontario Institute for Cancer Research (OICR) is a collaborative, not-for-profit research institute that conducts and enables high-impact translational cancer research to accelerate the development of discoveries for patients around the world while maximizing the economic benefit of this research for the people of Ontario.
OICR ensures Ontario’s world-class cancer research findings are benefiting patients and the Ontario economy. Here’s how we make that happen:
We conduct cross-disciplinary cancer research in fields such as genomics, immuno-oncology, informatics, drug discovery, and molecular pathology with partners in health care, research, government and the private sector;
We enable research in Ontario and worldwide by building collaborative networks, securely sharing data and making tools and resources available to the research community;
We translate our research findings to the clinic by developing clinical guidelines, supporting clinical trials and commercializing our innovations with our partner FACIT
Ontario Tumour Bank (OTB) provides cancer researchers with a diverse selection of high-quality biospecimens and derivatives, comprehensively annotated with de-identified clinical data. Biospecimens are the key to the development and testing of next-generation diagnostics and treatments. Since 2004, OTB has been making this type of research possible by collecting and dispensing the biospecimens needed for high-impact studies.
Operating at state-of-the-art hospitals and cancer centres across Ontario, OTB is made possible through collaboration. Working with local pathologists, medical oncologists, surgeons and other hospital personnel, specially trained staff members obtain patient consent, collect tissues and assemble comprehensive clinical information about each donor and the corresponding biospecimens. A robust governance model ensures that OTB meets the highest scientific and ethical standards.
The high-quality biospecimens, derivatives and clinical data are an important resource for scientists engaged in translational research who are developing better diagnostic tools and new drug therapies. Researchers can depend on OTB to provide products and services of high quality, diversity, and integrity.
OTB is a program of the Ontario Institute for Cancer Research (OICR). Funded by the Government of Ontario, OICR is a collaborative, not-for-profit research institute that conducts and enables high-impact translational cancer research to accelerate the development of discoveries for patients around the world while maximizing the economic benefit of this research for the people of Ontario.
Operatic (formerly Parallel) helps companies create amazing apps and websites, working with startups as well as some of the Ontario’s largest companies to build products that are intelligent, attractive, and user-friendly.
From a simple sketch, to a prototype, to the product launch, Operatic can effectively get it out in the real world. Our diverse team focused on design, technology, and strategy that can take a product idea from start to finish.
Our clients have come to us in various stages of the product life-cycle. Whether we’re starting from scratch on a new idea or updating and maintaining an existing platform, we’re good to tackle any challenge.
People and processes are core elements of success. That’s why we’ve brought together an ensemble of tech, creative and marketing talent who have experience in our key verticals. We’re data-driven and won’t make any decisions without first understanding the needs, wants and behaviours of your audience. These differentiators, or core principles, led us to craft a process that aligns precisely with our multidisciplinary services.
Optimal Innovation Group (OIG) offers strategic advising (research, analysis, strategy development) and executive management support for growing new ventures, business innovation, commercialization and for corporate development opportunities that drive the business growth strategy. Our team provides affordable consulting services to small-to-mid-sized enterprises (SMEs), large multinationals and some non-profit institutions within the life science/biotech, medical devices, health IT, cleantech and advanced materials/nanotechnology sectors.
The OIG team includes experienced senior advisors who are professionals in all areas of technology commercialization to support business growth. Below is a short list of the range of commercialization and business-building services that we provide to clients:
Corporate Innovation Services [for SMEs and large multinationals]
OrganoBiotech pioneers platform technologies that allow users to model complex biology with ease and without compromising experimental throughputs. We develop and sell a tissue culture platform (IFlowPlate™) used to grow stem cell-derived organoids with blood vessel networks to make more predictive pre-clinical models for drug discovery.
At OrganoBiotech, we understand that studying human biology and validating new medicine are complex endeavors. You need to build confidence in your discovery with models that recapitulate the complex biological process found in the human body. Our proprietary IFlowPlate platform technology allows users to model complex biology with ease and without compromising experimental throughputs so that you can focus on your discovery. Our IFlowPlate technology is supported by multiple scientific publications in Advanced Materials, Lab on a Chip , and ACS Biomaterials and Engineering
Organoids are miniaturized organs grown in a dish over time from a single or a small cluster of human stem cells. Organoids have a biological complexity that resembles the natural human organs and can offer valuable insights into the function of drugs, the mechanism of disease progression, and the process of organ development that cannot be provided with existing pre-clinical models. However, all existing organoid systems lack perfusable blood vessel networks. Blood vessels are the most prevalent biological structures in the human body, and all organs rely on them to function correctly. They are also closely associated with diseases and immunological responses. To solve this problem, we developed a platform technology (IFlowPlateTM) that can be used to grow blood vessels around various organoids to make more predictive human tissue models for drug screening and fundamental biological research.
Collaborators include Sigma, GSK, and Merck, among others. OrganoBiotech, Inc. is a startup company from McMaster University, and is active across Southern Ontario
Pairwise Affinity’s current focus is the development of innovative vision testing systems for research and clinical applications, optimized for measuring changes in visual function in patients with specific visual disorders, such as Age-Related Macular Degeneration and Diabetic Retinopathy.
Areas of Expertise: Visual Neuroscience, Scientific Computing, Algorithm Design and Implementation, and Custom Solutions for Scientific Research encompassing Data Collection, Signal Processing, Statistical Analysis, and Computational Modelling.
Paradigm Capital is an employee-owned independent Canadian investment dealer focused on companies with excellent long-term, secular growth characteristics. With an emphasis on diligence and a spirit of entrepreneurialism, the Paradigm team has deep expertise in the companies and sectors we cover. We connect investors to companies with excellent long-term, secular growth characteristics.
New drugs, new devices, and e-health solutions. Our Biotechnology & Healthcare team finds the best emerging companies working to benefit patients, payers and investors.
Parapixel is re-envisioning the digital pathology experience.
We are designing practical digital pathology workflow support tools with an interdisciplinary team of pathologists, engineers, and computer scientists. These tools address tangible, real-work workflow needs that are defined by pathologists. At the same time, we are introducing state-of-the-art technology known as multi-modal learning, where information from multiple sources (e.g., pathology images, diagnostic reports, molecular data) are simultaneously used to represent patients.
Our technology is coupled to a highly customized simple and easy-to-use interface that incorporates touch-screen capability and conversational analytics, where pathologists can converse with the software using natural language commands. Our innovative digital pathology framework encompasses multimodal learning and human-centric conversation-enabled interfaces to transform digital pathology and lead the field into a post-pandemic era of augmented diagnostics.
Pharmasonica is a medical device that utilizes ultrasound to trigger drug release resulting in improved treatment efficacy, reduced side-effects, and reduced visits to a specialist. Pharmasonica provides clinicians with enhanced control over a patient’s treatment while providing patients with a significantly higher standard of care.
The Population Health Research Institute (PHRI) is Canada’s premiere global health research institute and a world leader in large clinical trials and population studies. Through international collaboration and innovation, PHRI explores CVD, diabetes, kidney and lung diseases, brain health, cancer and more.
Originally formed with a focus on cardiovascular disease (CVD) and diabetes, PHRI’s research areas have broadened to include population genomics, perioperative medicine, stroke, thrombosis, CV surgery, renal, obesity, childhood obesity, bone and trauma and implementation science.
Over the years, the PHRI has developed unparalleled expertise in epidemiology, population health and clinical trials. Examining biological and genetic determinants of health, as well as social, environmental and policy factors, the research focuses on the prevention of cardiovascular disease, diabetes and other common conditions. PHRI’s capacity to conduct several international studies concurrently, with tens of thousands of participants in each, is a capability very few organizations in the world can match. To date, PHRI studies have enrolled almost 1,500,000 participants worldwide in 102 countries.
A core strength of the PHRI is the multidisciplinary team of world-class scientists and research support teams. The environment promotes collaboration and a multifaceted approach which allows researchers to capitalize on the wealth of collective knowledge as they each bring areas of expertise to a single study.
Predict Technologies would like to introduce Patient Health Integrated Electronic Records (PHIER).
Traditionally, physicians in the clinical setting use medical gestalt, patient medical history, and diagnostic testing in formulating a treatment.
Our solution will leverage patient-inputted medical history and best practice care processes in delivering a platform to reduce patient intake time, decrease charting time and incentivize post-visit discharge compliance.
PHIER is designed to assist and improve the diagnostic process for practicing physicians who currently employ electronic health record systems.
Program for Health Economics and Outcome Measures (PHENOM) is an academic research group that is aimed to support clinical and coverage decision making through collecting and synthesizing evidence. Our primary approach to generating new evidence is randomized clinical trials, observational studies, and population preference elicitation.
We also use systematic literature review, meta-analysis and economic modeling for synthesizing existing evidence. Our research can be used to address individual clinical and/or economic questions and to support coverage policy making. We are actively involved in educational activities related to research methodology for graduate training and knowledge exchange in health economics and patient-reported outcome measures.
The Programs for Assessment of Technology in Health (PATH) Research Institute was established in 2003, led by the world renowned Bernie O’Brien, and a group of researchers, including Ron Goeree, the current Director of PATH. PATH is based at St. Joseph’s Healthcare Hamilton, but has strong affiliations with McMaster University as well. The PATH Research Institute conducts and promotes evidence-based evaluations of the effectiveness and efficiency of new and existing health care technologies.
Over the years, both groups had contributed heavily in guiding the healthcare expenditures of our federal and provincial governments.
PATH has extensive expertise in conducting literature reviews, evidence synthesis, biostatistics, economic evaluation, costing, budget impact analysis, decision analytic modelling, policy analysis, health systems impact analysis, and techniques of research translation and knowledge uptake for new policy formation. PATH is particularly well suited to assist program, service and policy makers, at all levels of decision making, in making difficult decisions about efficient and equitable health care resource utilization.
At Prova Innovations, we are passionately driven to develop new technologies to aid children with mobility challenges. We are a start-up medical technology company. Our dedicated team is focused on creating a suite of at-home therapeutic products for children suffering from neurological conditions, such as cerebral palsy, brain and spinal cord injuries.
The products we are bringing to market promote the formation of neuromotor connections in the brain that encourage normal mobility patterns in young children. We are doing this in a way that is novel, intuitive, and outside of a clinical setting. Prova is providing the next step in at-home therapy and research
Qcard is an application developed specifically to improve the quality of life for those living with memory and cognitive impairment / disability, including executive dysfunction like brain injuries, Alzheimer’s, dementia, ADHD and the elderly. It helps strengthen memory, enhance organizational skills, and improves time management by acting as a notepad, to-do-list, calendar, alarm clock, and organizer, all in one.
Qcard gives the user an aid they can rely on; a safety net. It helps them achieve success in their day to day activities, by helping them plan, initiate, follow through and complete just about anything. Qcard helps families delegate and track tasks together while survivors learn to regain their independence.
Starting with just a few pieces of equipment in a single lab, QReserve has grown to house tens of thousands of resources and help thousands of people access and utilize those resources everyday.
Organizations house immense quantities of resources that are often siloed and spread across different locations. A QReserve Resource Sharing Network is your organization’s dynamic asset map and directory of resources. QReserve offers a full suite of research tools and management platforms, including:
Collaborating with the life sciences and medical technology companies as well as health care providers in Quality Management, Risk Management, Cyber Security, Type Approvals, Audits, etc. in the USA and in Finland.
Focus for the last 25 years has been developing quality management systems in start up or early stage organizations. Have extensive experience with Canadian Medical Device Regulations, FDA QSR, EU Medical device directive and the upcoming EU MDR and other international regulatory agencies. Considerable experience with validations, sterility and sterilization, implementation of automated systems including ERP and LIMS, and project management. Also act as a representative for Canada on the ISO committee for Medical Devices.
To grow, you need access to innovative products, services, and deep sector and operational expertise. It’s how companies scale, both now and into the future – and what RBCx was created for.
At every stage of growth, having access to innovative products, services, and deep sector and operational expertise helps companies scale—both now and into the future.
Our full-service team of strategic advisors specializes in helping entrepreneurs navigate the hardest pain points of scaling a business – from ideation to IPO and beyond – including capital, talent, commercialization, technology advisory, M&A, and so much more. Because we know that to go far it pays to go together.
With the full support of one of the world’s leading financial institutions – and with our network and global footprint at your fingertips – you can take advantage of exclusive RBCx discounts, offers, and introductions. No matter what stage you’re at.
Real Time Medical is a company created by clinicians, for clinicians. It was formed by three Canadian radiologists, including out of McMaster University.
Our vision was to grow and operate a nationwide radiology collaboration service for Canadian radiologists, with world class diagnostic workload balancing, workflow orchestration and diagnostic operations software.
The service network was launched in 2008. Turning the vision of Real Time Medical into an operational reality.
Redeemer University is a private Christian liberal arts and science university located in Hamilton, Ontario, Canada in the community of Ancaster. Founded in 1982, Redeemer stands in the Reformed Tradition and offers Bachelor of Arts, Bachelor of Education, and Bachelor of Science degrees. Redeemer offers degrees in one of 39 majors and streams offers experiential learning opportunities and a cross-functional set of knowledge.
Reliq Health Technologies is a rapidly growing technology company focused on developing innovative remote patient monitoring, care collaboration and telemedicine solutions for community-based healthcare. Our virtual care platform uses a high tech, low touch approach to provide high-quality healthcare in the community setting, while reducing the cost of care delivery.
Reliq’s iUGO Health technology platform is a comprehensive hardware and software solution that allows complex patients to receive high quality care in the home, improving health outcomes, enhancing quality of life for patients & families and reducing the cost of care delivery.
Reliq Health is focused on developing innovative mobile health (mHealth), care collaboration and telemedicine solutions for Community-Based Healthcare. Our virtual care platform uses a high tech, low touch approach to provide high quality healthcare in the community setting, while reducing the cost of care delivery.
RHPCS supports the computational and digital research infrastructure needs of researchers from all disciplines across McMaster University.
What we do:
Data storage and backups
Data visualization and analysis programming
Desktop and server system administration and support
High Performance and Advanced Research Computing Support (in partnership with SHARCNET)
Laboratory and research infrastructure design
Research data lifecycle planning and support
Research Software Engineering / Programming
Web survey implementation
Support with CFI and other funding applications
Graphics and visualization
Advanced / High-Performance Computing
A growing number of research fields require A/HPC as a key component of their tool-chests. RHPCS’ mandate is to support advanced and high-performance computing installations as a central part of the university infrastructure. Our services include:
Recommending hardware configurations and getting vendor quotes for funding grant applications
Site planning and configuration
Hardware and software installation and administration
Application software development, user management, integration with desktop systemshttps://research.mcmaster.ca/research-resources/local-it/rhpcs/
RIC Centre is a not-for-profit innovation hub and business incubator for Mississauga, Brampton, Caledon and other communities in Southern Ontario. RIC Centres’ focus is to be a dynamic catalyst for tech companies. We help our companies grow faster and stronger.
Our team consists of more than 100 expert advisors, industry, academic, government partners. The team helps companies in Advanced Manufacturing, Internet of Things, Hardware & Software, Cleantech and Life Sciences to commercialize their products and get them to market faster.
The Robert E. Fitzhenry Vector Laboratory has played a pivotal role in the development of immunotherapies in Canada. It was the first academic GMP facility in Canada that has manufactured viral vectors approved for use by Health Canada for human clinical trials in 2009.
We are committed to supporting translational medicine by providing virus-vector manufacturing services to researchers who want to move forward to clinical trial testing of their product.
Preclinical Manufacturing Services:
Manufacturing of Adenovirus and VSV batches for Toxicology testing using the same quality of starting materials as for GMP manufacturing
Creation of new Adenoviral vectors from cloning up to virus rescue and scale-up manufacturing
Catalog of ready-made recombinant Adenoviruses and VSV vectors expressing various reporter genes and cytokines available for pre-clinical research applications. Orders placed per vial or custom manufacturing for larger amounts
GMP Manufacturing Experience:
Creation of six master virus banks and clinical lots that passed quality testing for sterility, mycoplasma, endotoxin and adventitious viruses
Two qualified HEK 293 master cell banks
Serum-free suspension cell culture in disposable, sterile, pyrogen-free, single-use plasticware
Grown in chemically defined media, without serum or any animal-derived product
Equipment on site:
Five 6-foot Microzone and Nuaire Biosafety Cabinets, three of which are located inside ISO 7 cleanrooms
Three walk-in Honeywell temperature-controlled rooms that can be converted between 4˚C to 37˚C
Three Beckman Allegra benchtop centrifuges with SX4750 and GH3.8 rotors
One Beckman J6 MI floor centrifuge with JS4.2 rotor
Two Beckman Optima ultracentrifuges with two SW41 and one SW 55 rotors
1 Bio-Rad NGC Quest Plus Chromatography System
One SpectrumLabs KrosFlo MiniKros Pilot TFF pump
Two Masterflex L/S peristaltic pumps with Easy-Load 3 pump head
One -70˚C freezers, two -20 freezers, four 2-8˚C refrigerators,
Seven CO2 incubators
Two Hach HHPC-6 particle counters, two EMD MAS-100 air samplers
One Locator 6 liquid nitrogen tank, one Thermo Electron Cryo Plus Liquid Nitrogen storage system
24-hr continuous monitoring of temperature-controlled equipment
Two 50 Liter TFF bins for disposable bioreactor bags
ROME is suite of powerful logistics tools to manage your clinical trial study’s inventory, keep track of orders and shipments, and automatically resupply drug.
Single or double blind studies require a robust system to ensure the integrity of the study. ROME offers validated tools to dispense IP according to the randomized allocation while maintaining the blind. The inventory tools are designed the same way. When a blind is required, all involved in the supply chain can do their work without compromising the blind. ROME monitors the supply levels and places orders on behalf of sites and depots accordingly to ensure that inventory levels are adequate to meet recruitment and resupply demand.
When you choose ROME as your study management system, our team puts together a custom set of features and tools that have proven to be effective, creating the perfect solution for your clinical trial.
Note, ROME is available only to Population Health Research Institute (PHRI) investigators at this time.
SanteSuite Inc. (SSI) is one of the world’s most experienced teams in global digital health systems research, development and implementation around the globe. SSI was founded with a clear reason for being, which is to enable the best health for all citizens of the world using digital technologies. Crafting high impact, affordable digital health solutions is what we love, it is what we are good at and it is what the world needs..
Our team has led national-scale digital health system deployments in Canada, Jordan, Tanzania, and Southeast Asia. We have enabled +75 millions of patients to be cared for through leveraging digital solutions.
SanteSuite offers a collection of software solutions built upon the SanteDB iCDR and dCDR technologies. SanteSuite products aim to provide a cohesive platform for implementing a variety of solutions including Master Patient/Person Index (MPI), Master Facility Index (MFI), Master Provider Registry (MPR).
Senso Minds has designed and created line of sensory integrating products for children with sensory needs.
To date, we have provided over 30,000+ parents and their children with our proprietary Sensory Chew Necklaces to satisfy children’s oral motor input and sensory stimulation needs.
Whether a child is on the spectrum, or has some type of developmental condition, Senso Minds is on a mission to equip and empower all children, with the tools and products they need to best integrate into the spaces around them.
Mohawk’s Sensor Systems and Internet of Things (IoT) Lab helps Canadian companies become more effective in their adoption of IoT for industrial use (IIoT). The research team supports the adoption of IIoT technologies through the development of proof-of-concept and prototype systems in collaboration with industrial partners.
The lab was established by Mohawk’s Industrial Research Chair for Industrial Internet of Things (IIoT) Applications, with the support of industry partners such as CareGo, TruckSail, Merq, Brigade Electronics Inc, IBM, MTech Hub, IoT Foundry and Siemens Canada.
With a focus on vision health, the Sheardown Lab is invested in engineering novel solutions to treat a breadth of ocular pathologies. Our expertise lies in contact lenses, targeted drug delivery, preclinical modeling, and polymer chemistry, with an emphasis on commercialization.
We are working on the next-generation of contact lenses capable of delivering drug effectively to the front of the eye to treat anterior ocular conditions. We are also improving upon the formulation of contact lenses to improve patient comfort. Working with industry partners, we are helping formulations reach market fast.
Utilizing our expertise in drug delivery, we are developing novel methods for sustained drug delivery to ocular tissues through our patented technologies and biomedical modelling strategies.
Our vast knowledge allows us to design and synthesize original formulations that can prolong ocular residence time, increase tissue permeation, and deliver that vital cargo to where it needs to go. Our expertise in animal modeling allows us to study a breadth of ocular disease states as well as test our novel ocular biomaterials in-vivo.
Invested in commercialization, we collaborate with industry partners to help products get to market. Some current collaborations are shown below.
In 2017, the Shift Seating brand by Blake Medical Group Inc. was developed to address the risk of occupational exposure to whole-body vibration, prevalent in military and industrial occupations.
In 2015, BMG Inc. studied the whole-body vibration using a Geo-Matrix cushion with the National Research Council of Canada (NRC) and found that the Geo-Matrix cushion out-performed all other products with respect to comfort and vibration. As a result, Shift Seating created a solution to provide people the ability to sit longer and more comfortably within their field of work.
SONAMI is the Southern Ontario Network for Advanced Manufacturing Innovation.
SONAMI is a network of colleges and one university, who, through their respective Research and Innovation Centres, are collaborating with small- and medium-sized companies to turn innovations into commercialized products.
SONAMI leverages faculty, students and state-of-the-market equipment, together with funding from the Federal Economic Development Agency for Southern Ontario, to support manufacturing in southern Ontario.
Mohawk College and McMaster University, located in Hamilton (Ontario) are both members of the SONAMI network
Sound Options is an award-winning company that provides affordable tinnitus treatments that have been clinically tested to help people manage their tinnitus. We provide you with a tinnitus treatment that is customized for your unique hearing and tinnitus profile.
To do this we work with excellent hearing healthcare professionals across Canada and the U.S. Contact us or one of our partnering clinics to take your first steps towards taking control of your life.
In order to help businesses, accomplish their objectives, SOFII provides support to business owners by offering them repayable loans. Fed Dev Ontario supported WOCFDCA with capital investments in SOFII, as part of the agency’s Prosperity Initiative, originally in 2012 and subsequently in 2014 and 2019.
The SOFII program supports high-growth, innovative Small and Medium-sized Enterprises (SMEs) in rural and urban communities by offering loans of $150,000 to $1,000,000 to support all aspects of growth challenges facing them. The loans are intended to help finance:
Late stage commercialization;
New product or service development;
New applications or markets; or
Development or implementation of new processes or technologies.
Eligible businesses will be situated in the geographic area described as Southwestern Ontario. Both urban and rural centres are serviced by SOFII.
The Southern Ontario Fund for Investment in Innovation (SOFII) loan fund acts as a catalyst for increased investment in and support for innovation and is one element in the emerging climate of support for high-growth companies in Southern Ontario. SOFII is a $25 million fund, available to eligible organizations across South-Western Ontario.
Spark Centre was set up in 2010 as one of many Regional Innovation Centre (RIC) across the province. Alongside the other RICs across Ontario, we provide resources and on the ground commercialization and services to innovative and technology-based entrepreneurs and businesses. We serve technology and innovation entrepreneurs who require knowledge and support to launch, develop and grow.
St. Joseph’s Healthcare Hamilton (SJHH) delivers high-quality, evidence based, compassionate care to patients in Hamilton-Niagara-Haldimand-Brant and beyond. SJHH is a leading academic health science and research centre. Home to more than 5,000 staff, 700 physicians and 1000 volunteers, St. Joe’s is a multi-site, regional, tertiary centre, renowned for its strength in respiratory care, kidney and urinary care, mental health and addictions, surgical services, cancer surgery and women’s and infants’ care. SJHH’s emergency department sees more than 50,000 patients a year.
As a premier academic and research healthcare organization, St. Joseph’s Healthcare Hamilton is committed to making a difference in people’s lives and creating a lasting future for our community through integrated health services and internationally recognized programs. Our threefold mission is to provide dynamic research, revolutionary methods in health sciences education, and the highest standard of clinical care in a spirit of compassion, innovation and commitment.
SJHH is a member of the St. Joseph’s Health System (SJHS), and is affiliated with McMaster University, Mohawk College. St. Joseph’s is also home to the prestigious Firestone Institute for Respiratory Health and the high-tech Brain-Body Institute. The internationally renowned Centre for Minimal Access Surgery (CMAS) is among St. Joseph’s Healthcare Hamilton’s prominent teaching contributions.
SJHH has earned a national reputation for outstanding patient care and innovative medical and surgical treatments. The Hospital is particularly well known for excellence in respiratory care, kidney and urinary care, mental health and addictions, surgical services, cancer surgery and women’s and infants’ care. We are also recognized as a leading academic and research centre.
The St. Joseph’s Health System (SJHS) encompasses five cities, with over fifteen thousand staff serving a population of over 2 million.
Membership includes all forms of healthcare entities including academic and community hospitals, long-term care facilities, home care, shared service organizations, and regional health authorities.
SJHS is a sought after leader in the delivery of integrated care, which is transforming patient care and outcomes. Our member organizations each offer services according to their strengths, from acute care, long-term care, community care, to rehabilitation, hospice, community outreach, and mental health. SJHS leadership includes:
Largest Renal Program in Ontario
Single Largest Public Provider of Long Term Care in Ontario
Largest Regional Mental Health & Addiction Program
St. Joseph’s Health System Group Purchasing Organization originated in 1992 as a non-profit program and system-wide approach to supporting the needs of our three hospitals, two long term care facilities, and home care organization in two niche categories, capital equipment and food.
Over the years, SJHS-GPO has grown significantly and is now national in scope, representing over 400 member facilities across Canada. For over 26 years, the SJHS-GPO team has been pioneering advancements in procurement.
The organization regularly supports governments across Canada. At present, it is the lead healthcare capital procurement agent for all of New Brunswick, Newfoundland and Labrador, Prince Edward Island, Nova Scotia, and the Yukon Territory. The membership is comprised of academic health centres, community and rural hospitals, long term care facilities, shared services organizations,
St. Joseph’s Home Care (SJHC) tailors home care programs to meet the needs of each individual client. They serve a wide variety of clients with diverse cultural and socio-economic backgrounds. Services include a number of home support programs; assisted living in supportive housings, and Neighbourhood Model for Seniors at Risk; as well as retirement living and respite care in partnership with CityHousing Hamilton.
SJHC has a dedicated staff of approximately 350 employees and provide community home care services for the Hamilton-Niagara and Haldimand-Brant area.
St. Joseph’s Villa (SJV) is one of Ontario’s largest and most innovative long term care homes.
From long-term care for seniors and the most vulnerable, to convalescent care for those recovering from surgery, to respite care to support caregivers and families, to hospice care for patients and families facing a life-limiting illness, St. Joseph’s Villa has been caring for the community for nearly 140 years. SJV also offers vibrant community hub offering interactive year-round Adult Day Program and independent retirement living and accommodations for those over age 55.
St. Peter’s Hospital has specialized in enhancing the lives of seniors and those with chronic illness since 1890.
A complex continuing care hospital on Maplewood Avenue in downtown Hamilton, St. Peter’s provides inpatient, outpatient, and community-based programs and services that focus on four pillars of excellence: Dementia, Aging, Palliative Care and Rehabilitation.
Our team of dedicated and expert staff is committed to finding ways to minimize and manage the daily effects of lifelong illness by getting to know the person behind the illness. A high-touch, low-tech approach to caring ensures that the physical, mental, emotional and spiritual needs of each patient are met every day.
St. Peter’s Hospital is affiliated with McMaster University and Mohawk College. Outpatient clinics for diseases related to aging and the GERAS Centre for Aging Research, are also based at St. Peter’s.
StarFish Medical is Canada’s largest medical device design, development and contract manufacturing company. We help medtech innovators throughout North America overcome challenging technology obstacles to create breakthrough products that improve health and save lives.
StarFish provides a full complement of design, development, and manufacturing services in Victoria and Toronto. We successfully partner with innovative companies (both large and small) to create breakthrough products for a number of medical specialty areas.
Medical device product definition, technical engineering and product development use our proprietary Pathfinder process. Prototype and volume production are delivered in an ISO 13485 certified facilities with class 10,000 clean room capabilities.
SteriRight protects an organizations employees with mask reprocessing and decontamination services. Utilizing state-of-the art technology, SteriRight offers products and services that reduce contamination risk in a safe, effective and accessible manner. So whether your organization needs hospital grade N95 respirator reprocessing or Electrostatic Disinfection of hard surfaces, our team of trained technicians are ready day one.
SteriRight was born as a result of the COVID-19 pandemic, and particularly the crisis of personal protective equipment (PPE) availability. Critical shortages of PPE triggered Health Canada to look for innovative solutions from re-processors of normally disposable N95 respirators and from manufacturers of reprocessing equipment to meet current needs, and the gradual return to the “new normal” meant that organizations had to think about their office or work environment cleaning differently.
SteriRight is a Hamilton based start-up backed by its parent company Bay Area Health Trust and is managed by a dedicated team with significant experience in the health care and life science industries.
Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stryker has recently moved into a new 130,000-square-foot facility located in Hamilton (Ontario), representing a $100-million commitment to the City. The facility will include operations, distribution and business functions. The new building will bring the company’s employees, who were located in multiple buildings on Innovation Drive, under one roof.
Synmedix is a newly-founded biotechnology company created to commercialize a novel platform that dramatically enhances the effectiveness of antibiotics to address unmet medical need posed by the global health crisis in antibiotic resistance. Synmedix was founded on McMaster University technology, showing that bicarbonate dramatically improves the efficacy and spectrum of several antibiotics enabling the treatment of multidrug-resistant infections.
Synmedix is developing new antibiotic therapies for treating critical infections. Antibiotic resistance is one of the biggest threats to human health, and has undermined a linchpin of modern healthcare we depend on. Our mission is to deliver new therapies that avoid the pitfalls of the past – avoiding resistance, addressing clinical gaps, and delivering solid economics in an equitable manner. Our lead product is a first-in-class therapy developed to treat infections in patients suffering from diabetic foot ulcers.
When DNA was first recognized as the code of life, it was predicted that we might one day rewrite this code to overcome disease and other ailments. But, more than 60 years later it’s clear that writing DNA code is only half of the puzzle. DNA must be read in a cell before its power can be unwound. The other half of the puzzle is DNA delivery itself, which continues to be a huge obstacle for all branches of life sciences.
Synthetic Virus Technologies Inc. was founded to finally make effective DNA delivery a reality. Our unique technology is based on self-assembling DNA nanotechnology that brings together previously incompatible advances in non-viral smart drug delivery. Stepwise assembly of our liposome “bubble” vehicles allows for tailored delivery through multiple membrane barriers like the blood brain barrier or to the nucleus of the cell.
Our first product is a smart drug delivery kit for the research academic market that will make the delivery of DNA plasmids, chromosomes and genomes into living cells possible.
We are pioneering a new approach to the care of metabolic disorders with first-in-class small molecule SREBP inhibitors
Systemic Therapeutics Corp. is a Canadian pre-clinical stage, biotechnology company specialized in the development of new therapies focusing on the master regulator of lipid metabolism, sterol regulatory-element binding proteins (SREBP), based on first-in-class small molecule SREBP inhibitors. The Company aims to provide new treatment options for metabolic conditions such as dyslipidemia, via reduction of circulating PCSK9, and Non-Alcoholic Fatty Liver Disease.
TBIFinder uses Big Data analytics to identify the presence, severity, and location of a concussion. This means that no baseline scan is required so that physicians can link injured brain areas with clinical patient symptoms. Our services will provide you with a comprehensive report and a 3D image of your client’s injury to finally equip your team with the evidence necessary to make important concussion-related decisions.
Based on over 15 years of research, TBIFinder has created a specialized software that uses MRI data to unlock the mystery of concussion. Published scientific journals have proven the effectiveness of the TBIFinder technique and partnerships with leading physiatrists has established our data as essential for treatment-related decisions.
TechAlliance is at the forefront of Southwestern Ontario’s innovation economy, as the Province of Ontario’s Regional Innovation Centre for London and surrounding areas. Focused on supercharging our community, TechAlliance provides advice, experiences, and access to capital to launch startups, accelerate scale-ups and inspire talent.
We create an entrepreneurial culture, launch new startups, and accelerate growth for established tech companies, while attracting the next generation of tech talent and innovative entrepreneurs. We are creating the place for dreamers, innovators, and world-changing ideas.
At Tenomix, our mission is to develop novel technologies that target inefficiencies in the pathology workflow, to optimize cancer care and reduce healthcare costs.
Our dedicated team of engineers, medical doctors, and clinical scientists is currently working on Tenomix’s flagship device, which autonomously searches for lymph nodes in resected cancer tissues and marks their locations for efficient extraction.
This bench-top device replaces the existing tedious and unreliable manual lymph node finding process and greatly improves the speed and reliability of the cancer staging process. This enables clinicians to make better-informed treatment decisions, resulting in fewer patient complications and fatalities and ensures hospitals continuously meet their quality metrics.
The Forge is a business incubator serving innovative startups in the Hamilton Region and McMaster University. Launched in 2015, we work hands-on with entrepreneurs to develop their innovative business ideas, from ideation and validation to growth. The Forge is sector agnostic, offering cohort-based programming to entrepreneurs pursuing scalable, tech-based companies. So far 143 companies have been through The Forge Business Incubator program; together they have raised over $31M and are selling products in 50 countries.
Clients receive expert mentorship, non-dilutive seed funding, investor introductions, office space, workshops, access to a well-equipped makerspace and numerous services to ensure success. We do not take equity in the startups we support.
In addition to the McMaster community, our programs are available to innovative entrepreneurs from the Greater Toronto, Hamilton, and Niagara regions.
The Global Nexus for Pandemics and Biological Threats leverages our collective strength and international networks, building an environment for the world’s top experts across disciplines and sectors to work together.
Our collaborative efforts will ensure the world is better prepared to meet the challenges of future biological threats and will bolster the international recovery from the ongoing COVID-19 pandemic.
Bold discovery efforts, underpinned by interdisciplinary teams, will produce evidence, enhance understanding and deliver solutions across a multitude of areas, such as:
Advancing the development of novel treatments and vaccines
Identifying powerful diagnostics and creating tools to detect and diagnose threats
Developing and testing policy levers and rapidly generating data required for evidence-based policymaking
Using epidemiological models to inform decision-makers and support pandemic plans, protocols and actions
Creating social innovations that allow individuals and systems to withstand and rebound from future threats
This nexus will establish Canada as a leader among leaders within the international pandemic preparedness ecosystem. We will recruit the best and brightest to Canada to deliver on our ambition. The initiative will be based in a purpose-built building designed to foster collaboration among connected experts across scientific, medical, social, economic and political dimensions.
The new environment will provide space and infrastructure for pharma-grade drug screening platforms, ambulatory clinical space and biosafety level 3 facilities.
The Jacobs Institute is a one-of-a-kind medical innovation center located on the Buffalo Niagara Medical Campus in Buffalo, N.Y. All within a single building, the JI is the only place in the world that serves as an independently operated medical nonprofit, ISO 13485:2016 certified medical innovation center.
At the JI, a collaborative partnership of clinicians, researchers, engineers, and entrepreneurs work hand-in-hand to create and develop the next generation of medical devices. These devices will revolutionize the treatment of vascular diseases in Western New York and beyond.
Our facility is uniquely positioned between a state-of-the-art Kaleida Health’s Gates Vascular Institute and a world-class research facility, the University at Buffalo’s Clinical and Translational Research Center. The confluence of these active medical and research facilities, as well as the experts who work there, are the key to the JI’s innovative approach.
The Mayer Institute delivers world-class, evidence based diabetic foot wound care and education. Moving away from the standard sick model (where response is delayed and reactionary) and towards a preventative care model (where outcomes are anticipated and resources leveraged), TMI empowers its patients with customized treatment and highly personalized attention.
Our objective is to come alongside our patients and offer them optimum care. TMI’s evolutionary approach combines leading practices; the latest technology and equipment; experienced and skilled practitioners; and a network of experts and technicians in related medical fields. Above all, our aim is the continued health of our clients.
The Research Institute of St. Joe’s Hamilton is an academic and research community focused on improving the quality of life for our patients and community members, as well as those diagnosed with a diverse range of medical conditions around the world.
We function as a scientific community for the good of our community and the world we share. As faculty members of McMaster University, our world-class researchers work alongside local clinicians and students – fostering a culture of exploration, innovation and inquiry at St. Joseph’s Healthcare Hamilton.
Thrive Group is a non-profit, charitable organization that acts as the umbrella organization for charities with a health care focus by sharing best practices and back office resources. Thrive Group organizations include AbleLiving Services, Capability Support Services, Idlewyld Manor and St. Peter’s Residence at Chedoke.
Thrive Group can help build your organization’s capacity for growth, develop systems to enhance organizational performance and improve employee engagement. Our wide variety of services include: Finance, IT, Human Resources, Organizational Development, Facilities Management and Strategic Leadership, and can be customized to meet your current and future needs. Whether your organization is going through a time of transition, looking for opportunities to grow, or simply needing to add expertise and capacity, Thrive Group is here to help.
Thrive Group provides a spectrum of integrated services to support and care for individuals to live as independently as possible. By bringing together like-minded organizations we will:
Develop and deliver quality services that are responsive and innovative
Enhance collaborative approaches to service provision
Inform government directives and influence health care system transformation
The Thrombosis & Atherosclerosis Research Institute (TaARI) is located in the David Braley Research Institute, which they share with the Population Health Research Institute (PHRI) .
The core research programs at TaARI include:
The Experimental Thrombosis and Atherosclerosis (ETA) Program, which conducts fundamental research on the interplay of thrombosis and inflammation in the context of thrombosis, atherosclerosis, diabetes, cancer, and sepsis.
The Clinical Thromboembolism Program (CTP), which performs optimal prevention, diagnosis and treatment of patients with thrombotic problems, translating current research into clinical practice.
The Comparative Medicine Group, which supports the research of an interdisciplinary group of faculty veterinarians, physicians, and basic scientists who study animal models of human disease. The research is dedicated to the enhancement of human and animal health via research, training and services.
Toronto Innovation Acceleration Partners (TIAP) is a member-driven not-for-profit organization which was created in 2008 (at that time under the name “MaRS Innovation”) by 13 of Toronto’s top universities, institutions and research institutes, plus the MaRS Discovery District as host organization. Our mandate is to bring the members’ most promising research breakthroughs to market. In addition to member support, early funding came from the Federal Government through the Centres of Excellence for Commercialization and Research program.
Our portfolio is built upon a pipeline of health science discoveries from researchers within our member institutions. TIAP works with inventors to explore options to advance their highest potential innovations. This is accomplished through our suite of programs and funding mechanisms.
ToeFX Inc. is a Canadian medical device company that has created a safe, fast solution for the treatment of toenail fungus (onychomycosis). The solution is based on photodisinfection.
ToeFX is a non-invasive and drug-free method backed by proven research. Most topical treatments take months or even a year to show results. Our solution can restore a nail to health in as quickly as 12 weeks.
A Problem That Affects Millions:
10-20% of the population has toenail fungus.
Fungal infection of nails (onychomycosis) is among the most prevalent infectious diseases in humans. Some 60% of seniors have this condition.
The cure rate for topical treatments is only 6-23% after 1 year. Even after 1 year of treatment, topical treatments usually don’t work (Ontario College of Physicians and Surgeons).
Entrepreneurs working to bring their big ideas to life need people with the right experience, resources, and mindset to help them do what they do best—because we’re not meant to do it all alone.
Through our multidisciplinary experience and our passion for people, we invest more than just our capital–we’re invested in the process of bringing your vision to reality. We love seeing the impact.
At TRIO, we see success as a team sport. As a team, we’re structured but flexible in our approach. While we have tried-and-true systems in place, we know that, sometimes, you have to try something different, using instinct to know when to pivot to get the best result. We believe in “risking” and “winning” together—over the long-term.
We can connect you to customers, suppliers, innovators, and industry thought leaders. Bringing our own experience in real estate, finance, law, and more, we have the industry know-how and understanding to direct you to the right processes, the right relationships, and the right capital.
Helping our communities thrive by supporting causes working to effect positive change is one of our most important initiatives. And, when it comes to your ventures, we will work with you to consider the community you’re trying to impact throughout the entire process.
Triumvira Immunologic is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current cancer treatments, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Our proprietary T cell Antigen Coupler (TAC) technology recruits the entire natural T cell receptor and is independent of the major histocompatibility complex (MHC), allowing for the development of better therapies for a broader range of patients with solid or liquid malignancies and also with diseases other than cancer.
Our TAC platform offers competitive advantages over CAR-T and TCR therapies, including:
Co-opting the natural T cell signaling pathways
Design of a safer and more effective T cell therapy
Demonstration of superiority in preclinical models
A strong intellectual property platform including composition of matter applications, and freedom to operate
An expanding pipeline including solid and liquid tumor indications
Spanning the United States and Canada, our headquarters are in Austin, Texas and our research facilities are in Hamilton, Ontario.
TSS Medical is a division of Therapeutic Surface Solutions Inc. and part of a family of medical companies based out of Hamilton, Ontario.
For over 10 years TSS has brought change, innovative products and cost savings to our healthcare system. The TSS Medical division specializes in reconditioned hospital equipment for the Canadian market.
TSS Medical is very particular about the quality of the product that is delivered and backs all products with a 100% satisfaction guarantee.
TSS has all the required Medical Devices Active License Listings (MDAL) and Establishment licenses required by Health Canada and our reconditioned products bring cost savings of 30% – 50% versus new.
Turnstone Biologics is focused on driving innate and adaptive tumor immunity through the development of two independent, yet complementary platforms, built on a foundation of validated clinical success.
Turnstone Biologics is a privately-held clinical stage biotech company with offices and facilities in New York, Ottawa and Hamilton. Turnstone’s proprietary vaccinia virus platform is engineered to drive coordinated immune activation, potent viral activity plus local expression of encoded therapeutics, while the TIL cell therapy platform leverages clinically validated protocols to add industry-leading cell selection strategies. Our development programs drive innate and adaptive tumor immunity to provide benefit to the millions of cancer patients underserved by current treatment options.
TÜV SÜD is a trusted partner of choice for safety, security and sustainability solutions. Over the last 150 years, we have added value to our partners and customers through a comprehensive portfolio of testing, certification, auditing and advisory services. We have enabled progress in society and businesses by staying true to our purpose of protecting people, the environment and assets from technology-related risks.
We add tangible benefits to businesses, enable access to global markets and manage risks by providing testing and product certification, training, knowledge services, inspection as well as auditing and system certification. We offer our solutions across eight key customer segments: Chemical and process, Consumer products and retail, Energy, Healthcare and medical devices, Infrastructure and rail, Manufacturing, Mobility and automotive, and Real estate.
Thrombin generation is an overall blood clotting test, but it is not used clinically because the testing needs to be done in a specialized laboratory.
12 Squared has developed a novel test kit to measure thrombin generation at the point‐of care (POC‐TG). The Test kit consists of i) the recombinant sensor protein that is produced by bacteria, ii) a pre‐alpha device that is purchased from an optics company, and iii) an activator (cheap chemical). The only difference for each indication is software programming. POC‐TG can be useful in number of clinical scenarios. We have been developing four indications:
A) Hemophilia Factor Measurement: The worldwide market for hemophilia products is about $3 billion. POC‐TG testing will result in the more rationale use of replacement clotting factors, resulting in less overall use.
B) Diagnosis of Hemophilia in the Developing World: The World Federation of Hemophilia has a call for proposals to diagnose hemophilia in remote location. POC‐TG can do this.
C) Testing for Direct Oral Anticoagulants (DOACS): DOACs (Xarelto, Eliquis, Pradaxa, Savaysa) are a $20 billion market. POC‐TG can test for the presence of these drugs, but the cut‐offs are different for each drug. Thus POC‐TG testing could be used to market a specific drug as being safe.
D) Guiding bleeding management during complex surgery: POC‐TG will be able to guide in the treatment of patients undergoing complex surgery (bypass‐pumps, liver transplant etc.).
Urtech is an electronics manufacturing company that provides a wide array of services from product prototyping and engineering, to production-scale manufacturing and post production services to both North American companies and global Original Equipment Manufacturers (OEMs).
Urtech partners with our customers to deliver innovative manufacturing solutions aligned with their business objectives. Offer everything from full-service, turnkey product development and manufacturing to on-site engineering support. Urtech manufacturing expertise covers several different areas including: Prototyping, New Product Introduction, Volume Production, Customization and Configuration, Fulfillment and After Market Services.
Urtech is dedicated to providing exceptional manufacturing services to you as a customer by utilizing cutting edge technology, processes, and equipment. A focused engineering team with years of experience in the medical electronics and technology manufacturing. Urtech’s production team is fully trained to IPC specifications and skilled in assembly, test and fulfillment operations. Urtech is capable of 0.2mm pitch placement and ISO 13845 certified
Velocity is an incubator for early-stage, pre-seed tech startups.
We’ve combined startup expertise, tools, business advisory, and product development services in one program (and one amazing place—over 37,000 ft2!) to create a suite of extraordinary resources for exceptional founders.
The Velocity Program is the signature entrepreneurship program at the University of Waterloo and offers:
Velocity, our namesake incubator program for startups
Concept, our pre-incubator program for students
The Velocity Program builds on the University of Waterloo’s competitive assets:
strong academic training & talent output
commercially experienced graduates with co-op work experience
Located in York Region, Canada’s densest technology cluster, ventureLAB has supported over 2,000 entrepreneurs in a region that is home to over 4,300 technology companies and 65,000 tech jobs. ventureLAB’s 50,000 square foot innovation hub is home to over 45 tech companies and innovation partners that employ over 300 people. At ventureLAB, we support tech entrepreneurs through programs focused on capital, talent, technology, and customers, to advance Canada’s economy on a local, national and global scale.
ventureLAB is a non-profit regional innovation centre that has been cultivating, supporting, and celebrating entrepreneurs in York Region, Simcoe County, and Muskoka District since 2011. ventureLAB is also a member of the Ontario Network of Entrepreneurs (ONE).
VoxNeuro provides the world’s first objective brain health assessment that goes beyond a diagnosis. We deliver quantitative insights on brain function to assess performance, inform treatment and track brain health with unprecedented precision.
The Science: Highly specific & validated brain tests meet the precision and objectivity of EEG-based neuroimaging, processed and summarized into a user-friendly report.
VoxNeuro provides objective measurement of human brain function, unlocking the full potential of brain performance, recovery, and understanding.
Powered by the world’s largest and richest database on individual human brain function, VoxNeuro will usher in a new global gold standard of measuring, assessing and tracking brain function.
Semi-custom web, mobile & IoT solutions to optimize your business
Webility Solutions is a web development company dedicated to building high quality custom web and mobile applications. Since 2007, our team of experienced software developers have designed applications to improve operations, mitigate risk and cut unnecessary costs. Today, over 300 customers in more than 12 countries use Webility’s custom-made software and support to transform the way they operate in a range of industries, with particular expertise in healthcare.
Based in Hamilton, Ontario, we’re family doctors, nurse practitioners, registered nurses, and other health care professionals — each one passionate about delivering primary care and working with and for our patients. RAMcare (Rapid Access Medical Care) leverages emerging technology to deliver timely health care to Canadians that meets, and often exceeds, traditional standards of care.
Doctor’s care today includes a patient-focused team of medical professionals. RAMcare consolidates that care for patients, allowing for virtual care that meets or exceeds the standard of care in traditional clinics.
RAMcare creates bridges between marginalized and vulnerable individuals and accessible comprehensive medical care. RAMcare has created a social initiative called the Virtual House Call Program. Patients who may benefit from this program are already connected to the Local Health Integration Network (LHIN) services.
Weever is a highly flexible platform that you can use to digitize pretty much any continuous improvement workflow. Here are some of the more common use cases.
Incident Reports: Automate the incident report workflow so that you are aware of what is happening and staff have the tools they need to be compliant, effective and productive.
Safety Observations: Foster a culture of safety by requiring staff to periodically assess the safety of other staff. Review observation reports and take corrective actions.
Safety Audits and Inspections: Ensure inspection and audit schedules are completed on-time and by appropriate staff to ensure compliance.
Abnormality Reports: Collect valuable data on product defects to inform preventive actions and KPIs. Learn more CAPA Ensure your corrective and preventive actions are thorough, efficient and follow your business rules.
LShift Reports: Don’t skip a beat between shifts by providing a seamless stream of insights.
Suggestions: Fuel continuous improvement through rich suggestions from front-line staff.
Document Management: Regulatory compliant document management solution with comprehensive audit trail and eSignature approvals.
WLMH has been providing exceptional care and service to over 65,000 residents of West Niagara since 1946. WLMH officially became a site of Hamilton Health Sciences in 2013 through amalgamation. As a site of Hamilton Health Sciences, WLMH also serves as a point of access to one of the largest health systems in Canada for patients requiring more specialized care.
On average each year, staff and physicians at WLMH care for more than: 25,000 individuals who visit the Emergency Department, 2,900 patients who are admitted to the hospital, and 1,000 babies and moms. In addition, WLMH performs over 3,700 surgeries, of which 80 per cent are on an outpatient basis. WLMH is unique in its focus on integrating primary care. Local and family physicians comprise the medical staff working in the Emergency Department, operating rooms and throughout all areas of the hospital.
In partnership with McMaster University’s Michael G. DeGroote School of Medicine located at Brock University, WLMH is also a teaching site for medical students in Niagara.
Westinghouse HQ offers one-of-a-kind office space in a historic Hamilton landmark.
Westinghouse HQ offers over 40,000 square feet of space for unique of Class-A retail and office opportunities. Westinghouse has been synonymous with industrial and corporate excellence in Hamilton, be part of the tradition by selecting Westinghouse HQ for your business.
Yordas is a leading international provider of scientific and technical services, regulatory advice, sustainability services and training to industry in the fields of chemicals management and risk assessment. Originally founded to provide commercial services relating to the EU REACH regulation, we now provide registration and notification services, as well as global regulatory compliance and chemicals management support for hundreds of clients in markets around the globe. We are headquartered in the UK, with offices in North America (Hamilton, Ontario) and Europe and representation in Asia Pacific, Eurasia and South America.
Yordas delivers innovative solutions for business, industry and government across a broad range of industries. Our strapline, ‘Business through Science’, reflects our drive to underpin our work with exceptional technical and scientific expertise. We offer a broad range of services that have developed from our roots in chemicals regulatory management and product stewardship. From hazard communications, scientific analysis and Green Chemistry to software development, risk/hazard assessments and quality management systems – we can help you to work towards a better, safer world for all.
Yordas is rooted in client care that is holistic and collaborative. We build client relationships on mutual trust, respect and effective communication. We try to think with you, to be not just responsive, but to anticipate and help you to become future-proof. We want to get to know you and your business so that we can work with you efficiently and tailored to your needs. Yordas offers clients work that is cost-effective, solution-focused and fit-for-purpose.
YSpace is York University’s newest community innovation hub located at the heart of Downtown Markham. We help build great companies by connecting them with high-end equipment, access to capital and a network of influencers and entrepreneurs. We are creating a vibrant physical hub that encourages creativity and bridges the gap between large enterprises and startups within the York Region ecosystem.
YSpace is managed by Innovation York. Innovation York is the innovation office for the University with a mandate to facilitate and maximize the commercial, economic, and social impacts of research and innovation, and to create a culture of engaged scholarship and experiential learning.
Zentrela’s neurotechnology platform is the first scientifically proven test to objectively quantify cannabis psychoactive effects.
Zentrela was founded in 2016 by Israel Gasperin when he combined his fascination with brainwave analysis and his business observation that every facet of the exploding cannabis sector was going to need access to objective product effect data.
Israel was joined by Dr. Dan Bosnyak, a neuroscientist teaching at McMaster University, and together they established the foundations of Zentrela, a neurotechnology pioneer using AI to analyze EEG data in pursuit of the world’s largest database of cannabis psychoactive effects.
Healthcare design agency leveraging design thinking, agility & AI to create solutions that improves patient outcomes
Through years of iteration and customer-focused service, we at ZL Technovation have handcrafted an approach to our medical projects. We apply agile processes to understand the root of your biggest challenges, and then ideate and rigorously test and prototype concept.
Our goal is to create innovative solutions that address your toughest problems.